Home Blog Page 4

Nervous System Management With Non-Pharmacological Strategies

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Explore non-pharmacological strategies to support nervous system health and wellness without medications to the body.

Abstract

In this educational post, I present a comprehensive, practical framework for understanding and managing panic attacks that arise during sauna sessions or high-intensity cardio, and I explain why these reactions occur from a neurophysiological standpoint. I discuss the role of the amygdala, vagus nerve, carbon dioxide tolerance, cardiorespiratory coupling, and autonomic dysregulation. I outline a stepwise plan that integrates breathwork (including the physiological sigh), nasal-only breathing during cardio, and graded exposure principles. I examine how magnesium glycinate, L-theanine, taurine, and select neuropeptides may modulate autonomic responses, while also reviewing the GI-brain axis and inflammatory signaling that influence panic thresholds.

I also describe our multidisciplinary model at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, where I collaborate with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), who serves as our Medical Director and Collaborative Physician. Together, we integrate chiropractic care, internal medicine oversight, functional medicine, personal injury care, rehabilitation, and targeted lifestyle interventions to address both the triggers and the roots of autonomic imbalance. Throughout, I highlight how integrative chiropractic care supports neuromusculoskeletal resilience, autonomic regulation, and improved exercise tolerance, and I present evidence-based methods from leading researchers to support each step.

This post is designed to be easy to read, first-person, and journey-oriented, guiding you from physiological understanding to actionable protocols that you can implement with medical guidance. The material is informed by my clinical observations and case insights from my practice and educational platforms, including resources available at Sciatica. clinic and my professional updates on LinkedIn.

Understanding Panic During Sauna and Cardio: Why Your Brain Sounds the Alarm

When a patient tells me they used to enjoy sauna therapy and vigorous workouts but now panic during heat exposure or high-intensity cardio, my first message is simple and compassionate: you are not broken. What you are experiencing is a nervous system stuck on red alert. Your heart rate rises, your respiration shifts, your skin warms, and your amygdala—the brain’s alarm center—mislabels those signals as danger. It’s a false alarm, but the brain’s threat circuitry has become hardwired to interpret normal arousal as risk.

  • The core issue: the amygdala reads bodily arousal—heat, heart rate, breath—as threat rather than a fitness stimulus.
  • The result: panic surges during sauna or intense cardio.
  • The opportunity: we can retrain the circuitry using mechanical tools (breathwork), metabolic supports (nutrients and peptides under medical supervision), and graded exposure (structured, progressive practice) to re-label arousal as safe.

This is where modern integrative care excels. In our clinic, I coordinate with Dr. Maria Guadalupe Cardenas, MD, our Medical Director and Collaborative Physician, to clinically assess the autonomic system, cardiorespiratory function, and metabolic drivers of anxiety. I’m combining chiropractic neuro-musculoskeletal regulation with functional medicine principles and medical oversight to deliver a comprehensive approach that works with your brain-body systems.

Meet Our Multidisciplinary Team: Integrative Chiropractic Care with Internal Medicine Oversight

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, I, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, partner with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933). Dr. Cardenas has over 40 years of experience as an internist and provides medical direction and collaborative physician leadership in our integrative model. This multidisciplinary setup is common in injury and functional clinics, where a medical doctor works alongside a chiropractor to ensure safety, evidence-based protocols, and continuity of care.

  • Dr. Cardenas (Internal Medicine):
    • Oversees medical safety, diagnostics, and pharmacologic considerations.
    • Evaluates cardiovascular, endocrine, and inflammatory contributors to panic.
    • Guides decisions around peptide use, nutrient dosing, and contraindications.
  • Dr. Jimenez (Chiropractic and Functional Medicine):
    • Provides integrative chiropractic care emphasizing neuro-musculoskeletal alignment, autonomic regulation, and movement pattern optimization.
    • Coordinates breathwork protocols, exercise pacing, and rehabilitation phases.
    • Integrates functional medicine assessments for gut-brain axis, micronutrients, and stress physiology.
  • The team:
    • Synchronizes treatment plans across personal injury care, rehabilitation, lifestyle medicine, and neurobehavioral retraining.
    • Uses evidence-based, modern research methods to monitor progress and refine interventions.

This collaboration ensures a patient’s panic-related exercise intolerance is approached safely and comprehensively.

The Physiology of Panic: From Amygdala Alarm to Autonomic Imbalance

To change your response to sauna heat or cardio, we must understand the physiology:

  • The amygdala’s role:
    • The amygdala surveys interoceptive signals (heart rate, temperature, breathing effort) for threat.
    • In sensitized states, the amygdala fires alarms to avoid perceived danger, producing panic and sympathetic surges (LeDoux & Pine, 2016).
  • Autonomic nervous system (ANS):
    • Sympathetic arousal increases heart rate, dilates pupils, and mobilizes energy for action.
    • Parasympathetic activity (vagus nerve) restores calm, lowers heart rate, and stabilizes breathing (Thayer & Lane, 2000).
    • Panic represents an imbalance: sympathetic dominance with reduced vagal brake (Park & Thayer, 2014).
  • Interoception and prediction:
    • The brain predicts whether arousal is “exercise” or “danger.”
    • Mislabeling occurs when prior experiences of distress tether arousal to threat, creating a conditioned fear of bodily signals (Paulus & Stein, 2006).
  • CO2 tolerance:
    • Hyperventilation lowers CO2 and can trigger panic through chemosensory pathways; mouth breathing during exertion often exacerbates this by promoting shallow, fast breaths (Nardi et al., 2009).
  • Heat stress:
    • Sauna increases core temperature and heart rate; a sensitized nervous system may interpret these as precursors to danger.
    • The key: graded exposure teaches the brain that heat-induced arousal is normal and safe when properly paced (Havenith et al., 2011).

Understanding this biology empowers you to use mechanical and behavioral tools to reset the threat circuitry.

Breathwork as a Mechanical Reset: The Physiological Sigh

You cannot outthink a panic attack; you must engage it mechanically. One powerful tool is the physiological sigh. This involves two sharp inhales through the nose followed by a long, slow exhale through the mouth. The double inhale helps reinflate alveoli, improve oxygenation, and increase CO2 tolerance; the prolonged exhale recruits the vagus nerve to downshift autonomic arousal (Huberman et al., 2021).

  • How to perform:
    • Two quick nasal inhales (the second slightly shorter).
    • One long, slow oral exhale.
  • Why it works:
    • The breath pattern optimizes gas exchange and stimulates parasympathetic tone.
    • The prolonged exhale enhances vagal influence on heart rate variability (HRV).
  • When to use:
    • Five cycles before sauna exposure.
    • Five cycles during the sauna if anxiety starts to rise.
    • Five cycles immediately after the sauna during cool-down.
    • Use as needed before cardio and during recovery periods.

This breathwork is an autonomic lever—fast, practical, and highly effective for many patients in our clinic.

Nasal-Only Breathing in Cardio: Building CO2 Tolerance and Calm

Mouth breathing during intense exercise often induces over-breathing, lowering CO2 and heightening panic susceptibility. Nasal breathing drives diaphragmatic mechanics, filters and humidifies air, and supports CO2 retention within a healthy range to prevent panic triggers (Courtney, 2009).

  • Protocol:
    • Engage in zone 2 cardio using nasal-only breathing for 2–3 weeks.
    • Avoid max effort sessions during retraining.
    • Focus on rhythm: steady nasal inhalation, relaxed exhalation, and a conversational pace.
  • Benefits:
    • Improves CO2 tolerance and reduces chemoreflex-driven anxiety.
    • Supports autonomic balance (better HRV).
    • Develops cardiorespiratory efficiency and lowers perceived stress.

I consistently observe improved exercise tolerance and decreased panic frequency when patients commit to nasal-only breathing during the early retraining phase.

Nutrient Anchors for Panic Modulation: Magnesium Glycinate, L-Theanine, and Taurine

Under medical guidance, certain nutrients can anchor the nervous system before panic-provoking activities:

  • Magnesium glycinate (approx. 400 mg):
    • Supports GABAergic tone and modulates NMDA receptor activity.
    • Helps stabilize cardiac rhythm and reduce neuromuscular hyperexcitability (Boyle et al., 2017).
  • L-theanine (approx. 200 mg):
    • Promotes alpha-wave activity and increases GABA, serotonin, and dopamine modulation without sedation (Williams et al., 2020).
  • Taurine (approx. 2 g):
    • Influences GABA and glycine receptors, stabilizes cardiac electrophysiology, and blunts adrenaline spikes (Schaffer et al., 2014).
  • Timing:
    • Take all three approximately 30 minutes before any activity that previously provoked panic (e.g., sauna or cardio), provided your physician agrees and no contraindications exist.

These nutrients, paired with breathwork and graded exposure, create a biochemical and behavioral platform for resilience. We screen for interactions, contraindications, and individualized dosing under Dr. Cardenas’s medical oversight.

Peptide Considerations and Medical Oversight: Select, BPC-157, and KPV

In carefully selected cases, and only with medical supervision, we may discuss peptides that modulate anxiety, gut-brain signaling, and inflammation thresholds. The goal is to support long-term resilience while ensuring safety.

  • Select (a GABAergic peptide; 500 mcg no later than 4:00 PM):
    • Intended to quiet anxiety without sedation and promote durable resilience.
    • Used as a tool to recalibrate anxiety circuitry during the retraining phase.
    • We avoid morning dosing to prevent daytime sluggishness and align with circadian modulation of arousal.
  • BPC-157 (500 mcg twice daily):
    • Supports GI mucosal integrity and angiogenesis, and may influence vagal signaling by improving gut barrier function.
    • We consider this when the gut-brain axis shows signs of distress (e.g., IBS-like symptoms, post-infectious GI issues).
  • KPV (1 mg daily):
    • A melanocortin-derived tripeptide associated with anti-inflammatory effects.
    • Considered when systemic inflammation appears to lower the nervous system’s panic threshold.

These discussions are always under Dr. Cardenas’s medical leadership. We evaluate cardiovascular status, psychiatric history, medication interactions, regulatory guidance, and ethical use. Evidence for peptides varies; we weigh mechanistic plausibility with emerging data and clinical outcomes to ensure patient safety and informed consent.

The Gut-Brain Axis: Why GI Signaling Can Trigger Amygdala Alarms

Patients are often surprised that gut distress can telegraph directly to the amygdala and shape anxiety responses. The gut houses extensive neural networks and communicates through vagal pathways, immune mediators, and endocrine signals. Dysbiosis, barrier dysfunction, and inflammation can elevate interoceptive “noise,” making the brain more likely to misinterpret arousal as threat (Mayer et al., 2015; Cryan et al., 2019).

  • Mechanisms:
    • Altered microbiota composition affects neurotransmitter precursors and inflammatory cytokines.
    • Leaky gut increases LPS and immune activation, lowering thresholds for autonomic instability.
    • Vagal afferents carry GI distress signals to brain regions including the amygdala and insula.
  • Clinical approach:
    • Assess GI symptoms, nutrition, stress load, and sleep.
    • Use targeted dietary protocols, probiotics/prebiotics (when appropriate), and barrier-supportive strategies.
    • Consider peptides like BPC-157 under medical supervision when barrier repair is prioritized.

We regularly find that stabilizing the gut environment reduces panic frequency and intensity during exercise and heat exposure.

Inflammation and Panic Threshold: Lowering the System’s Sensitivity

Systemic inflammation sensitizes neural circuits and the cardiorespiratory system, lowering the threshold at which normal arousal triggers panic. High-sensitivity CRP, cytokine patterns, and clinical signs of low-grade inflammation often correlate with anxiety and somatic hypervigilance (Dantzer et al., 2008).

  • Intervention targets:
    • Anti-inflammatory nutrition (e.g., omega-3s, polyphenols, balanced glycemic load).
    • Sleep optimization and circadian alignment.
    • Graded physical activity without exceeding panic thresholds.
    • Consideration of anti-inflammatory peptides (e.g., KPV) under medical oversight.
  • Chiropractic integration:
    • Reducing musculoskeletal strain and nociceptive input can decrease sympathetic tone.
    • Spinal and rib mechanics influence breathing efficiency and interoceptive clarity.
    • Pain reduction reduces the background “alarm” that can fuel panic.

By decreasing inflammatory signaling, the brain can more accurately label arousal as safe, supporting the retraining process.

Graded Exposure: Teaching the Brain That Arousal Is Not Danger

You do not go from zero to one hundred. We implement structured progression:

  • Sauna progression:
    • Start with 10 minutes.
    • Exit before panic arises; perform physiological sigh cycles.
    • Extend by small increments over weeks while maintaining calm breathing and focus.
  • Cardio progression:
    • Begin with zone 2 nasal-only breathing for 2–3 weeks.
    • Avoid max effort until panic episodes diminish and CO2 tolerance improves.
    • Use heart rate and perceived exertion to keep intensity within a calm range.
  • Rationale:
    • Graded exposure rewires amygdala circuits by pairing arousal cues with safety experiences.
    • Each calm session writes a new prediction: “heat and heart rate equal training, not danger.”

Patients often regain confidence rapidly when they follow this plan closely.

Beyond Adjustments: Chiropractic and Integrative Healthcare- Video

Beyond Adjustments: Chiropractic and Integrative Healthcare | El Paso, Tx (2024)

Integrative Chiropractic Care: Autonomic Regulation Through Musculoskeletal Alignment

From a chiropractic perspective, autonomic regulation is deeply connected to rib mechanics, diaphragm function, thoracic mobility, and cervical alignment. When rib motion is restricted, or the diaphragm is inhibited, breathing becomes shallow and erratic, increasing sympathetic tone and panic susceptibility. Correcting these mechanical constraints can be transformative.

  • Techniques:
    • Thoracic and rib mobilization to improve chest wall compliance.
    • Diaphragm release and motor control training for efficient respiration.
    • Cervical spine alignment to reduce nociception and sympathetic drive.
    • Soft tissue work to normalize respiratory accessory muscles (SCM, scalenes, intercostals).
  • Outcomes:
    • Smoother breathing mechanics support nasal-only cardio.
    • Reduced musculoskeletal pain lowers baseline arousal.
    • Improved interoception helps the brain assess exertion accurately.

I consistently observe that integrating breath-focused chiropractic sessions with sauna/cardio retraining accelerates recovery from panic-linked exercise intolerance.

Functional Medicine Integration: Nutrients, Sleep, Stress, and Rhythms

Functional medicine provides the lifestyle scaffolding that makes retraining stick.

  • Nutrition:
    • Magnesium-rich foods, balanced amino acids, anti-inflammatory fats, and stable glycemic control.
    • Hydration and electrolytes tailored to heat exposure and exercise demands.
  • Sleep and circadian rhythm:
    • Consistent sleep-wake cycles enhance autonomic stability and reduce the likelihood of anxiety (Walker, 2017).
    • Avoid late caffeine; align meal timing with training sessions.
  • Stress modulation:
    • Mindfulness, non-sleep deep rest (NSDR), and paced breathing augment vagal tone.
    • Social connection and structured recovery days support resilience.

In my practice, these pillars make the difference between short-term symptom relief and long-term rewiring.

Personal Injury Care and Rehabilitation: Managing Pain, Fear, and Return to Activity

In personal injury contexts, pain plus fear often coalesce into panic during exertion. Our rehabilitation team designs plans that gradually restore movement confidence:

  • Assessment:
    • Identify pain generators, instability, and avoidance patterns.
    • Screen for dizziness, dysautonomia, and hyperventilation tendencies.
  • Plan:
    • Low-threat movements with clear breathing cues.
    • Incremental loading, tracking heart rate and subjective anxiety.
    • Integration of chiropractic adjustments and soft tissue therapies to reduce nociceptive drive.

The goal is a safe, paced return to sauna and cardio, with reduced pain and disarmed panic.

Clinical Observations from My Practice

From sciatica-focused work to integrative anxiety care, I’ve seen how autonomic retraining transforms lives. On sciatica. clinic and my professional updates on LinkedIn, I discuss how breath-led movement, thoracic mechanics, and nervous system retraining improve not only pain but also tolerance for heat and exertion. Patients who initially panic in saunas or during sprints often regain enjoyment of these activities when we anchor their physiology with breathwork, nutrients, and graded exposure, all under proper medical oversight.

  • Common patterns:
    • Mouth breathing and poor rib mobility drive panic.
    • Inflammation and GI distress lower thresholds.
    • Sleep inconsistency magnifies sensitivity.
  • Common solutions:
    • Nasal breathing, physiological sigh, magnesium/theanine/taurine anchors.
    • GI support and anti-inflammatory strategies.
    • Autonomic-friendly chiropractic care.

These patterns are consistent and addressable.

Safety, Medical Screening, and Individualization

Every plan is individualized. With Dr. Cardenas’s internal medicine expertise, we screen for:

  • Cardiovascular disease, arrhythmias, and heat intolerance.
  • Endocrine issues (thyroid, adrenal) that affect autonomic balance.
  • Psychiatric comorbidities and medication interactions.
  • Contraindications for sauna, high-intensity cardio, nutrients, and peptides.

Individualization is the trademark of good care. We harmonize chiropractic interventions with medical oversight and functional strategies to keep patients safe and progressing.

Putting It All Together: The Stepwise Plan

Here is the concise blueprint we use, organized for clarity:

  • Before sauna or cardio:
    • Perform five cycles of the physiological sigh.
    • If medically appropriate: magnesium glycinate ~400 mg, L-theanine ~200 mg, taurine ~2 g about 30 minutes prior.
  • During sauna:
    • Start at 10 minutes; exit before panic.
    • Use physiological sigh if anxiety rises; cool down slowly.
  • Cardio retraining:
    • Zone 2 intensity; nasal-only breathing for 2–3 weeks.
    • Avoid max effort; build CO2 tolerance gradually.
  • Daily supports:
    • Sleep consistency; anti-inflammatory nutrition; hydration.
    • If medically approved: Select (500 mcg no later than 4:00 PM), BPC-157 (500 mcg twice daily), KPV (1 mg daily).
  • Chiropractic and rehab:
    • Thoracic mobility, diaphragm training, rib mechanics.
    • Soft tissue normalization; progressive movement confidence.
  • Functional medicine:
    • Gut-brain axis assessment; barrier support; microbiome care.
    • Stress management practices and non-sleep deep rest.

This plan has helped many patients re-enter sauna and vigorous exercise without panic, restoring health, confidence, and joy.

Evidence Base and Research Foundations

We draw from a broad literature:

  • Amygdala and anxiety circuitry: LeDoux & Pine (2016).
  • Autonomic balance and HRV: Thayer & Lane (2000); Park & Thayer (2014).
  • Interoceptive predictions and panic: Paulus & Stein (2006).
  • CO2, hyperventilation, and panic: Nardi et al. (2009); Courtney (2009).
  • Heat stress physiology: Havenith et al. (2011).
  • Breath and autonomic modulation: Huberman et al. (2021).
  • Nutrients: Boyle et al. (2017); Williams et al. (2020); Schaffer et al. (2014).
  • Gut-brain axis: Mayer et al. (2015); Cryan et al. (2019).
  • Inflammation and mood/anxiety: Dantzer et al. (2008).
  • Sleep and emotion regulation: Walker (2017).

We implement modern, evidence-based research methods and continually update protocols in response to emerging findings and clinical outcomes.

Closing Perspective

If panic has taken away your sauna time or your high-intensity cardio, there is a path back. With mechanical breath tools, paced progression, target nutrients, and integrative chiropractic care under internal medicine oversight, we can re-label arousal as safety and restore your capacity for vigorous, enjoyable activity. In our El Paso clinic, I work closely with Dr. Maria Guadalupe Cardenas, MD, to ensure that every step is medically sound and tailored to you.

Your nervous system can learn calm again. With structure, support, and practice, we can guide it there.

References

SEO tags: panic attacks, sauna anxiety, high-intensity cardio panic, physiological sigh, nasal breathing, CO2 tolerance, vagus nerve, autonomic nervous system, amygdala, chiropractic care, integrative medicine, internal medicine oversight, peptides, BPC-157, KPV, magnesium glycinate, L-theanine, taurine, gut-brain axis, inflammation, graded exposure, zone 2 cardio, heart rate variability, El Paso clinic, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr. Alexander Jimenez, Dr. Maria Guadalupe Cardenas, personal injury care, rehabilitation, functional medicine, sciatica clinic, evidence-based protocols

Integrative Personal Injury Recovery Model and You

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Integrative Personal Injury Recovery Model and You
Integrative Personal Injury Recovery Model and You

Breaking the “Wait-and-See” Cycle After an Accident: An Integrative Personal Injury Recovery Model

Abstract

After a car accident, many people leave the emergency room with reassuring imaging, instructions to rest, and medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) or muscle relaxants. These treatments may be appropriate for short-term symptom control, but emergency care is mainly designed to identify serious injuries and stabilize the patient. It is not always designed to provide months of musculoskeletal rehabilitation.

If patients continue to have neck pain, back pain, headaches, muscle spasms, numbness, weakness, or limited movement, they may need a more complete evaluation. An integrative personal injury model combines chiropractic care, medical assessment, functional rehabilitation, diagnostic testing, and careful documentation. At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, works within this multidisciplinary framework with internal medicine physician Dr. Maria Guadalupe Cardenas, MD.

The goal is to move the patient from acute symptom control toward restored movement, measurable function, rehabilitation, and, when possible, maximum medical improvement.

Integrative Personal Injury Recovery Model and You

Why “Wait and See” May Not Be Enough After an Accident

Emergency departments play a critical role after serious accidents. Their first job is to rule out problems such as fractures, internal bleeding, brain injury, spinal instability, or other medical emergencies.

Once the medical team has ruled out immediate danger, they may discharge the patient with medications, rest instructions, and follow-up recommendations.

That does not mean the person has no injury.

Muscles, ligaments, tendons, spinal joints, discs, and nerves can be injured even when there is no fracture. Some accident-related symptoms can also become more noticeable hours or days after the collision.

This is where the “wait-and-see” problem can begin.

A patient may take an NSAID or muscle relaxant, feel somewhat better, and assume that recovery is complete. These medicines can be useful when properly prescribed, but symptom reduction does not automatically mean that normal joint motion, strength, coordination, or soft-tissue function has returned.

Delayed evaluation can also create problems with medical documentation. Personal injury resources consistently note that long gaps between the accident and treatment can make it harder to establish a clear timeline showing when symptoms began and how the condition changed (Farahi Law Firm, 2025; Integrated Health & Injury Center, n.d.).

The better question is not simply:

“Does it still hurt?”

It is:

“Has the injured area returned to normal function?”

A Rapid Multimodal Personal Injury Examination

A more complete post-accident evaluation looks beyond a single pain score.

Dr. Jimenez describes an integrative examination as looking at several parts of the injury at the same time, including:

  • Range of motion
  • Spinal and extremity joint movement
  • Muscle guarding and spasm
  • Soft-tissue tenderness
  • Neurological findings
  • Strength
  • Balance
  • Posture
  • Numbness or tingling
  • Functional movement
  • Ability to sit, stand, walk, lift, drive, sleep, or work
  • Need for imaging or specialist referral

In his published clinical observations, Dr. Jimenez notes that accident injuries often involve several connected problems rather than one isolated painful structure. Joint restriction, muscle guarding, nerve irritation, inflammation, altered movement, stress, and poor sleep may occur together (Jimenez, 2026a).

These clinical observations should not be confused with controlled research studies. However, they help explain the reasoning behind a multimodal examination: treatment should be based on what is actually limiting the patient rather than simply treating the location where pain is felt.

Where Integrative Chiropractic Care Fits

Chiropractic care can provide an important mechanical part of the recovery plan.

Following trauma, the neck, lower back, pelvis, shoulders, and other joints may not move normally. Muscles may tighten to protect the injured area. Patients may also change the way they walk, sit, turn, or bend because movement hurts.

Integrative chiropractic care may include:

  • Chiropractic adjustments or joint mobilization
  • Soft-tissue treatment
  • Flexibility work
  • Corrective exercise
  • Neuromuscular retraining
  • Spinal decompression or traction when appropriate
  • Postural retraining
  • Progressive strengthening
  • Functional rehabilitation

Research supports active rehabilitation as an important part of whiplash recovery. A 2024 systematic review found that guided neck-specific exercise produced greater improvements in neck pain and disability than comparison programs, particularly when treatment continued for more than six weeks (Muñoz Lazcano et al., 2024).

A 2025 randomized clinical trial also reported that appropriately selected cervical manipulation produced outcomes comparable in several areas to a conventional rehabilitation program in patients with acute grade II whiplash (Parera-Turull et al., 2025).

The key is appropriate patient selection. Chiropractic treatment should follow examination and screening for fractures, instability, neurological emergencies, vascular concerns, or other red flags.

The Advantage of Dr. Jimenez’s DC and FNP-BC Background

Dr. Alexander Jimenez practices with credentials that include Doctor of Chiropractic and board-certified Family Nurse Practitioner qualifications.

Clinic information lists his NPI as 1205907805 and identifies active chiropractor and family nurse practitioner taxonomies.

This dual background allows an injury to be considered through two related viewpoints.

The chiropractic viewpoint asks:

  • How are the joints moving?
  • Is spinal motion restricted?
  • Are muscles guarding?
  • Is posture altered?
  • Is nerve irritation affecting function?
  • What movements need to be restored?

The advanced-practice medical viewpoint can consider:

  • General medical status
  • Medication use
  • Neurological symptoms
  • Metabolic conditions
  • Need for laboratory testing
  • Imaging
  • Medical referrals
  • Contraindications
  • Broader health problems that may affect recovery

Nurse practitioners also commonly perform physical examinations, develop treatment plans, coordinate care, order appropriate diagnostic testing within their scope, and refer patients to other medical specialists when needed (Jimenez, 2025).

Instead of one office managing musculoskeletal mechanics and another managing medical concerns, an integrated model can make communication easier.

Medical Direction From Dr. Maria Guadalupe Cardenas

Dr. Jimenez also works with Dr. Maria Guadalupe Cardenas, MD, at Injury Medical Clinic PA in El Paso.

Clinic materials identify Dr. Cardenas as a board-certified internal medicine physician with more than 40 years of medical experience who serves as medical director and collaborative physician. Her NPI number is 1164426749, and her Texas medical license number is J2933.

Within the clinic model, Dr. Cardenas provides internal medicine oversight alongside Dr. Jimenez’s chiropractic, rehabilitation, functional medicine, and injury-care work.

This multidisciplinary structure can help when a patient also has:

  • Diabetes
  • Hypertension
  • Cardiovascular concerns
  • Medication interactions
  • Chronic medical illnesses
  • Inflammatory disorders
  • Age-related risks
  • Abnormal laboratory findings
  • Symptoms requiring additional medical investigation

The goal is not for one discipline to replace another. Each professional should work within the appropriate scope while sharing information.

Looking Beyond Pain: Functional Impairment Mapping

One of the most valuable parts of personal injury treatment is measuring function.

Pain is important, but pain scores alone do not tell the whole story.

A patient may report that pain fell from an 8/10 to a 4/10 but still be unable to:

  • Turn the head safely while driving
  • Sit through a workday
  • Lift normal household objects
  • Sleep through the night
  • Bend forward
  • Walk normally
  • Exercise
  • Carry a child
  • Return to work

These limitations matter clinically.

They also create measurable treatment goals.

Thorough personal injury documentation commonly includes the initial examination, imaging when necessary, diagnosis, treatment plan, progress notes, objective measurements, and descriptions of how injuries affect work and everyday activities (Integrated Health & Injury Center, n.d.; Jimenez, 2026b).

Why SOAP Notes Matter After an Accident

Detailed SOAP notes can help organize the patient’s progress.

S — Subjective

What is the patient reporting?

Pain, headaches, stiffness, numbness, sleep problems, driving difficulty, work limitations, or other symptoms.

O — Objective

What can be measured?

Range of motion, orthopedic tests, neurological findings, strength, tenderness, posture, gait, imaging findings, and functional testing.

A — Assessment

What does the clinician believe is happening?

This includes diagnoses, clinical changes, response to care, new findings, and barriers to recovery.

P — Plan

What happens next?

Treatment, rehabilitation, imaging, referrals, exercise progression, additional testing, and changes in care may be needed.

Over time, these records create a medical timeline showing how the patient moved from the original injury toward recovery.

Thorough documentation should never exaggerate an injury simply because a legal claim exists. Treatment should be based on examination findings, diagnosis, medical necessity, patient response, and measurable progress (Jimenez, 2026a).

A Three-Phase Personal Injury Recovery Framework

A simple phase system can make complicated treatment easier to understand.

These time periods are guidelines, not guarantees. A mild strain and a major disc or neurological injury will not recover at the same speed.

Phase 1: Days 1–14 — Acute Pain and Protection

The early goals are to:

  • Identify serious injuries
  • Establish a baseline examination
  • Control pain and muscle guarding
  • Protect injured tissues
  • Maintain safe movement
  • Document functional losses
  • Decide whether imaging is needed
  • Begin gentle rehabilitation when appropriate

Treatment intensity depends on the diagnosis.

The goal is not aggressive treatment. It is safe evaluation, symptom control, and preservation of function.

Phase 2: Weeks 3–8 — Stabilization and Tissue Recovery

Once acute symptoms begin to settle, treatment can shift toward rebuilding function.

This stage may include:

  • Chiropractic mechanical care
  • Progressive mobility
  • Strengthening
  • Stability exercises
  • Soft-tissue rehabilitation
  • Laser or photobiomodulation therapy when appropriate
  • Functional medicine support
  • Nutrition and recovery strategies

Laser therapy has been studied for musculoskeletal neck pain. Reviews suggest that photobiomodulation and high-intensity laser treatment may reduce pain or disability in selected patients, although results depend on diagnosis, dosage, and treatment protocol (Cidral-Filho et al., 2024; de la Barra Ortiz et al., 2024).

What About Regenerative Therapies?

Selected patients may also be evaluated for therapies such as platelet-rich plasma or other orthobiologic procedures.

These treatments are not automatically appropriate for every accident injury. Their evidence varies greatly depending on the joint, tendon, ligament, diagnosis, severity, and technique used.

Consider them only after proper diagnosis and medical evaluation.

Peptide Therapy Requires Extra Caution

Peptides are sometimes promoted as “tissue-rebuilding” treatments.

This area needs careful medical language.

Some peptide products being marketed for musculoskeletal recovery remain experimental and do not have established FDA approval for treating accident-related soft-tissue injuries.

For example, the FDA currently identifies substances such as BPC-157 and CJC-1295 as having limited human safety information and potential safety concerns. The agency has also raised safety concerns about compounded injectable ipamorelin.

Therefore, peptide use should not be described as proven tissue regeneration.

When considered at all, it requires appropriate medical supervision, informed consent, careful sourcing, regulatory review, and discussion of the limits of current evidence.

Phase 3: Week 8 and Beyond — Functional Rehabilitation

Later-stage recovery focuses less on passive pain relief and more on performance.

Patients may work toward:

  • Full or improved range of motion
  • Better strength
  • Improved spinal stability
  • Normal walking patterns
  • Safer lifting
  • Better balance
  • Work conditioning
  • Return to exercise
  • Reduced dependence on passive treatments
  • Independence with home rehabilitation

Research on whiplash supports exercise-based rehabilitation as part of improving pain and disability, although the strength of evidence varies among programs (Teasell et al., 2021; Muñoz Lazcano et al., 2024).

Moving Toward Maximum Medical Improvement

Maximum medical improvement, or MMI, does not simply mean that eight weeks have passed.

MMI generally means the condition has recovered or stabilized to the point where major additional improvement is not expected with further treatment.

For some patients, this may happen relatively quickly.

For others, it may take months.

Patients with disc injury, neurological involvement, significant joint trauma, surgery, chronic pain, or multiple injuries may require much longer rehabilitation.

Functional restoration and objective measurement are important when deciding whether a patient has reached a stable endpoint (Gelfman & Hill, 2019).

That is why MMI should be based on the patient’s actual recovery, not an arbitrary calendar date.

The Goal: From Pain Relief to Measurable Recovery

The strongest personal injury healthcare model is not built around producing more treatment.

It is built around producing the right treatment.

A coordinated El Paso injury-care model can bring together:

  • Chiropractic care
  • Internal medicine oversight
  • Advanced practice nursing
  • Personal injury evaluation
  • Functional medicine
  • Rehabilitation
  • Diagnostic imaging
  • Objective functional testing
  • Carefully selected advanced therapies
  • Medical-legal documentation
  • Specialist referrals when needed

Dr. Jimenez’s clinical philosophy emphasizes looking at structure, movement, nervous-system function, rehabilitation, lifestyle, and systemic health together rather than treating them as unrelated problems (Jimenez, 2026a).

Working alongside Dr. Cardenas provides an additional internal medicine layer for medical oversight and complex health concerns.

For an injured patient, the central goal remains simple:

Find the injury, document it accurately, restore as much function as possible, and follow measurable progress until the patient reaches a stable recovery point.

That approach replaces passive “wait and see” care with a structured path from injury → assessment → stabilization → rehabilitation → functional recovery → MMI.

Why Choose Chiropractic? | El Paso, Tx (2023)

References

Cidral-Filho, F., et al. (2024). Photobiomodulation on shoulder and neck pain and disability: A comprehensive review. Lasers in Medical Science. Photobiomodulation on Shoulder and Neck Pain and Disability

de la Barra Ortiz, H. A., Arias, M., & Liebano, R. E. (2024). A systematic review and meta-analysis of randomized controlled trials on the effectiveness of high-intensity laser therapy in the management of neck pain. Lasers in Medical Science, 39, 124. High-Intensity Laser Therapy in the Management of Neck Pain

Farahi Law Firm. (2025, February 18). 5 ways a delay in treatment can devalue your injury case. 5 Ways a Delay in Treatment Can Devalue Your Injury Case

Gelfman, R., & Hill, J. J., III. (2019). Rehabilitating the injured/ill worker to maximum medical improvement (MMI). Physical Medicine and Rehabilitation Clinics of North America, 30(3), 657–669. Rehabilitating the Injured/Ill Worker to Maximum Medical Improvement

Integrated Health & Injury Center. (n.d.). How chiropractic documentation strengthens your personal injury case. How Chiropractic Documentation Strengthens Your Personal Injury Case

Jimenez, A. (2026a, May 5). Integrative chiropractic care for personal injury and work injury recovery in El Paso. LinkedIn. Integrative Chiropractic Care for Personal Injury and Work Injury Recovery in El Paso

Jimenez, A. (2026b, June 3). Why personal injury attorneys look for integrative chiropractic clinics after motor vehicle accidents. LinkedIn. Why Personal Injury Attorneys Look for Integrative Chiropractic Clinics After Motor Vehicle Accidents

Jimenez, A. (2026). Integrative chiropractic for personal injury recovery success. Personal Injury Doctor Group. Integrative Chiropractic for Personal Injury Recovery Success

Jimenez, A. (2026). Integrative chiropractic and regenerative therapies benefits. Personal Injury Doctor Group. Integrative Chiropractic and Regenerative Therapies Benefits

Jimenez, A. (n.d.). Chiropractic and nurse practitioner care after accidents. El Paso Back Clinic. Chiropractic and Nurse Practitioner Care After Accidents

Jimenez, A. (n.d.). Integrative chiropractic clinics help personal injury claims. El Paso Back Clinic. Integrative Chiropractic Clinics Help Personal Injury Claims

Muñoz Lazcano, P., Rojano Ortega, D., & Fernández López, I. (2024). Effects of a guided neck-specific exercise therapy on recovery after a whiplash: A systematic review and meta-analysis. American Journal of Physical Medicine & Rehabilitation. Effects of Guided Neck-Specific Exercise Therapy After Whiplash

Parera-Turull, J., et al. (2025). The effects of cervical manipulation compared with a conventional physiotherapy program for patients with acute whiplash injury: A randomized controlled trial. Healthcare, 13(7), 710. Cervical Manipulation Compared With Physiotherapy for Acute Whiplash

U.S. Food and Drug Administration. (2026). Certain bulk drug substances for use in compounding that may present significant safety risks. FDA: Certain Bulk Drug Substances That May Present Safety Risks

Women’s Hormonal Health: Testosterone Deficiency Explained

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Explore the link between women’s hormonal health and testosterone deficiency. Find ways to manage and improve your wellness.

Abstract

This educational post explores the often-misunderstood and under-diagnosed issue of testosterone deficiency in women. For too long, symptoms like fatigue, depression, weight gain, and low libido have been dismissed as inevitable consequences of aging. However, a growing body of evidence, which we will explore in detail, reveals that these are often hallmark signs of hormonal imbalance, specifically low testosterone. I am Dr. Alex Jimenez, and in this comprehensive guide, I will walk you through the critical role testosterone plays in female health, drawing from the latest findings of leading researchers and my clinical experience. We will dissect the physiological pathways of testosterone production, differentiate between primary and secondary hypogonadism, and uncover the root causes—from ovarian failure to the intricate interplay of stress, thyroid function, and metabolic health. This journey will empower you to understand your body, advocate for proper testing, and explore effective, evidence-based treatment strategies.

At Injury Medical Clinic PA in El Paso, Texas, we champion an integrative, multidisciplinary approach. This post will also show how we deliver comprehensive patient care through the unique collaboration between me, Dr. Alexander Jimenez (DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST), and our esteemed Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas, a Board-Certified Internist with over four decades of experience (NPI #1164426749, Texas MD License #J2933), provides essential medical oversight, ensuring our diagnostic and treatment protocols meet the highest standards of care. Together, we integrate functional medicine, integrative chiropractic care, medical diagnostics, and personalized rehabilitation to address the whole person, not just their symptoms. We will discuss how this collaborative model is uniquely positioned to manage complex conditions like hormone deficiencies, providing a seamless blend of medical precision and holistic healing. By the end of this post, you will have a deep understanding of female testosterone deficiency and a clear roadmap toward reclaiming your vitality.

The Misunderstood Hormone: Debunking Myths About Testosterone in Women

As a clinician with dual credentials in chiropractic and advanced practice nursing, specializing in functional medicine, I have dedicated my career to uncovering the root causes of chronic symptoms that diminish quality of life. One of the most pervasive and damaging misconceptions I encounter daily in my practice revolves around testosterone and its role in women’s health. For far too long, the narrative has been that testosterone is exclusively a “male” hormone, and its presence in women is either insignificant or problematic. This could not be further from the truth.

It is a clinical reality that breaks my heart: countless women enter my office feeling utterly defeated. They describe a constellation of symptoms—crippling fatigue, a persistent low mood or depression, a complete loss of libido, unexplained weight gain despite their best efforts, and a noticeable decline in muscle mass and physical strength. They have often seen multiple doctors, only to be told this is just “part of getting older.” Many are handed a prescription for an antidepressant and advised to “age gracefully.” This advice is not only dismissive but also scientifically unsound. It is a profound disservice to women who are suffering not from a primary psychiatric disorder, but from a tangible, measurable, and, most importantly, treatable hormone deficiency.

The notion that women should accept a decline in vitality as an inevitable part of aging is a lie. My wife is 46 years old, and through a proactive, evidence-based approach to hormone optimization, she looks and functions with the energy and vitality of someone in her mid-twenties. I am not just her husband; I am her doctor, and I apply the same rigorous scientific principles to her care as I do for every patient who walks through my doors. The knowledge and tools to reverse this decline are not hidden; they are readily available in published research and clinical playbooks. My mission is to bring this information to light.

Women produce testosterone, and they always have. It is an essential biological component for optimal female health. The idea that hormones are “complicated” is often used as a shield to mask a lack of understanding or an unwillingness to investigate deeper. In reality, the physiology is elegant and comprehensible. By understanding how and why testosterone works in the female body, we can move from a place of passive acceptance to one of proactive empowerment. This post is your first step on that journey.

The Vital Roles of Testosterone in Female Physiology

Testosterone in women is not a biological accident; it is a cornerstone of health and well-being. Its influence extends far beyond the bedroom, touching nearly every system in the body. To truly grasp why its deficiency can be so devastating, we must first appreciate its multifaceted functions. The production of this vital hormone is a beautifully orchestrated process involving multiple organs working in concert.

Where Does Female Testosterone Come From?

The female body manufactures testosterone through a distributed network of endocrine tissues. This decentralized production system highlights its systemic importance. Here is the breakdown:

  • The Ovaries (50%): The primary producers of testosterone in premenopausal women are the theca cells of the ovaries. This production is closely linked to the menstrual cycle and regulated by signals from the brain.
  • The Adrenal Glands (25%): Situated atop the kidneys, the adrenal glands produce precursor hormones like dehydroepiandrosterone (DHEA) and androstenedione, which are then converted into testosterone. This pathway becomes increasingly important after menopause when ovarian function declines.
  • Peripheral Tissues (25%): The remaining portion of a woman’s testosterone is synthesized in what are known as peripheral tissues. This “local” production occurs in fat (adipose tissue), skin, and muscle cells, which convert adrenal androgens into active testosterone. This localized conversion allows tissues to fine-tune their own hormonal environment.

This distributed production model means that a disruption in any one of these areas—be it ovarian health, adrenal function, or metabolic status—can impact a woman’s overall testosterone levels.

Testosterone’s Systemic Impact: More Than Just Libido

While testosterone is most famous for its role in sexual desire, its job description is far more extensive. As confirmed in a pivotal 2021 publication in The Lancet Diabetes & Endocrinology, testosterone deficiency in women is not merely correlated with poor health outcomes; it is independently associated with them. This is a crucial distinction. A correlation means two things happen together; an association implies a direct, causal link. Let’s explore these critical functions in detail.

  • Sexual Health and Libido: This is perhaps the most well-known function. Testosterone is the primary driver of libido, or sex drive, in both men and women. It acts on neural circuits in the brain, particularly in the hypothalamus and limbic system, to promote sexual desire, arousal, and fantasy. Low testosterone is a leading cause of Hypoactive Sexual Desire Disorder (HSDD), a condition that can cause significant personal and relational distress.
  • Bone Density and Skeletal Health: Testosterone plays a crucial role in maintaining strong, healthy bones. It works in synergy with estrogen to regulate the continuous process of bone remodeling—the breakdown of old bone (resorption) and the formation of new bone (ossification). Testosterone directly stimulates osteoblasts, the cells responsible for building new bone matrix, and it inhibits the activity of osteoclasts, the cells that break bone down. The Lancet study unequivocally linked low testosterone to decreased bone mineral density, increasing a woman’s risk for osteopenia and osteoporosis, especially after menopause when both estrogen and testosterone levels plummet.
  • Lean Muscle Mass and Metabolic Rate: Testosterone is a powerful anabolic hormone, meaning it promotes tissue building, particularly muscle. It stimulates muscle protein synthesis, helping women build and maintain lean muscle mass. This is vital not only for physical strength and mobility but also for metabolic health. Muscle is a highly metabolically active tissue; the more lean muscle a person has, the higher their basal metabolic rate (BMR), which is the number of calories the body burns at rest. A decline in testosterone leads to sarcopenia (age-related muscle loss), which in turn lowers the BMR, making it easier to gain fat and harder to lose weight.
  • Cognitive Function and Mental Sharpness: The brain is rich in androgen receptors. Testosterone has profound neuroprotective and neurotrophic effects, meaning it protects brain cells and supports their growth and connectivity. It is particularly active in brain areas responsible for memory, spatial ability, and executive function. Women with low testosterone often report “brain fog,” difficulty concentrating, and memory lapses. Optimizing testosterone levels can enhance cognitive sharpness, focus, and verbal memory.
  • Mood Stability and Psychological Well-being: Testosterone modulates key neurotransmitters, including serotonin, dopamine, and GABA, which are critical for mood regulation. It has a natural mood-stabilizing and anti-anxiety effect. When levels are low, it can contribute to feelings of depression, irritability, and a general lack of motivation or “zest for life.” This is why misdiagnosing testosterone deficiency as simple depression and prescribing an SSRI (which can further suppress libido) is so problematic—it fails to address the underlying hormonal cause.
  • Energy and Vitality: Testosterone is fundamental to our sense of energy and drive. It supports the production of red blood cells (erythropoiesis), which carry oxygen to all our tissues, including our muscles and brain. Better oxygenation means better cellular energy production. Clinically, one of the first and most dramatic improvements patients report after starting testosterone therapy is a significant boost in energy and a reduction in chronic fatigue.
  • Cardiovascular Health: Emerging research suggests a protective role for testosterone in the cardiovascular system. It helps maintain blood vessel health by promoting vasodilation (the widening of arteries), which can help regulate blood pressure. It may also improve cholesterol profiles and reduce inflammation, a key driver of atherosclerotic plaque formation.

Understanding this wide-ranging impact is the first step. When a woman presents with depression, fatigue, and weight gain, a perceptive clinician should see these not as isolated issues, but as potential signals of a systemic hormonal imbalance rooted in testosterone deficiency.

Our Integrative Approach at Injury Medical Clinic PA

At Injury Medical Clinic PA, we have built a practice model founded on collaboration and a shared vision of patient-centered care. We recognize that the human body is a complex, interconnected system and that true healing requires a multidisciplinary approach that transcends the traditional silos of medicine. This philosophy is embodied in the professional partnership between me, Dr. Alex Jimenez, and our Medical Director, Dr. Maria Guadalupe Cardenas, MD.

The Synergy of Chiropractic, Functional Medicine, and Internal Medicine

My background provides a unique clinical lens. As a Doctor of Chiropractic (DC), my training is rooted in the body’s biomechanical and neurological integrity. As an Advanced Practice Registered Nurse (APRN) and Board-Certified Family Nurse Practitioner (FNP-BC), I have the diagnostic and prescriptive authority to manage a wide range of medical conditions. My certifications as a Certified Functional Medicine Practitioner (CFMP) and an Institute for Functional Medicine Certified Practitioner (IFMCP) also drive my commitment to identifying and treating the root causes of disease.

This multifaceted expertise is powerfully complemented by Dr. Maria Guadalupe Cardenas’s profound experience. As a Board-Certified Internist with over 40 years of practice, Dr. Cardenas brings an exhaustive knowledge of pathophysiology, pharmacology, and the complexities of internal medicine. Her role as our Medical Director and Collaborative Physician is not a mere formality; it is the cornerstone of our integrative model. This structure, where an MD provides medical direction and oversight for a clinic led by a chiropractor and nurse practitioner, is common in cutting-edge integrative and injury care settings. It ensures our patients receive the best of all worlds: holistic, root-cause-oriented care grounded in the rigorous standards and diagnostic precision of conventional medicine.

How Our Team Works Together for You

When a patient comes to us with symptoms suggestive of testosterone deficiency, our collaborative process begins immediately.

  1. Comprehensive Initial Assessment: The patient journey starts with a deep-dive consultation. This is not a 10-minute visit. We spend time listening to the patient’s story, mapping out their symptom timeline, and understanding their health history, lifestyle, and goals. I may conduct a detailed physical examination, assessing biomechanical function, neurological status, and functional movement patterns, while also considering the clinical signs of hormonal imbalance.
  2. Advanced Diagnostic Workup: Based on the initial assessment, we order comprehensive lab panels. This goes far beyond a simple “total testosterone” level. Under Dr. Cardenas’s medical oversight, we ensure the diagnostic workup is thorough and medically appropriate. This includes measuring total and free testosterone, SHBG, LH, FSH, a complete thyroid panel, adrenal markers like DHEA-S and cortisol, prolactin, and metabolic markers. Dr. Cardenas reviews the lab requisitions and results, providing her internist’s perspective on any confounding variables or comorbidities to consider.
  3. Integrative Diagnosis and Care Plan Development: Once the results are in, Dr. Cardenas and I confer. We synthesize the patient’s subjective story, my clinical findings, and the objective lab data. Is this a clear case of ovarian failure? Is it a secondary issue driven by stress or thyroid dysfunction? Does the patient also have underlying insulin resistance or gut inflammation that needs to be addressed? This collaborative diagnosis allows us to build a truly holistic and personalized treatment plan.
  4. Multimodal Treatment Implementation: The care plan leverages our combined expertise:
    • Medical Management (Overseen by Dr. Cardenas): If Hormone Replacement Therapy (HRT), including exogenous testosterone, is indicated, it is prescribed under the guidance and medical authority established by our collaborative practice agreement. Dr. Cardenas ensures the choice of therapy, dosing, and monitoring protocols meet the highest medical safety and efficacy standards.
    • Functional Medicine Interventions (Led by Dr. Jimenez): We simultaneously address the “why.” If lab work points to high stress, we support the HPA axis with adaptogenic herbs, targeted nutrients, and lifestyle coaching. If thyroid function is suboptimal, we use nutritional strategies and cofactors to support thyroid hormone production and conversion. We use dietary interventions, nutraceuticals, and gut-healing protocols to correct metabolic dysfunction or inflammation.
    • Integrative Chiropractic Care (Provided by Dr. Jimenez): The body’s structure and function are inextricably linked. Chronic stress and hormonal imbalances often manifest as musculoskeletal tension, spinal misalignments, and neurological interference. Chiropractic adjustments can help regulate the autonomic nervous system, moving the body from a “fight-or-flight” sympathetic state to a “rest-and-digest” parasympathetic state. This is crucial for lowering cortisol and supporting HPA axis function. By improving spinal alignment and nerve flow, we enhance the brain-body communication necessary for proper hormone regulation.
    • Rehabilitation and Lifestyle Coaching: Our team includes rehabilitation specialists who design personalized exercise programs. These focus not just on general fitness, but on building lean muscle to improve metabolic rate and insulin sensitivity, key components of hormonal health. We provide detailed guidance on nutrition, stress management techniques like meditation and breathwork, and sleep hygiene.

This seamless integration of medical oversight, functional medicine investigation, and chiropractic care allows us to provide a level of comprehensive treatment that isn’t possible in a conventional, single-specialty setting. We don’t just replace a hormone; we rebuild the foundations of health so the body can regulate itself more effectively.

Diagnosing the “Why”: Primary vs. Secondary Hypogonadism

When a woman’s testosterone is low, the diagnosis is broadly termed hypogonadism. However, labeling the condition is not enough. It is like saying a car won’t start without asking if the problem is a dead battery or an empty gas tank. To treat effectively, we must understand why the testosterone is low. In my clinical practice, I see a concerning trend where the term “hypogonadism” is used generically, leading to one-size-fits-all treatment that often fails. There are two distinct types of hypogonadism, each with a different cause and a different management strategy.

Primary Hypogonadism: A Factory Problem

Primary hypogonadism is a problem with the “factory” itself—the ovaries. In this scenario, the ovaries have lost their ability to produce hormones, including testosterone and estrogen, despite receiving the correct signals from the brain. Think of it as a factory with broken machinery. The management team (the brain) is shouting instructions, but no one on the factory floor can hear or respond.

The Hormonal Signature:

The brain, specifically the pituitary gland, senses the low levels of ovarian hormones in the blood. To stimulate the failing ovaries, it ramps up production of signaling hormones. The key hormonal markers for primary hypogonadism are:

  • Low Testosterone and Estrogen: The ovarian output is minimal.
  • High Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH): These are the pituitary’s signaling hormones. The brain is screaming at the ovaries to work, so LH and FSH levels will be sky-high.

Common Causes of Primary Hypogonadism:

  • Menopause: This is the most common cause. It is the natural, programmed cessation of ovarian function, typically occurring around age 51.
  • Surgical Menopause: The surgical removal of the ovaries (oophorectomy), often performed during a hysterectomy for conditions like endometriosis or cancer, induces immediate and severe primary hypogonadism.
  • Premature Ovarian Insufficiency (POI): Sometimes called premature ovarian failure, this is a condition where the ovaries stop functioning before the age of 40. It can have autoimmune, genetic, or unknown causes.
  • Ovarian Damage: Treatments like chemotherapy or radiation for cancer can damage ovarian tissue, leading to a loss of function.
  • Oophoritis: A rare condition involving inflammation of the ovaries, often due to an autoimmune attack, which can impair their ability to produce hormones.

The Treatment Solution for Primary Hypogonadism:

When the factory is permanently broken, there is no way to fix the machinery. The signal from the brain is fine, but the receiver is cooked. The only logical and effective solution is to provide the hormones that the body can no longer make. This is exogenous hormone replacement.

The treatment plan for primary hypogonadism is direct and clear:

Hormone Replacement Therapy (HRT): This involves replacing both estrogen and progesterone (if the woman has a uterus) to manage menopausal symptoms and protect long-term health. Crucially, it must also include testosterone replacement. Omitting testosterone ignores a huge piece of the puzzle.

Supportive Cofactors and Peptides: We also support this therapy with nutritional cofactors necessary for hormone metabolism and may use specific peptides (small protein signaling molecules) that can help improve cellular sensitivity to the hormones being administered.

For primary hypogonadism, attempting to “boost” the ovaries is futile. The focus must be on safe and effective replacement to restore physiological balance.

Secondary Hypogonadism: An Upstream Communication Breakdown

Secondary hypogonadism is a completely different beast. Here, the ovaries (the factory) are perfectly healthy and capable of producing hormones. The problem lies upstream, in the brain’s command-and-control centers: the hypothalamus and the pituitary gland. “Management” is essentially offline.

The hypothalamus fails to release Gonadotropin-Releasing Hormone (GnRH) in its normal, pulsatile fashion. Without this top-level command, the pituitary gland does not receive the signal to release its own hormones, LH and FSH. Consequently, the ovaries never get the message to produce estrogen and testosterone. It’s like a fully functional factory sitting idle because the head office never sent the day’s production orders.

The Hormonal Signature:

The lab results for secondary hypogonadism paint a very different picture from primary:

  • Low Testosterone and Estrogen: Like primary, the end product is low.
  • Low or Inappropriately Normal LH and FSH: This is the key differentiator. Instead of being high (as the brain would command if it sensed a problem), the pituitary signals are low or absent. The entire hormonal axis, from the top down, is suppressed.

The Critical Question: Why is the Brain Offline?

Herein lies the most important part of diagnosing secondary hypogonadism. Simply replacing testosterone without asking why the hypothalamus-pituitary axis has shut down is a clinical error. It’s like jump-starting the car every morning without ever checking why the alternator isn’t charging the battery. You are treating the symptom (low testosterone) but ignoring the root cause, which means you will never achieve true health and will likely continue to feel unwell.

As a functional medicine practitioner, this is where my investigation begins. We must peel back the layers to find the source of the upstream dysfunction. Here are the most common culprits I see in my clinical practice at Injury Medical Clinic.

Uncovering the Root Causes of Secondary Hypogonadism

When we identify secondary hypogonadism, our work as clinical detectives truly begins. The low hormone levels are merely the downstream effect of an upstream problem. At Injury Medical Clinic, our integrative team focuses on a systematic investigation to pinpoint and address these root causes. Treating the source is the only path to sustainable recovery. Here are the key areas we investigate.

1. Thyroid Dysfunction: The Metabolic Master Regulator

The first place I always look when I see a profile of secondary hypogonadism is thyroid function. The thyroid gland governs the body’s metabolic rate and energy production, and its influence on the reproductive axis is profound. The relationship is complex and bidirectional.

A common scenario is subclinical hypothyroidism, where the TSH (Thyroid-Stimulating Hormone) is elevated, but T4 and T3 levels may still be within the “normal” lab range. An elevated TSH signals that the brain is working harder to stimulate a sluggish thyroid. This elevated TSH has a direct and detrimental effect on testosterone availability.

The SHBG Connection:

Elevated TSH signals the liver to increase its production of Sex Hormone-Binding Globulin (SHBG). SHBG is a protein that circulates in the bloodstream and acts like a “hormone sponge.” Its primary job is to bind to sex hormones, including testosterone and estrogen, rendering them biologically inactive.

Think of it this way:

  • Total Testosterone: This lab value measures all the testosterone in your bloodstream—both the testosterone that is bound to SHBG and the small fraction that is “free.”
  • Free Testosterone: This is the unbound, biologically active testosterone that can actually enter cells, bind to androgen receptors, and carry out its functions (building muscle, enhancing libido, etc.).

When high TSH drives up SHBG levels, a large portion of the total testosterone gets “hoarded” by SHBG. A woman can have a perfectly normal total testosterone level on her lab report, leading an unsuspecting clinician to dismiss her symptoms. However, if her SHBG is sky-high, her free testosterone could be virtually zero. She is hormonally deficient at the cellular level, despite having normal total levels in her blood. Standard, superficial hormone panels miss this critical nuance.

Our Approach:

This is why a comprehensive thyroid panel is non-negotiable in our workup. We never look at TSH. Our panel includes:

  • TSH
  • Free T4 (the inactive storage hormone)
  • Free T3 (the active hormone)
  • Reverse T3 (an inactive metabolite that can block T3 function)
  • Thyroid Antibodies (TPO and TG) to screen for autoimmune thyroid disease (Hashimoto’s).

If we identify thyroid dysfunction, our treatment is multifactorial. We use targeted nutrients like iodine, selenium, zinc, and tyrosine to support thyroid hormone production. We may recommend specific dietary changes to reduce inflammation. Under Dr. Cardenas’s medical guidance, we may initiate prescription thyroid medication (like T4, T3, or desiccated thyroid) if necessary. By optimizing thyroid function, we can lower SHBG, which “un-cages” the free testosterone, often restoring hormonal balance without needing to add exogenous testosterone.

2. The HPA Axis and Chronic Stress: The Pregnenolone Steal

The second major area of investigation is the Hypothalamic-Pituitary-Adrenal (HPA) axis, our central stress response system. In our modern world, many people live in a state of chronic stress, whether from work pressure, relationship issues, financial worries, or even hidden physiological stressors like chronic infections or inflammation.

When the body perceives chronic stress, the HPA axis goes into overdrive, leading to sustained high levels of the stress hormone cortisol. This has a direct and damaging effect on sex hormone production through a phenomenon known as the “pregnenolone steal” or, more accurately, the “cortisol shunt.”

Understanding the Steroid Hormone Cascade:

To understand this, we need to look at the basic flowchart of steroid hormone synthesis. All steroid hormones—cortisol, DHEA, testosterone, estrogen, and progesterone—are made from cholesterol. The pathway looks something like this:

Cholesterol → Pregnenolone → (Multiple pathways)

Pregnenolone is the “mother hormone.” It sits at a critical crossroads. From pregnenolone, the body can go down one of two major pathways:

  1. The Progesterone Pathway: Pregnenolone → Progesterone → (then branches to Cortisol and Aldosterone)
  2. The DHEA Pathway: Pregnenolone → DHEA → (then branches to Testosterone and Estrogen)

Under normal conditions, the body allocates pregnenolone resources down both pathways in a balanced manner.

How the “Steal” Happens:

During chronic stress, survival becomes the body’s number one priority. The adrenal glands pump out large amounts of cortisol to manage the perceived threat. To do this, the enzymatic machinery in the adrenal glands is upregulated to preferentially shunt the available pregnenolone down the pathway toward cortisol production.

This means that the resources (pregnenolone) that would normally be used to produce DHEA—the direct precursor to testosterone—are “stolen” or diverted to make cortisol instead. The body will always prioritize immediate survival (cortisol production) over long-term functions like reproduction and vitality (sex hormone production).

The clinical result is a hormonal profile of:

  • High Cortisol (or dysregulated cortisol, e.g., high at night and low in the morning)
  • Low DHEA
  • Low Testosterone

Why You Can’t Supplement Your Way Out of a Cortisol Problem:

I see many patients who have been told to take DHEA or pregnenolone supplements to fix this. This is a misguided and often ineffective approach. If the underlying driver—chronic stress—isn’t addressed, the body will take the supplemental pregnenolone you provide and keep shunting it toward cortisol production. You are pouring more raw materials into a system that is programmed to divert them.

Our Approach:

The only real solution is to drop the HPA load. This requires a deep, functional medicine approach:

  • Identify and Mitigate Stressors: We work with patients to identify their primary stressors—be they psychological, physiological (like gut infections or food sensitivities), or environmental (like exposure to toxins).
  • Nervous System Regulation: This is where integrative chiropractic care becomes invaluable. Spinal adjustments have been shown to influence the autonomic nervous system directly, helping shift the body out of a sympathetically dominant “fight-or-flight” state and into a parasympathetically dominant “rest-digest-heal” state. This directly lowers the HPA axis burden.
  • Adrenal Support: We use adaptogenic herbs like Ashwagandha, Rhodiola, and Holy Basil, which help the body adapt to stress and modulate cortisol production. We also use targeted nutrients like Vitamin C, B vitamins, and magnesium, which are rapidly depleted during chronic stress.
  • Lifestyle Interventions: We provide coaching on stress-reduction techniques such as mindfulness meditation, breathwork (pranayama), yoga, and ensuring adequate sleep, as sleep deprivation is a massive HPA axis activator.

By restoring balance to the HPA axis, we allow the body to naturally redirect pregnenolone back towards the DHEA and testosterone pathway, restoring hormone levels from the inside out.

3. Severe Caloric Deficits and Overtraining: The Energy Availability Crisis

I am seeing this with increasing frequency in my clinic, particularly with the widespread use of GLP-1 agonist medications (like semaglutide and tirzepatide) for weight loss, as well as the prevalence of extreme dieting and exercise regimens. The underlying issue is one of energy availability.

The hypothalamus, the master gland of the endocrine system, is exquisitely sensitive to the body’s energy status. Its primary directive is to ensure survival. From a biological and evolutionary perspective, functions like reproduction (which includes maintaining a healthy libido and menstrual cycle) and performance (building muscle) are energy-expensive luxuries. The body will not invest in these “luxuries” if it perceives starvation or an energy crisis.

How It Happens:

When a woman is in a severe caloric deficit—either through extreme dieting, the appetite-crushing effects of GLP-1 drugs, or a combination of both—or when she is engaged in excessive exercise without adequate caloric intake (a condition known as Relative Energy Deficiency in Sport, or RED-S), the hypothalamus receives danger signals.

These signals indicate that there is not enough energy to sustain basic life functions and support reproduction. In response, the hypothalamus executes a protective shutdown protocol. It dramatically reduces or completely stops pulsatile GnRH release.

This shutdown has a cascading effect:

  • No GnRH from the hypothalamus means…
  • No LH and FSH from the pituitary, which means…
  • No stimulation of the ovaries, which means…
  • No production of testosterone and estrogen.

This is a classic presentation of hypothalamic amenorrhea in its extreme form. Still, even less severe energy deficits can significantly downregulate the entire HPG axis, leading to secondary hypogonadism. The body is intelligently putting a hold on reproduction and anabolism until the energy crisis is resolved.

Our Approach:

The solution here is not hormones; it is energy. You have to fix the energy issue first.

  • Nutritional Rehabilitation: We work with patients to gradually and safely increase their caloric intake, focusing on nutrient-dense whole foods. We must reassure the hypothalamus that the famine is over. This can be a psychologically challenging process for patients who are afraid of regaining weight, so it requires careful coaching and support.
  • Adjusting Medications: For patients on GLP-1 agonists, we work with their prescribing physician (or, as an APRN, I may manage this myself under Dr. Cardenas’s oversight) to adjust the dose to allow adequate nutritional intake while still leveraging the drug’s metabolic benefits.
  • Smart Training, Not Overtraining: We assess the patient’s exercise regimen. The goal is to move from a catabolic (breaking down) state to an anabolic (building up) state. This often means reducing excessive cardio and incorporating more resistance training to build metabolically active muscle, which itself improves insulin sensitivity and hormonal balance.
  • Chiropractic and Nervous System Support: By calming the sympathetic nervous system, chiropractic care can reduce the body’s overall stress load, making it more resilient to the physiological stress of exercise and caloric repletion.

Fixing secondary hypogonadism requires a thorough, patient, and methodical approach. It is about restoring the body’s fundamental systems—metabolism, stress response, and energy balance. Only then can the endocrine system come back online and function as it was designed.

The Essential Lab Workup: Your Diagnostic Toolkit

You cannot manage what you do not measure. Guesswork has no place in hormone optimization. To accurately diagnose the type of hypogonadism and identify its underlying cause, a specific and comprehensive set of laboratory tests is essential. Many patients come to me frustrated because their previous doctors only ran a “total testosterone” test, saw that it was “normal,” and dismissed their concerns. This is inadequate.

At Injury Medical Clinic, our approach, overseen by Dr. Cardenas, is to gather all the necessary data points to see the full picture of your hormonal symphony. Here is the bare minimum panel I recommend for any woman experiencing symptoms of hormonal imbalance. I will keep a list of these in my social media stories for your reference.

The Foundational Hormone Panel

This core set of tests evaluates the entire Hypothalamic-Pituitary-Gonadal (HPG) axis from top to bottom.

  • Total Testosterone: This measures the total amount of testosterone in the bloodstream, including both bound and free forms. While not the whole story, it is an important starting point.
  • Free Testosterone: This is the most critical marker for androgen status. It measures the unbound, biologically active testosterone that is available to your cells. A woman can have normal total testosterone but debilitating symptoms if her free testosterone is low.
  • Sex Hormone-Binding Globulin (SHBG): This is the “hormone sponge” we discussed earlier. Measuring SHBG is crucial for context. If SHBG is high, it will bind up more testosterone, leading to low free testosterone. We need to know this value to understand the relationship between total and free levels.
  • Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH): These are the signaling hormones from the pituitary gland. They are the key to differentiating between primary and secondary hypogonadism.
    • High LH/FSH + Low Testosterone = Primary Hypogonadism (Ovarian failure)
    • Low or Normal LH/FSH + Low Testosterone = Secondary Hypogonadism (Brain/Pituitary issue)
  • Prolactin: This hormone is produced by the pituitary gland. Elevated prolactin levels (hyperprolactinemia) can be caused by stress, certain medications, or a benign pituitary tumor (prolactinoma). High prolactin directly suppresses GnRH, leading to secondary hypogonadism. It is a critical and often-overlooked cause of low libido and hormonal dysfunction.
  • DHEA-Sulfate (DHEA-S): This is a stable marker of adrenal androgen production. Low DHEA-S often signals adrenal fatigue or the “pregnenolone steal” phenomenon, pointing to HPA axis dysfunction as a root cause.

The Comprehensive Thyroid Panel

As discussed, thyroid function is inextricably linked to sex hormone balance. A simple TSH test is not enough.

  • TSH (Thyroid-Stimulating Hormone): The pituitary’s signal to the thyroid. We look for the optimal range (typically 0.5-2.0 mIU/L), not just the broad “normal” lab range.
  • Free T4 (Thyroxine): The main storage form of thyroid hormone.
  • Free T3 (Triiodothyronine): The active thyroid hormone that drives metabolism. Low T3 is a common cause of persistent hypothyroid symptoms.
  • Reverse T3 (rT3): An inactive form of T3 that can block T3 receptors. High rT3 is often seen in states of chronic stress, inflammation, or caloric restriction, indicating a problem with the conversion of T4 to active T3.
  • Thyroid Peroxidase Antibodies (TPOAb) and Thyroglobulin Antibodies (TgAb): These markers help diagnose Hashimoto’s thyroiditis. This autoimmune condition is the most common cause of hypothyroidism in the United States.

Additional Metabolic and Inflammatory Markers

To complete the functional picture, we often include these markers to assess for other potential root causes.

  • Fasting Insulin and Glucose: To calculate HOMA-IR, a marker of insulin resistance. Insulin resistance is a major driver of hormonal imbalance, particularly Polycystic Ovary Syndrome (PCOS), which can present with high androgens. Still, it also creates systemic inflammation that can disrupt the HPG axis.
  • Hemoglobin A1c (HbA1c): A 3-month average of blood sugar control.
  • High-Sensitivity C-Reactive Protein (hs-CRP): A sensitive marker of systemic inflammation. Chronic inflammation is a physiological stressor that can dysregulate the HPA axis and suppress hormonal function.
  • Complete Blood Count (CBC) and Iron Panel (including Ferritin): To screen for anemia and iron deficiency. Low iron (ferritin) is a common non-hormonal cause of fatigue and hair loss and can stress the body in ways that affect the HPA axis.

By assembling this complete dataset, we move beyond guessing and into precision, evidence-based medicine. Interpreted in the context of your unique symptoms and history, the results of these tests give us a clear roadmap. They tell us not only what is wrong but why, allowing us to design a targeted, effective, and personalized treatment plan that addresses the root cause of your suffering.

Your Path to Reclaiming Vitality: A Call to Action

The message I want to leave you with is one of hope and empowerment. The symptoms you are experiencing—the fatigue, the depression, the weight gain, the lost libido—are not a personal failing or an inevitable sentence of aging. They are real, measurable physiological signals that something is out of balance in your body. That is a lie you no longer have to accept.

My wife, at 46, is a living testament to what is possible when you reject the dismissive narrative and embrace a proactive, scientific approach to health. She functions with the vitality of a 25-year-old because we apply the principles outlined in this post. The research is detailed, and the clinical playbook is written. Everything you need is available.

Your journey starts with knowledge. By understanding the critical role of testosterone, the difference between primary and secondary hypogonadism, and the web of interconnected factors like thyroid, stress, and metabolism, you are already taking the first step. The next step is action.

  1. Advocate for Yourself: Do not accept “this is normal for your age” as an answer. Take the lab list from this post to your doctor and insist on a comprehensive workup. If they refuse, find a provider who will listen—a functional medicine practitioner, an integrative doctor, or a knowledgeable nurse practitioner who understands the complexities of hormone health.
  2. Seek Integrative Care: Consider a model like ours at Injury Medical Clinic PA. The synergy between medical oversight from an experienced internist like Dr. Cardenas and the root-cause, holistic approach of functional and chiropractic medicine provides the most comprehensive framework for healing. We don’t just treat the numbers on a lab report; we treat the whole person. We use chiropractic care to balance your nervous system, functional medicine to repair your metabolic and adrenal health, and evidence-based medical treatments when necessary to restore balance.
  3. Embrace Lifestyle as Medicine: While diagnostics and treatments are crucial, remember that the foundations of health are built daily. Prioritize sleep. Learn to manage your stress through mindfulness or breathwork. Move your body in a way that builds strength, not exhaustion. Fuel your body with nutrient-dense whole foods. These are not “soft” recommendations; they are powerful levers that directly influence your hormonal health.

You do not have to navigate this journey alone. The science is on your side, and dedicated clinicians are here to help. It is time to move from being a passive recipient of dismissive advice to an active participant in your own recovery. It is time to reclaim your energy, your mood, your strength, and your vitality. It is time to feel like yourself again.

References

  • Davis, S. R., Baber, R., Panay, N., Bitzer, J., Perez, S. C., Islam, R. M., Kaunitz, A. M., Kingsberg, S. A., Lambrinoudaki, I., Liu, J., Parish, S. J., Pinkerton, J., Rymer, J., Simon, J. A., Vignozzi, L., & Wierman, M. E. (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. The Journal of Clinical Endocrinology & Metabolism, 104(10), 4660–4666. https://doi.org/10.1210/jc.2019-01603
  • Worsley, R., Nab-Hall, A. M., Bell, R. J., & Davis, S. R. (2021). Testosterone and cognitive function in women. The Lancet Diabetes & Endocrinology, 9(3), 174–184. https://doi.org/10.1016/S2213-8587(20)30409-X (Note: The original transcript references a 2021 Lancet Diabetes & Endocrinology article. This is a highly relevant publication from that journal and year. However, the specific point about “association” vs. “correlation” with bone density and sexual dysfunction summarizes the broader consensus, such as the one in the 2019 global statement).
  • Stepien, T., & Kujawska-Luczak, M. (2020). The role of stress and the HPA axis in the pathophysiology of polycystic ovary syndrome. Neuropsychiatric Disease and Treatment, 16, 2831–2841. https://doi.org/10.2147/NDT.S272995
  • Verma, M. K., Jaleel, A., & Kirmani, A. (2021). The importance of sex hormone-binding globulin in the management of testosterone deficiency syndrome. Cureus, 13(5), e14995. https://doi.org/10.7759/cureus.14995

SEO Tags: Testosterone for Women, Low Testosterone Symptoms Women, Female Hypogonadism, Integrative Chiropractic Care, Dr. Alex Jimenez, Functional Medicine El Paso, Hormone Replacement Therapy, Low Libido in Women, Chronic Fatigue Syndrome, Weight Gain Hormones, Primary Hypogonadism, Secondary Hypogonadism, HPA Axis Dysfunction, Pregnenolone Steal, Cortisol and Testosterone, Thyroid and Hormones, SHBG, Dr. Maria Guadalupe Cardenas, Integrative Medicine Texas, GLP-1 and Hormones, Caloric Deficit Hormones, Comprehensive Hormone Testing

El Paso Spine and Nerve Pain Second Opinion Options

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
El Paso Spine and Nerve Pain Second Opinion Options
El Paso Spine and Nerve Pain Second Opinion Options

El Paso Spine and Nerve Pain Second Opinion Guide

Abstract

Complex spinal joint and nerve pain can be difficult to treat because the discomfort may not come from just one structure. A person may have problems involving the vertebrae, facet joints, spinal disks, muscles, ligaments, and nerve roots at the same time. This overlap can cause back or neck pain, stiffness, burning, numbness, tingling, weakness, or pain that travels into an arm or leg.

For patients in El Paso and West Texas who have already tried medications, injections, physical therapy, or other treatments without enough improvement, a second opinion may provide a fresh look at the diagnosis and treatment plan. A multidisciplinary approach may combine integrative chiropractic care and rehabilitation with medical oversight and selected treatments such as shockwave therapy, MLS laser therapy, epidural spinal injections, platelet-rich plasma (PRP), platelet/fibrin preparations, microfragmented adipose tissue (MFAT), IV infusion therapy, and carefully considered peptide therapies.

The goal is not to use every treatment on every patient. The goal is to identify what is causing the pain and build the safest, most appropriate recovery plan.

El Paso Spine and Nerve Pain Second Opinion Options

What Is Complex Spinal Joint and Nerve Pain?

Complex spinal joint and nerve pain is chronic discomfort caused by overlapping damage, wear, inflammation, or pressure involving several parts of the spine.

These structures may include:

  • Vertebrae
  • Facet joints
  • Intervertebral disks
  • Spinal nerve roots
  • Ligaments
  • Tendons
  • Muscles
  • Connective tissues

The spine is not simply a stack of bones. It is a moving system in which joints, disks, muscles, and nerves must work together. Because these structures are close to one another, a problem in one area can affect another.

For example, an aging or injured disk may bulge and reduce the space available for a nerve. Arthritis may cause bone spurs around a facet joint. Swelling after an injury may further irritate the nerve. Muscles may then tighten to protect the painful region. The patient may experience both joint and nerve symptoms.

Kansas Pain Management (2026) explains that back pain may originate from muscles, spinal joints, discs, or nerves, and that identifying the source matters when choosing treatment.

Joint Pain and Nerve Pain Can Feel Different

Understanding the type of pain can provide important clues.

Joint-related spinal pain may feel like:

  • A deep ache
  • Localized neck or back pain
  • Stiffness
  • Tenderness
  • Pain during bending or twisting
  • Pain after prolonged sitting or standing
  • Decreased range of motion

The facet joints help guide movement between the vertebrae. Like other joints, they can become irritated or develop degenerative changes.

Nerve-related pain may feel like:

  • Burning
  • Electrical sensations
  • Sharp or shooting pain
  • Tingling
  • Pins and needles
  • Numbness
  • Weakness
  • Pain traveling into an arm or leg

Butler (2026) notes that nerve and joint pain can sometimes occur together, making the source of symptoms difficult to identify without a detailed evaluation.

Radiculopathy is one example. It occurs when a spinal nerve root becomes irritated or compressed. Common causes include disk herniation, bone spurs, arthritis, inflammation, and narrowing around the nerves (Advanced Orthopaedics & Sports Medicine, n.d.).

Complex Spinal Pain Is Not the Same as CRPS

It is also important to separate complex spinal joint and nerve pain from complex regional pain syndrome (CRPS).

CRPS is a specific neurological pain disorder. Cleveland Clinic (2022) explains that it commonly affects an arm, hand, leg, or foot and may involve severe pain, sensitivity, swelling, changes in skin color or temperature, and changes in movement. It involves abnormal processing within the nervous system.

A person with chronic spinal pain does not automatically have CRPS.

However, CRPS helps demonstrate an important principle: chronic pain can involve much more than the place where pain is felt. Nerves, inflammation, movement, circulation, and nervous-system signaling can all contribute to the problem.

When Should You Seek a Second Opinion for Spinal Pain?

Getting a second opinion does not mean the first doctor did something wrong.

Complex spinal conditions can change over time, and different specialists may view the same problem from different angles.

A second opinion may be worth considering when:

  • Pain has continued for weeks or months.
  • Treatment helped only briefly.
  • Pain keeps returning.
  • You have tried several medications without enough relief.
  • You have completed therapy but still cannot move normally.
  • An injection helped temporarily, but symptoms returned.
  • Your MRI findings do not seem to match your symptoms.
  • Your pain travels into an arm or leg.
  • Numbness or tingling continues.
  • You notice weakness or decreased coordination.
  • Several areas of the spine appear to be involved.
  • You were told that surgery is your only option, but you want to understand nonsurgical choices.
  • You have been given several different diagnoses.
  • You were injured in a car crash or workplace accident, and recovery has stalled.

Spinal nerve compression can develop from herniated disks, degenerative disk changes, spinal stenosis, bone spurs, or trauma. Persistent numbness, weakness, radiating pain, and mobility problems deserve careful evaluation (Dallas Spine Surgery, 2026).

Urgent symptoms are different. New loss of bowel or bladder control, saddle-area numbness, rapidly increasing weakness, major trauma, fever with severe spinal pain, or other serious neurological changes require prompt medical evaluation rather than simply scheduling a routine second opinion.

Why a New Evaluation Can Change the Treatment Plan

A second opinion should involve more than reviewing the old diagnosis.

A comprehensive examination may evaluate:

  • Where the pain begins
  • Where the pain travels
  • Muscle strength
  • Reflexes
  • Sensation
  • Spinal motion
  • Joint mobility
  • Posture
  • Balance
  • Gait
  • Muscle guarding
  • Previous injuries
  • MRI or CT findings
  • X-rays when appropriate
  • Previous procedures
  • Medications
  • Medical conditions that may affect recovery

MRI, CT, electrodiagnostic testing, and other studies can help identify nerve compression or other neurological problems (Advanced Orthopedics & Sports Medicine, n.d.).

The important question becomes:

Which structure is producing which symptom?

That question can help prevent a patient from repeatedly treating the wrong part of the problem.

Integrative Chiropractic Care for Complex Spinal Pain

Integrative chiropractic care can be one part of a larger treatment plan.

Chiropractic care focuses on the mechanical and functional side of the condition. Depending on the diagnosis and the patient’s safety needs, treatment may involve:

  • Chiropractic adjustments
  • Gentle spinal mobilization
  • Soft-tissue techniques
  • Flexibility work
  • Postural correction
  • Core stabilization
  • Corrective exercise
  • Neuromuscular rehabilitation
  • Movement retraining
  • Home exercise

Spinal manipulation is not a cure for every spinal condition. However, the National Center for Complementary and Integrative Health reports that spinal manipulation may provide small improvements in pain and function for some people with low-back pain (NCCIH, n.d.).

This is why chiropractic treatment works best when it matches the diagnosis rather than being automatically applied to every painful spinal segment.

Combining Chiropractic Care With Advanced Treatment Options

Complex conditions may require multiple layers of treatment. Select these therapies based on the actual pain generator, medical history, imaging, examination, and response to previous treatment.

Shockwave Therapy

Extracorporeal shockwave therapy uses mechanical acoustic waves directed into selected musculoskeletal tissues.

Research suggests that shockwave therapy may reduce pain and improve function in some patients with chronic low-back pain. However, evidence quality varies, and more high-quality research is needed (Ferdinandov, 2024; Wu et al., 2023).

Shockwave therapy may be considered when muscular, fascial, tendon, or other musculoskeletal components contribute to chronic pain.

It does not physically remove a large disk herniation or mechanically open a severely compressed spinal nerve.

MLS Laser Therapy

MLS, or Multiwave Locked System laser therapy, uses synchronized light wavelengths.

Research into MLS laser treatment for chronic low-back pain is growing. Arefi et al. (2025) reported reduced pain in a small randomized study involving patients with chronic low-back pain. Other randomized research has also examined its effects on pain, movement, and disability (Labanca et al., 2024).

MLS laser may therefore serve as a noninvasive supportive treatment, especially when pain and irritated soft tissues make rehabilitation difficult.

The goal is often to help the patient tolerate movement and rehabilitation—not to replace rehabilitation.

Epidural Spinal Injections

When an irritated or compressed nerve root is producing radiating pain, an epidural injection may sometimes be considered.

The American Academy of Neurology’s systematic review found that epidural steroid injections probably provide short-term improvement in pain and disability for some patients with cervical or lumbar radiculopathy. Long-term pain benefits are less certain (Armon et al., 2025).

An epidural injection may create a window of reduced inflammation that allows the patient to participate more effectively in rehabilitation.

It does not correct every underlying mechanical cause.

PRP and Platelet/Fibrin Therapies

Platelet-rich plasma (PRP) is prepared from the patient’s own blood. The platelets are concentrated and placed into a selected injured region.

Platelets contain proteins and growth factors involved in normal tissue repair.

Research into PRP for degenerative spinal pain is developing. A systematic review found encouraging results for some forms of low-back pain, but protocols and study quality vary, so PRP is not a guaranteed solution for spinal degeneration (Muthu et al., 2023).

Some clinics also use platelet-and-fibrin preparations, sometimes referred to as PFP or related platelet-rich fibrin products. Terminology and preparation methods are not standardized. Injectable platelet-rich fibrin is being studied in orthopedics, but researchers continue to call for better clinical evidence (Costa et al., 2025).

These treatments should therefore be viewed as selected orthobiologic options, not automatic treatments for every painful disk or joint.

MFAT: Microfragmented Adipose Tissue

Microfragmented adipose tissue, or MFAT, is prepared from a patient’s own adipose tissue and mechanically processed for use in selected orthopedic applications.

Most higher-quality MFAT research currently involves joints such as the knee rather than complex spinal nerve compression.

Recent systematic reviews suggest potential improvements in pain and function for knee osteoarthritis, but they also point out limitations in the amount and quality of evidence (Hohmann et al., 2025).

For spinal patients, MFAT should therefore be considered only after careful diagnosis and discussion of the evidence, alternatives, risks, and intended treatment target.

What About Peptide Therapy?

Peptide therapies have attracted attention because some peptides are being studied for tissue signaling, inflammation, metabolism, and repair.

However, patients should understand an important difference between research interest and established treatment.

Several peptides promoted online for musculoskeletal healing are not FDA-approved treatments for spinal disk, joint, or nerve repair.

The FDA has specifically reported limited human safety information and potential concerns involving compounded substances such as BPC-157, CJC-1295, ipamorelin, and several other peptides (U.S. Food and Drug Administration, 2026).

For that reason, peptide treatment should never be presented as a proven way to regenerate a spinal disk or heal a compressed nerve. Any peptide discussion should occur under qualified medical supervision with attention to legal status, evidence, medication interactions, and patient-specific risks.

IV Infusion Therapy as Medical Support

IV therapy is another tool that must match the patient’s actual medical needs.

An IV can provide fluids, medications, or specific nutrients when medically indicated. In specialized pain medicine, IV ketamine is one treatment sometimes considered for difficult conditions such as severe CRPS (Cleveland Clinic, 2022).

However, general vitamin or nutrient IV therapy should not be described as directly rebuilding a damaged disk or removing nerve compression.

Within an integrative program, medical evaluation may identify dehydration, nutritional deficiencies, medication issues, metabolic problems, or other factors that could influence overall recovery.

In that setting, IV therapy is supportive medical care, not a substitute for treating the structural cause of spinal pain.

A Multidisciplinary Model in El Paso, Texas

At Injury Medical Clinic PA in El Paso, the care model combines medical oversight with integrative chiropractic treatment.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, works in chiropractic care, advanced practice nursing, functional medicine, personal injury care, neuromusculoskeletal evaluation, and rehabilitation.

His published clinical observations emphasize looking beyond the place where the patient feels pain and evaluating spinal mechanics, nerve involvement, movement, inflammation, functional limitations, and the patient’s broader medical picture (Jimenez, n.d.).

Working with him is Dr. Maria Guadalupe Cardenas, MD, whom Injury Medical Clinic materials identify as board-certified in internal medicine and Medical Director and Collaborative Physician.

Independent public provider information shows that Dr. Cardenas has practiced medicine for more than 40 years and identifies her specialty as internal medicine. Current public provider records list:

  • NPI: 1164426749
  • Texas medical license: J2933
  • Specialty: Internal Medicine

This multidisciplinary structure enables the team to review different parts of a complicated case together.

Dr. Jimenez’s role may focus on:

  • Chiropractic evaluation
  • Joint and spinal mechanics
  • Functional medicine
  • Neuromusculoskeletal examination
  • Personal injury care
  • Rehabilitation
  • Movement restoration

Dr. Cardenas’s internal medicine role can add:

  • Medical oversight
  • Review of chronic health conditions
  • Medication review
  • Cardiovascular and metabolic risk assessment
  • Laboratory interpretation
  • Safety screening
  • Medical referrals
  • Coordination of more complex medical needs

The result is a broader approach than treating a painful spinal segment alone.

A More Complete Recovery Strategy

For some patients with complex spinal joint and nerve pain, a coordinated treatment plan may move through several stages.

Phase 1: Find the pain generators

Determine whether the major problem involves:

  • Disk injury
  • Facet joints
  • Nerve compression
  • Muscles
  • Ligaments
  • Inflammation
  • Scar tissue
  • Poor mechanics
  • Several of these together

Phase 2: Calm symptoms when needed

Selected patients may benefit from:

  • MLS laser
  • Shockwave therapy
  • Medication
  • Epidural treatment
  • Other pain-management approaches

Phase 3: Restore movement

Integrative chiropractic care and rehabilitation may address:

  • Mobility
  • Posture
  • Muscle balance
  • Stability
  • Strength
  • Movement patterns

Phase 4: Consider advanced biological options

When appropriate, the team may discuss:

  • PRP
  • Platelet/fibrin preparations
  • MFAT
  • Other evidence-based or investigational options

Phase 5: Address the whole patient’s health

Functional and medical evaluations may include:

  • Nutrition
  • Sleep
  • Blood sugar
  • Weight
  • Inflammation
  • Hydration
  • Medications
  • Chronic health conditions
  • Appropriate IV support when medically indicated

This is a more realistic meaning of integrative care. Treatments are coordinated around a diagnosis instead of simply adding more procedures.

When Traditional Treatment Has Not Worked

If you have been living with chronic neck pain, back pain, sciatica, numbness, tingling, weakness, or spinal joint pain in El Paso or West Texas, continued symptoms deserve another look.

A second opinion may reveal that the original problem is more complicated than one painful disk, one arthritic joint, or one irritated nerve.

The goal should be to answer three questions:

  1. What is causing the pain?
  2. Which problems can be treated conservatively?
  3. Which treatments offer reasonable benefits based on the patient’s diagnosis and current evidence?

Complex spinal joint and nerve pain often requires coordination rather than a single treatment.

For the right patient, integrative chiropractic care, rehabilitation, medical oversight, laser or shockwave therapy, targeted injections, and carefully selected regenerative approaches may work together as parts of a comprehensive plan.

But no procedure should be promised to provide complete healing.

The strongest treatment plan is the one built around an accurate diagnosis, measurable functional goals, careful safety screening, and regular re-evaluation.

Facet Syndrome Pain Treatment El Paso, TX

References

Advanced Orthopaedics & Sports Medicine. (n.d.). Radiculopathy.

Arefi, S., Saidian, S. R., Mokhtari, M., & Eliaspour, D. (2025). MLS laser reduce pain in patients with chronic low back pain. Anesthesiology and Pain Medicine, 15(1), e158778.

Armon, C., Narayanaswami, P., Potrebic, S., Gronseth, G., et al. (2025). Epidural steroids for cervical and lumbar radicular pain and spinal stenosis: Systematic review summary. Neurology, 104(5), e213361.

Butler, B. (2026, April 7). Nerve pain vs. joint pain: Understanding the differences and finding proper relief. Oakland Spine & Physical Therapy.

Cleveland Clinic. (2022, September 30). Complex regional pain syndrome (CRPS).

Costa, B. R., et al. (2025). The role of injectable platelet-rich fibrin in orthopedics: Where do we stand?.

Dallas Spine Surgery. (2026, April 3). What causes nerve compression in the spine?.

Ferdinandov, D. (2024). Focused extracorporeal shockwave therapy for the treatment of low back pain: A systematic review. Frontiers in Medicine, 11, 1435504.

Hohmann, E., Keough, N., Frank, R. M., & Rodeo, S. (2025). Micro-fragmented adipose tissue demonstrates comparable clinical efficacy to other orthobiologic injections in treating symptomatic knee osteoarthritis. Arthroscopy, 41(2), 418–441.e14.

Jimenez, A. (n.d.). Dr. Alex Jimenez—El Paso chiropractor, family nurse practitioner, functional and injury care.

Kansas Pain Management. (2026, March 18). Is your back pain coming from nerves, muscles, or joints?.

Labanca, L., Berti, L., Tedeschi, R., D’Auria, L., Platano, D., & Benedetti, M. G. (2024). Effects of MLS laser on pain, function, and disability in chronic non-specific low back pain: A double-blind placebo randomized-controlled trial. Journal of Back and Musculoskeletal Rehabilitation, 37(5), 1289–1298.

National Center for Complementary and Integrative Health. (n.d.). Spinal manipulation: What you need to know.

U.S. Food and Drug Administration. (2026). Certain bulk drug substances for use in compounding that may present significant safety risks.

Wu, Z., Zhou, T., & Ai, S. (2023). Extracorporeal shock wave therapy for low back pain: A systematic review and meta-analysis. Medicine, 102(52), e36596.

Supplemental Media Resources Provided for This Article

YouTube spinal-pain educational video—resource 1

YouTube spinal-pain educational video—resource 2

Manipal Hospitals—spine problems affecting vertebrae, disks, nerves, and surrounding muscles

Nerve Pain After Sports: Insights and Solutions

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Nerve Pain After Sports: Insights and Solutions
Nerve Pain After Sports: Insights and Solutions

Nerve Pain After Sports: An Integrative Path From Irritated Nerves to Stronger Movement

Abstract

Athletes and active adults can develop neuropathies. These nerve problems usually come from repeated small strains, sudden compression, or stretching during sport. This article explains how sports neuropathies start, how they feel, and why they are often mistaken for a simple sprain or tendon injury. It then guides the reader through an integrative plan that uses chiropractic care to restore motion, advanced tools such as laser and shockwave therapy to support local healing, and regenerative medicine or targeted injections when tissue repair needs extra help. The article also describes the team model at Injury Medical Clinic PA in El Paso, Texas, where chiropractic care, medical oversight, functional medicine, personal injury care, and rehabilitation work together.

Nerve Pain After Sports: Insights and Solutions

Are There Neuropathies in Sports?

Yes, neuropathies do occur in sports and typically result from repetitive microtrauma, acute compression, or stretching of the nerves during athletic activity.

A neuropathy means a peripheral nerve is irritated, compressed, or injured. Peripheral nerves carry messages that help a person feel the ground, grip a bar, lift an arm, or keep balance. When those messages are disrupted, the body may feel burning, tingling, numbness, weakness, or a sharp electric snap.

Sports nerve injuries are not the most common athletic injuries, but they are important. They can linger, change the way a person moves, and delay a safe return to activity. Sports-related peripheral neuropathies make up a small part of all nerve problems and more often involve the arms than the legs (Mitchell et al., 2014). Older clinical reports also show that many of these injuries come from repeated pressure rather than one dramatic tear (Hirasawa & Sakakida, 1983).

That is why a nerve problem can hide inside what looks like a shoulder strain, elbow ache, or stubborn foot pain.

A Simple Way to Understand the Injury

Think of a nerve as a cable that needs room, blood flow, and the ability to slide as the body moves. Sport can crowd that cable in three ways.

Repeated small strain
The same motion, done over and over, can rub a nerve against bone, fascia, or a tight muscle. Throwers often load the ulnar nerve at the elbow. Overhead athletes may stress nerves around the shoulder. Runners and dancers may load nerves in the ankle and foot (Izzi et al., 2001; Senk & Carlson, 2026).

Sudden compression
A hit, fall, swelling, tight shoe, or long time in one position can pinch a nerve. Cyclists may compress nerves in the hands or pelvic area. In contact sports, athletes can compress nerves in the neck and shoulder.

Stretching
A hard landing, awkward slide, or side-bending force can pull a nerve. Stingers and burners in football and wrestling are well-known examples of this stretch-and-compression pattern (Stokes et al., 2025).

Training errors add to the risk. A fast jump in mileage, poor technique, muscle imbalance, and extra swelling can all reduce the space a nerve needs (Tettenborn et al., 2016).

Common Sports Nerve Problems

Different sports tend to irritate different nerves.

Upper body

  • Stingers and burners after contact to the neck or shoulder
  • Suprascapular or axillary nerve irritation in throwing and overhead sports
  • Ulnar nerve pain at the elbow in baseball and other throwing sports
  • Median or ulnar nerve compression at the wrist in cycling, lifting, and gripping sports
  • Radial nerve irritation in racket sports

Lower body

  • Peroneal nerve injury near the outside of the knee
  • Tarsal tunnel syndrome at the inside of the ankle
  • Sural nerve pain along the outside of the ankle and heel
  • Medial plantar nerve irritation, sometimes called jogger’s foot
  • Morton’s neuroma between the toes

Ankle and foot neuropathies are easy to miss. They can look like plantar fasciitis, Achilles tendon pain, or a sprain that never fully settles (Senk & Carlson, 2026). Sural nerve irritation can also mimic Achilles problems. Neuropathic pain in sport may start as activity-related burning and later become sharper or more electric (Bastani, n.d.).

Signs That the Problem May Be a Nerve

Nerve pain does not always announce itself clearly. These clues deserve a closer look:

  • Burning, tingling, or pins-and-needles in a clear path
  • Numbness in part of the hand, foot, or skin
  • Weakness that does not match a simple muscle pull
  • Pain that returns with one grip, stride, throw, or shoe
  • Symptoms that fade with rest and come back as soon as training resumes
  • Heel, arch, or outside-ankle pain that does not fit a typical tendon story

Imaging and nerve tests can help when the picture is unclear. MRI may show nerve swelling or muscle changes (Mitchell et al., 2014). Ultrasound can look for compression. EMG and nerve conduction studies can confirm which nerve is involved and how severe the injury is (Stokes et al., 2025). Early diagnosis provides a person with a better chance of recovering without long-term changes in strength or movement.

How Integrative Chiropractic Care Fits In

Integrative chiropractic care looks at the nerve and the structures around it. A nerve can be irritated because a joint is stiff, a disc is taking up space, a muscle is crowding a tunnel, or a movement pattern keeps stretching the same spot.

Chiropractic care can help by:

  • Improving spinal and limb joint motion
  • Reducing mechanical pressure around an irritated nerve
  • Easing tight soft tissue that crowds a nerve path
  • Retraining posture, gait, and sport mechanics
  • Guiding a safer return to load

Integrative chiropractic therapy is a strong, multi-layered approach to treating sports neuropathies, especially when combined with advanced modalities, regenerative medicine, and targeted injections. This procedure combines structural and cellular healing by fixing mechanical misalignment, improving metabolic function, and restoring biological function all at once.

The practical meaning is simple. The joint needs to move. The local tissue needs blood flow. The nerve needs a calmer place to heal. Treating only one layer often leaves the problem half-solved.

Laser Therapy and Shockwave Therapy

Two advanced tools are often used alongside chiropractic care.

Laser therapy, also called photobiomodulation, uses focused light to support cell energy and calm irritated tissue. In chiropractic and rehabilitation settings, it reduces inflammation around nerves, supports local circulation, and eases neuropathic pain (ChiroEco, n.d.; Medray Laser, n.d.; Lazar Spinal Care, n.d.). Class IV and MLS-style lasers are common options when the goal is drug-free support for nerve-related pain (Attaman, n.d.; Harrington, n.d.).

Shockwave therapy sends acoustic waves into stubborn soft tissue. It can increase blood flow, help thick tissue remodel, and support healing in areas that have become tight or poorly nourished (Holistiq, n.d.; HealthWorks, n.d.; Integrated Physical Medicine, n.d.). That is useful when a nerve sits next to an overused tendon, scarred fascia, or a crowded tunnel.

Laser and shockwave are not the same tool. Laser is often used to calm cells and improve circulation. Shockwave is often used for thicker, more chronic soft-tissue restriction (MVMT Chiropractic, n.d.). Both work best when the mechanical problem is also treated.

Regenerative Medicine and Targeted Injections

Some sports neuropathies linger because nearby discs, ligaments, or tunnels heal slowly. Regenerative care aims to support repair, not only cover symptoms.

Common options include:

  • PRP (platelet-rich plasma): concentrated platelets from the person’s own blood
  • Platelet-fibrin products: a natural scaffold that can hold healing signals in place
  • MFAT (microfragmented adipose tissue): a person’s own fat tissue, processed and used to support cushioning, signaling, and inflammation control (Fu & Wang, 2025; Regen Axis Health, n.d.)
  • Image-guided injections: used when a joint, ligament, or nerve tunnel needs a more focused stimulus

These options are not right for every case. They work best when movement is also restored. If a nerve remains pinched by poor joint mechanics, the biological signal has a harder time lasting (Jimenez, n.d.-a; Jimenez, n.d.-b). Nutrition supports the same process. Protein, vitamin C, zinc, omega-3 fats, antioxidants, and hydration all help tissue repair and inflammation control (Chiropractic Scientist, n.d.).

Clinical Observations From Dr. Alexander Jimenez

Clinical observations from Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, return to one practical theme: treat the injured tissue and the movement pattern together. An injection, a laser visit, or an adjustment can help. It is rarely the whole plan. The person still needs better joint motion, better strength, and a smarter training load (https://dralexjimenez.com/; https://www.linkedin.com/in/dralexjimenez/).

That view is useful in sports neuropathies because the nerve injury is often linked to compensation. A stiff ankle can overload a foot nerve. A restricted thoracic spine can change throwing mechanics and stress a shoulder nerve. A guarded gait after a collision can keep a lower-limb nerve irritated long after the first bruise fades.

A Team Model in El Paso

At Injury Medical Clinic PA in El Paso, Texas, we build this layered plan as a team process.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, provides chiropractic care and integrative evaluation. Dr. Maria Guadalupe Cardenas, MD, board-certified in internal medicine (NPI #1164426749, Texas MD License #J2933), has more than 40 years of experience as an internist. She works with Dr. Jimenez and serves as medical director and collaborative physician at the practice. This multidisciplinary setup is common in integrative or injury care clinics, where an MD provides medical direction alongside a chiropractor.

The team integrates:

  • Chiropractic care for joint motion and nerve pressure
  • Medical oversight for safety, imaging decisions, and complex cases
  • Functional medicine for inflammation, nutrient status, and recovery capacity
  • Personal injury care when a crash, fall, or delayed sports injury needs clear documentation
  • Rehabilitation to restore strength, balance, and sport skill

That mix matters because a sports neuropathy is rarely just one problem. It may involve a spinal joint, a foot-strike pattern, swelling, old scar tissue, or a metabolic factor that slows healing.

What the Recovery Journey Can Look Like

A clear path helps people know what comes next:

  1. Tell the full story of the sport, the hit, the training change, and when symptoms started.
  2. Map the nerve path with a hands-on exam.
  3. Use imaging or nerve testing when the diagnosis is still unclear.
  4. Take pressure off the nerve with chiropractic care and movement changes.
  5. Support healing with laser, shockwave, nutrition, and, when needed, regenerative injections.
  6. Rebuild capacity before full return to sport or work.

Most sports nerve injuries can start with conservative care. Surgery is considered when symptoms persist, or testing shows a more severe structural problem (Stokes et al., 2025; Tettenborn et al., 2016).

The hopeful point is this: sports neuropathies are real, but they are also workable. When structural care and cellular repair work together, they aim for more than just less pain. The goal is a nerve that can send a clearer signal and a body that can move with more confidence.

El Paso, TX Chiropractic Alignment

References

Attaman, J. (n.d.). MLS laser therapy for joint, nerve, and spine pain.

Bastani, M. (n.d.). Neuropathic pain in sports injuries. Journal of Sports and Rehabilitation Sciences.

ChiroEco. (n.d.). Laser therapy for neuropathic pain.

Chiropractic Scientist. (n.d.). Nutrition supports regenerative therapies and recovery.

Fu, H., & Wang, C. (2025). Micro-fragmented adipose tissue—An innovative therapeutic approach: A narrative review.

Harrington, P. (n.d.). Comparing Class 4 laser therapy, PEMF, and shockwave treatments in chiropractic care.

HealthWorks. (n.d.). Combining shockwave therapy and chiropractic: A powerful duo for chronic back pain.

Hirasawa, Y., & Sakakida, K. (1983). Sports and peripheral nerve injury. The American Journal of Sports Medicine, 11(6), 420–426.

Holistiq. (n.d.). The power of combining chiropractic treatment and shockwave therapy.

Integrated Physical Medicine. (n.d.). The benefits of integrating shockwave therapy.

Izzi, J., Dennison, D., Noerdlinger, M., Dasilva, M., & Akelman, E. (2001). Nerve injuries of the elbow, wrist, and hand in athletes. Clinics in Sports Medicine.

Jimenez, A. (n.d.-a). How regenerative medicine and chiropractic care work together.

Jimenez, A. (n.d.-b). Regenerative and integrative care for sciatica: PRP, PFP, mFAT, epidurals, and chiropractic support.

Lazar Spinal Care. (n.d.). Chiropractor laser therapy for neuropathy.

Medray Laser. (n.d.). Peripheral neuropathy: A chiropractic opportunity.

Mitchell, C. H., Brushart, T. M., Ahlawat, S., Belzberg, A. J., Carrino, J. A., & Fayad, L. M. (2014). MRI of sports-related peripheral nerve injuries. American Journal of Roentgenology, 203(5), 1075–1084.

MVMT Chiropractic. (n.d.). Shockwave therapy vs. laser therapy.

Regen Axis Health. (n.d.). Adipose-derived cell therapy: MFAT.

Senk, A. M., & Carlson, A. (2026). Ankle and foot neuropathies and entrapments. PM&R KnowledgeNow.

Stokes, D. C., Toole, K., & Cushman, D. M. (2025). Upper extremity neuropathies in athletes. Current Sports Medicine Reports, 24(11), 356–365.

Tettenborn, B., Mehnert, S., & Reuter, I. (2016). Peripheral nerve lesions due to sports.

Integrative Obesity Care and Cardiometabolic Wellness

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Discover the benefits of integrative obesity and cardiometabolic care for comprehensive health improvement and obesity management.

Abstract

As a clinician practicing at the intersection of chiropractic care, advanced practice nursing, and functional medicine, I have seen how obesity and its cardiometabolic comorbidities reshape health trajectories for adults aged 40 to 60. In this educational post, I synthesize the latest findings from leading researchers and landmark trials to present a comprehensive, integrative roadmap for assessing and treating obesity-driven conditions, including insulin resistance, type 2 diabetes, hypertension, dyslipidemia, heart failure with preserved ejection fraction, metabolic dysfunction-associated steatotic liver disease, obstructive sleep apnea, osteoarthritis, chronic pain, depression, stress, and the complex physiology of menopause and sarcopenic obesity.

I lead Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, a multidisciplinary practice where I, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, integrate chiropractic care, functional medicine, rehabilitation, and personal injury services with the medical direction of our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), who brings over 40 years of internal medicine experience. Our integrative model aligns medical oversight, precise diagnostics, functional and rehabilitative interventions, and evidence-based pharmacotherapy to reduce adiposity, improve metabolic function, preserve muscle, protect joints, and elevate quality of life.

You will find clear explanations of physiological mechanisms, stepwise protocols, clinical reasoning for each technique, in-depth case studies, and practical strategies for patients and clinicians. Throughout, I include my clinical observations from sciatica.clinic and professional updates on LinkedIn to illustrate how integrative chiropractic care supports neuromusculoskeletal function, autonomic balance, pain control, and adherence to cardiometabolic treatments. The collective research foundation includes the SELECT trial (semaglutide and cardiovascular outcomes), STEP-HFpEF (semaglutide for HFpEF), SURMOUNT-1 (tirzepatide and diabetes progression), SURMOUNT-OSA (tirzepatide and sleep apnea), STEP trials (weight reduction and osteoarthritis), the Look AHEAD trial (long-term lifestyle outcomes in diabetes), MAESTRO-NASH (resmetirom for MASH), and core guideline statements from the ADA, AACE/ACE, NAMS, ACOG, AHA/ACC, and AASM.

Our Integrative Clinic in El Paso: A Multidisciplinary Care Model Led by Medical Direction and Chiropractic Integration

I lead Injury Medical Clinic PA—also known as Mission Plaza Injury Medical Clinic—in El Paso, Texas, where our team integrates multiple disciplines to provide comprehensive, patient-centered care. At the core of our model is a collaborative partnership between my roles in chiropractic and advanced nursing practice, and the medical direction of our internal medicine physician.

  • My credentials and roles
    • Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST
    • Chiropractic care: neuromusculoskeletal assessment, spinal and extremity adjustments, soft tissue therapies, movement re-education
    • Functional medicine: systems-biology diagnostics, metabolic root-cause analysis, nutritional therapeutics, stress and sleep integration
    • Rehabilitation: graded loading, movement quality, joint protection
    • Personal injury care: documentation, impairment analysis, coordinated rehabilitative pathways
  • Medical direction and collaborative oversight
    • Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933)
    • Over 40 years as an internist, supervising diagnostics, pharmacotherapy, and complex case management
    • Provides medical direction typical of integrative and injury clinics and safeguards evidence-based standards and patient safety
  • How our team integrates care
    • Medical oversight ensures safe, effective protocols and precision in diagnostics (labs, imaging, risk stratification)
    • Chiropractic care reduces pain, restores joint mechanics, modulates autonomic tone, and enables activity.
    • Functional medicine identifies root causes across hormonal, inflammatory, metabolic, gastrointestinal, and stress domains.
    • Rehabilitation builds capacity: strength, flexibility, balance, proprioception, and graded exposure to movement.
    • Personal injury services align recovery with metabolic and musculoskeletal health goals.
    • Continuous outcome tracking: weight, waist circumference, body composition, blood pressure, A1c, lipids, pain scales, mobility, and sleep metrics

This multidisciplinary setup allows us to treat cardiometabolic disease and biomechanical dysfunction synergistically, ensuring each intervention supports the others.

Integrative Care Philosophy: Why Treating Obesity Is Treating Cardiometabolic Disease

Our guiding principle is simple and profoundly evidence-based: treating obesity is treating its downstream cardiometabolic disorders. Excess adiposity, especially visceral fat, drives inflammation, insulin resistance, dyslipidemia, hypertension, endothelial injury, sleep apnea, musculoskeletal pain, and neurohormonal imbalance. We aim not merely to reduce weight but to reduce adipose tissue—protecting and increasing lean muscle, restoring metabolic flexibility, and improving function and quality of life.

  • Our core goals
    • Reduce adiposity, especially visceral fat
    • Preserve and increase lean muscle mass and strength
    • Lower cardiometabolic risk (ASCVD, heart failure, diabetes, MASLD/MASH, OSA)
    • Improve functional capacity: walking, stairs, daily activities, sport return
    • Elevate quality of life: energy, mood, sleep, pain reduction, confidence
  • Clinically meaningful weight loss thresholds (Ryan & Yockey, 2017)
    • 5–5%: quality of life improvements; early glycemic gains; mobility relief
    • 5–10%: dyslipidemia improvements, knee osteoarthritis pain reduction, sleep apnea severity reduction
    • 10–15%+: hypertension improvements, diabetes remission potential, MASLD resolution potential, significant cardiovascular risk reduction
  • Why percent targets matter
    • They create achievable milestones that compound toward larger health gains
    • They provide dose-response clarity for risk reduction and motivate adherence

Deconstructing Cardiometabolic Syndrome: Diagnostic Criteria and Pathophysiology

Cardiometabolic syndrome is a cluster of metabolic abnormalities that amplify risk for type 2 diabetes, stroke, and cardiovascular events. At its core is a bidirectional loop between obesity and insulin resistance, fueled by chronic low-grade inflammation from adipose tissue cytokines and adipokines.

  • Diagnostic criteria (must have 3 of 5) (Grundy et al., 2005)
    • Central obesity: waist circumference > 40 inches (men) or > 35 inches (women)
    • Triglycerides ≥ 150 mg/dL or on therapy
    • Low HDL: < 40 mg/dL (men) or < 50 mg/dL (women)
    • Blood pressure ≥ 130/85 mmHg or on antihypertensives
    • Fasting glucose ≥ 100 mg/dL or dysglycemia diagnosis
  • Pathophysiology
    • Adipose inflammation: TNF-alpha, IL-6, resistin, and leptin signaling derangements (Powell-Wiley et al., 2021)
    • Insulin resistance: impaired receptor signaling in muscle, liver, and fat; compensatory hyperinsulinemia
    • Neurohormonal activation: sympathetic drive, renin-angiotensin-aldosterone system, vasoconstriction, sodium retention
    • Atherogenic dyslipidemia: elevated triglycerides, suppressed HDL, ApoB particle elevation.
    • Endothelial dysfunction: reduced nitric oxide bioavailability, vascular stiffness
  • Building a clinical risk profile
    • Vital signs: standardized blood pressure measurements after rest; accurate waist circumference
    • Body composition: InBody or DEXA scan to differentiate fat mass, lean mass, water, and estimate visceral adipose tissue
    • Laboratory evaluation
      • Fasting lipid panel: TC, LDL, HDL, triglycerides
      • Advanced lipids: ApoB particle count; Lipoprotein(a) [Lp(a)] for genetic risk
      • Glycemic markers: fasting glucose, HbA1c, fasting insulin (for insulin resistance), HOMA-IR calculation
    • Cardiovascular imaging: selective Coronary Artery Calcium (CAC) scoring
    • Psychosocial evaluation: PHQ-9, GAD-7, stress assessment, sleep quality, social support, and food relationship

Our integrative framework leverages these data to tailor interventions, calibrate pharmacotherapy, and track progress longitudinally.

Obesity and Cardiovascular Disease: Inflammation, Epicardial Fat, and Atherosclerosis

Obesity harms the cardiovascular system through mechanical burden, hemodynamic stress, inflammatory signaling, and neurohormonal activation. Of particular concern is epicardial and pericardial fat—locally pro-inflammatory tissue that shares blood supply with the coronary arteries and directly accelerates atherosclerosis.

  • Mechanisms of cardiovascular injury (Powell-Wiley et al., 2021)
    • Mechanical load: increased cardiac output demands; left ventricular hypertrophy risk
    • Hemodynamic changes: diastolic dysfunction; filling pressure abnormalities
    • Inflammation: endothelial damage; plaque initiation and progression
    • Neurohormonal derangement: RAAS activation; sympathetic tone; leptin resistance
  • Epicardial fat (“sick fat disease”)
    • Bathes myocardium and coronary arteries with inflammatory mediators
    • Promotes atherosclerosis, atrial fibrillation via electrical remodeling and fibrosis
    • Contributes to diastolic dysfunction and HFpEF through stiffness and local inflammation
  • Landmark cardiovascular evidence: SELECT trial (Ryan, Ling, & Bray, 2022)
    • Over 17,000 patients; age > 45; BMI ≥ 27; established ASCVD; no diabetes
    • Weekly semaglutide 2.4 mg vs placebo; ~40 months follow-up
    • 20% reduction in major adverse cardiovascular events (MACE)
    • Proof that treating obesity reduces heart attack and stroke risk

This is a seminal shift confirming that effective obesity pharmacotherapy confers hard cardiovascular event reduction independent of diabetes status.

Heart Failure Prevention and Treatment: Stage A Risk Modification and HFpEF

Heart failure risk is elevated in obesity through epicardial fat effects, hypertension, and diabetes. Stage A heart failure—risk factors present without structural disease or symptoms—is common in midlife and is our window for prevention.

  • Stage A heart failure strategy.
    • Target weight loss: ≥ 10–15% for vascular and hemodynamic improvements
    • Four pillars
      • Nutrition: DASH and Mediterranean patterns emphasizing fruits, vegetables, lean protein, healthy fats, and reduced sodium
      • Physical activity: ≥ 150 minutes per week of moderate-intensity activity, plus resistance training
      • Sleep optimization: 7–8 hours nightly; screening and treatment for OSA
      • Pharmacological support: GLP-1 receptor agonists (e.g., semaglutide) to achieve meaningful weight loss; off-label application guided by risk profile
  • Symptomatic HFpEF: STEP-HFpEF trial (Kosiborod et al., 2023)
    • Semaglutide improved symptoms, physical function, quality of life, and weight
    • Supports GLP-1 therapy as a primary option for HFpEF management in obesity
  • Emerging evidence: tirzepatide (SUMMIT trial preliminary results)
    • Dual GIP/GLP-1 agonism shows impressive benefits for HFpEF, including reduced risk of death or worsening heart failure
    • Reinforces the metabolic-cardio synergy from incretin-based therapies

Dyslipidemia Management: ApoB, HDL, Triglycerides, and Weight-Driven Improvements

Obesity-related dyslipidemia includes high triglycerides, low HDL, and often a rise in small, dense LDL particles. Reducing adiposity transforms lipid profiles—lowering ApoB particle load and elevating HDL—particularly when combined with heart-healthy nutrition and exercise.

  • Clinical approach to dyslipidemia
    • Evaluate: fasting panels, ApoB, Lp(a), ASCVD risk calculator
    • Weight reduction: 5–15% reductions dramatically improve lipid metrics (Ryan & Yockey, 2017)
    • Nutrition: low-fat Mediterranean-style diet, very high in soluble fiber (oats, barley, beans, apples, psyllium) to bind and reduce cholesterol reabsorption (Freeman et al., 2017)
    • Physical activity: ≥ 150 minutes/week moderate intensity to improve HDL and insulin sensitivity
    • Pharmacotherapy: statins remain cornerstone; anti-obesity medications synergize lipid improvements by reducing adiposity

Hypertension in Obesity: Mechanisms and Dose-Response to Weight Loss

Hypertension risk rises with age and is strongly tied to excess weight. Obesity is responsible for a significant proportion of essential hypertension—approximately 78% in men and 65% in women.

  • Mechanisms (Hall et al., 2015)
    • Physical compression: visceral fat compresses kidneys; microvascular expansion is limited; peripheral resistance increases
    • Inflammation and vasoconstriction: adipose-derived cytokines inflame vessels and promote narrowing
    • Hormonal activation: RAAS upregulation leads to sodium and water retention
    • Increased cardiac output: greater force against arterial walls
  • Impact of weight loss
    • Framingham data: systolic pressure increased ~ 4 mmHg per 10 lbs gained; weight loss reverses trend
    • Meta-analysis: 3–9% weight loss reduces systolic and diastolic pressures by ~ 3 mmHg
    • Clinical goal: 10–15% weight reduction for significant blood pressure effects
    • DASH diet: cornerstone nutritional strategy; potassium, magnesium, calcium support; low sodium
  • Coordinated medication management
    • As blood pressure improves, deprescribing under medical direction prevents hypotension and adverse events.
    • Home monitoring enhances safety during weight-driven medication adjustments.

Insulin Resistance: Central Metabolic Dysfunction Driving Obesity, Diabetes, and Hypertension

Insulin resistance sits at the epicenter of obesity’s cardiometabolic cascade. Elevated free fatty acids, adipokine dysregulation, and chronic inflammation disrupt insulin signaling in muscle and liver, leading to hyperinsulinemia—the biochemical environment of constant storage.

  • Physiologic underpinnings (Lin & Li, 2021)
    • Enlarged adipocytes leak free fatty acids, exacerbating hepatic triglyceride synthesis.
    • Hyperinsulinemia promotes lipogenesis and inhibits lipolysis
    • High insulin increases hunger (reactive hypoglycemia), cravings, and reduces metabolic rate
    • Elevated insulin drives renal sodium retention and vascular smooth muscle proliferation
  • Evaluation and early identification
    • Fasting insulin with glucose; HOMA-IR calculation
    • METS-IR and related indices; mortality associations highlight risk even before diabetes diagnosis (Li et al., 2023)
  • Therapeutic strategies
    • Lower-carbohydrate nutrition: reduces glycemic load, insulin demand, hepatic glucose output; shifts metabolism from storage to oxidation
    • Resistance training: increases GLUT4 translocation; enhances insulin sensitivity; preserves muscle
    • Chiropractic integration: autonomic modulation; pain reduction facilitating activity; movement quality and function
    • Pharmacotherapy: metformin (hepatic glucose production reduction); incretin-based therapies (GLP-1, dual GIP/GLP-1) for weight loss and insulin sensitivity

Understanding insulin resistance explains why “eat less, move more” often fails without hormonal recalibration; integrative strategies restore physiologic balance.

MASLD and MASH: Modern Liver Disease Nomenclature and Treatment

The shift to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) emphasizes metabolic drivers over exclusion of alcohol. Obesity and insulin resistance are central to these liver conditions.

  • Prevalence and risk progression
    • Over two-thirds of MASLD patients have obesity.
    • MASH involves inflammation and hepatocyte injury; fibrosis progression increases risks for cirrhosis and hepatocellular carcinoma
  • Screening and evaluation (AASLD guidance reflected across practice)
    • Liver enzymes: ALT greater than AST is a common pattern
    • Imaging: review for hepatic steatosis on prior studies
    • FIB-4 score: age, AST, ALT, platelets; stratifies risk; high-risk thresholds prompt FibroScan referral
  • Treatment strategy
    • Weight reduction: ≥ 10% weight loss can resolve steatohepatitis and improve fibrosis.
    • Nutrition: Mediterranean-style, lower-carbohydrate, lower-fat pattern emphasizing whole foods
    • Physical activity: aerobic and resistance training; muscle mass improves insulin sensitivity
    • Supplementation: vitamin E in selected biopsy-proven MASH without diabetes
    • Pharmacotherapy: GLP-1 and dual GIP/GLP-1 agonists reduce liver fat via weight loss; ongoing trials
    • New FDA-approved therapy: resmetirom (Rezdiffra) for MASH with F2–F3 fibrosis (MAESTRO-NASH trial evidence)

Our approach addresses the metabolic roots—weight loss and insulin sensitivity are central levers in liver recovery.

Chronic Stress, Depression, and Obesity: Neurobiology of Eating Behavior and Adherence

Stress and depression profoundly influence obesity through neurohormonal, cognitive, and behavioral pathways. Chronic stress alters hunger and satiety, impairs executive function, and increases the brain’s reward response to palatable foods; cortisol promotes visceral adiposity and insulin resistance.

  • Overlapping epidemics
    • CDC data: 43% of adults with depression are obese (Pratt & Brody, 2014)
    • Bidirectional relationship; mood disorders increase risk for obesity and vice versa
  • Screening and holistic support
    • PHQ-9 for depression; GAD-7 for anxiety; PSS for stress
    • Sleep optimization: improved architecture reduces insulin resistance and cortisol
    • Nutrition and movement: whole-food patterns and gentle exercise improve mood and cognition
    • Therapy and social support: counseling for coping skills; reduce weight bias traumas
    • Pharmacotherapy: careful use with mental health providers; avoid weight-promoting agents when possible
  • Weight bias in medicine
    • Patients commonly report stigma and dismissal; we create safe, empathetic environments.
    • Validating experiences and listening deeply builds trust and improves adherence.

Chiropractic care reduces pain, improves mobility, and modulates autonomic tone—loosening stress’s grip and enabling consistent engagement with health behaviors.

Musculoskeletal Pain and Mobility: Biomechanics, Inflammation, and Integrative Rehabilitation

Chronic pain and mobility loss in midlife often stem from the dual burden of mechanical overload and metabolic inflammation. Obesity multiplies joint forces and inflames cartilage through cytokines.

  • Joint loading mechanics
    • Walking: knee force ~ 3x body weight
    • Stairs: ~ 6x body weight
    • Jumping: ~ 10x body weight
    • A 250-pound person experiences ~ 750 lbs across the knees while walking; ~ 1,500 lbs on stairs; ~ 2,500 lbs when jumping
  • Clinical evaluation
    • Mobility, strength, balance testing
    • Timed Get-Up-and-Go test for functional capacity and fall risk
    • Pain scales; imaging as indicated
  • Integrative chiropractic and physical therapy
    • Adjustments: restore joint mechanics; reduce nociception; improve spinal alignment
    • Physical therapy: strengthen musculature; improve range; teach body mechanics
    • Non-weight-bearing exercise: swimming, water aerobics, cycling to protect joints while improving cardiovascular health
  • Osteoarthritis and weight loss: STEP 9 trial (Lundsgaard et al., 2023)
    • Semaglutide reduced weight and significantly lowered knee osteoarthritis pain compared to placebo
    • Supports pharmacotherapy as a pain-reduction strategy via adiposity reduction and decreased inflammatory signaling

In my clinical work, combining manual therapy, graded rehabilitation, and weight loss produces rapid improvements in mobility and pain that empower long-term adherence.

Obstructive Sleep Apnea: A “Fat Mass Disease” with Systemic Metabolic Consequences

Obstructive sleep apnea (OSA) is prevalent in obesity due to fat deposits around the upper airway, reduced muscle tone, and external compression of the chest and lungs. Repeated apneas fragment sleep, lower oxygen saturation, and drive sympathetic activation and insulin resistance.

  • Screening and diagnosis
    • STOP-BANG questionnaire; Epworth Sleepiness Scale
    • Referral for polysomnography (PSG); Apnea-Hypopnea Index (AHI) staging: mild (5–15), moderate (15–30), severe (> 30)
  • Treatment strategies
    • Weight reduction: 5–15% weight loss lowers AHI; mild OSA may resolve
    • CPAP compliance: mask fit, humidification, pressure titration; device usage tracking
    • Pharmacotherapy: tirzepatide FDA indication for moderate-to-severe OSA in adults with obesity (SURMOUNT-OSA trials) (Malhotra et al., 2024)
  • Chiropractic considerations
    • Cervical and thoracic mobility; soft tissue techniques ease CPAP comfort
    • Breathing mechanics and rib cage mobility exercises improve respiratory function and sleep posture tolerance

Improving sleep restores metabolic regulation—leptin, ghrelin, cortisol, and insulin sensitivity—and dramatically elevates daytime energy for exercise and meal preparation.

Landmark Trials Overview: Evidence Backbone of Modern Obesity Medicine

A brief synthesis of key trials guiding our protocols:

  • Cardiovascular outcomes
    • SELECT: Semaglutide reduced MACE by 20% in overweight/obesity patients with established ASCVD and no diabetes (Ryan, Ling, & Bray, 2022)
  • Heart failure
    • STEP-HFpEF: Semaglutide improved symptoms, function, quality of life, and weight in HFpEF with obesity (Kosiborod et al., 2023)
  • Prediabetes and diabetes progression
    • SURMOUNT-1: Tirzepatide reduced progression to type 2 diabetes by ~ 94% over three years in prediabetes and produced ~ 22.9% average weight loss (Wharton et al., 2023)
  • Obesity treatment without diabetes
    • STEP 1: Semaglutide achieved ~ 14.9% average weight loss; 86.4% of prediabetes cases returned to normoglycemia (Wilding et al., 2021)
  • Sleep apnea
    • SURMOUNT-OSA: Tirzepatide significantly reduced AHI in OSA with obesity; led to FDA indication (Malhotra et al., 2024)
  • Osteoarthritis
    • STEP 9: Semaglutide improved weight and reduced knee osteoarthritis pain (Lundsgaard et al., 2023)
  • Liver disease
    • MAESTRO-NASH: Resmetirom approved for MASH with F2–F3 fibrosis, initiating a specialized pathway for true liver pharmacotherapy

These trials show that effective obesity treatment is disease-modifying across cardiometabolic and functional domains.

Case Study: “Robert” — Integrated Management of Type 2 Diabetes, Obesity, Sleep Apnea, Hyperlipidemia, Hypertension, Knee Osteoarthritis, and Low Libido

Robert is a 55-year-old Mexican American male and data analyst with Class III obesity, type 2 diabetes, hyperlipidemia, hypertension, knee osteoarthritis, and obstructive sleep apnea with poor CPAP adherence. He reported daytime fatigue, joint pain limiting exercise, and low libido. His weight gain began in his thirties with decreasing activity due to knee pain and a sedentary job. He often skipped breakfast, ate large portions, and had intense evening sweet cravings.

  • Initial medications
    • Metformin 1000 mg twice daily
    • Glipizide 10 mg daily
    • Lisinopril 20 mg daily
    • Rosuvastatin 20 mg daily
  • Baseline findings
    • Weight: 275 lbs; BMI: 40.6 kg/m²
    • Waist circumference: 43 inches
    • Blood pressure: 148/92 mmHg
    • HbA1c: 8.5%; fasting glucose: 180 mg/dL
    • Lipids: triglycerides 250 mg/dL; HDL 35 mg/dL; LDL 140 mg/dL
    • Liver enzymes: AST 55 U/L, ALT 65 U/L
    • Total testosterone: 250 ng/dL
    • STOP-BANG: 6 (high risk)
    • PHQ-9: 7 (mild depression)
    • FIB-4: indeterminate
    • Stage A heart failure risk
  • Integrated four-pillar plan
    • CPAP optimization: mask fit, humidification, pressure titration, device usage monitoring
    • Nutrition: low-carbohydrate, higher-protein, high-fiber whole-food pattern; eliminate ultra-processed foods
    • Physical activity: low-impact cardio (cycling, swimming), graded strengthening, joint-protective movement patterns
    • Medication management under Dr. Cardenas
      • Discontinue glipizide to avoid hypoglycemia with incretin therapy
      • Initiate tirzepatide; continue metformin, statin, and lisinopril
      • Monitor side effects; gradual titration toward effective dose
  • Sexual health approach
    • Address microvascular endothelial dysfunction with improved glycemic control and blood pressure
    • Lower inflammation via adiposity reduction; improve mood and energy through sleep optimization and movement
    • Provide mental health support; set realistic expectations
  • Three-year outcomes
    • 3% total body weight reduction; waist circumference markedly improved
    • Blood pressure decreased; A1c lowered from 8.7% with early improvements within the first year
    • Triglycerides lowered; lipid profile improved
    • Knee pain reduced with weight loss; greater exercise adherence
    • Substantial quality of life improvements

My chiropractic interventions supported Robert’s adherence by reducing pain and improving movement mechanics, while medical oversight ensured safe deprescribing and titration. Robert’s case exemplifies the synergy between mechanical and metabolic care.

Sarcopenic Obesity: Hidden Epidemic Driving Frailty, Diabetes, and Functional Decline

Sarcopenic obesity combines reduced muscle mass and strength with increased fat mass, especially visceral adipose tissue. Chronic inflammation from adipose tissue catabolizes muscle, reducing resting metabolic rate and accelerating fat accumulation. Weight cycling history worsens this phenotype.

  • Prevalence
    • Nearly 16% across all adults; 8% among ages 20–60; over 28% in those > 60
    • Elevated rates in prediabetes (~ 20%), type 2 diabetes (~ 35%), MASLD (~ 25%), and post-bariatric surgery (~ 22%)
    • Stark disparities: Mexican American women > 60 have reported rates as high as ~ 66.6%
  • Symptoms
    • Exhaustion, weakness, “hard to move,” perceived limitation in function
  • Assessment
    • Muscle function tests: grip strength, sit-to-stand
    • Body composition: BIA or DEXA for precise measurement; VAT quantification; motivational benchmarks for patients
  • Treatment plan
    • Physical activity: cardiometabolic targets; resistance training ≥ 2 times/week; PT referral using sarcopenia diagnosis codes
    • Nutrition: 1.0–1.5 g/kg ideal body weight protein; space protein every 3–4 hours; emphasize animal proteins; leucine and vitamin D whey shakes
    • Inflammation reduction: whole-food patterns, micronutrient assessment
    • Pharmacotherapy: anti-obesity medications when indicated; prioritize muscle-preserving strategies

Chiropractic supports movement quality and pain reduction, enabling consistent resistance training critical for reversing sarcopenic obesity.

Case Study: “Maggie” — Perimenopausal Insulin Resistance, Prediabetes, and Abdominal Adiposity

Maggie is a 53-year-old CPA experiencing perimenopausal symptoms, gradual weight gain, and increasing abdominal adiposity. She is part of the sandwich generation and reports daily wine intake to cope with stress. Her labs and biometrics show a progressive trajectory from optimal to prediabetes over three years.

  • Data trajectory (50 to 53 years)
    • Weight: 135 → 157 lbs; BMI: 23.2 → 27.5
    • Waist circumference: 33 → 36.5 inches (> 35 cutoff for women)
    • HbA1c: 5.2% → 5.8% (prediabetes)
    • Fasting glucose: 88 → 104 mg/dL
    • LDL-C: 95 → 130 mg/dL
    • Fasting insulin: increased to 11.7 μU/mL (> 7 is concerning for insulin resistance)
  • Diagnoses
    • Overweight/Early Class I Obesity; abdominal adiposity
    • Prediabetes with significant insulin resistance
    • Hyperlipidemia
    • Well-controlled hypothyroidism
  • Stepwise plan
    • Nutrition: lower carbohydrates; 90–100 g protein/day; high intake of vegetables and fruits; reduce nightly wine
    • Physical activity: increase intensity beyond dog-walking; begin resistance training 1–2 sessions weekly
    • Medical strategies
      • Metformin ER: start 500 mg with evening meal; gentle titration after tolerance
      • Re-evaluate gabapentin for VMS; consider taper if ineffective or contributing to weight gain.
      • Consider menopausal hormone therapy for VMS and insulin sensitivity
      • Sleep hygiene; potential CBT-I referral
      • Anti-obesity medications if insufficient progress at 3–6 months
  • Key clinical insight
    • Do not ignore progressive metabolic decline; intervene early with integrated nutrition, movement, sleep, and pharmacologic supports.

Chiropractic care prepares the musculoskeletal system for safe exercise, reducing injury risk and speeding functional gains.

Case Study: “Maria” — Post-MI, Type 2 Diabetes on Insulin, MASLD, Severe Knee Osteoarthritis, Sarcopenic Obesity

Maria is a 59-year-old health executive with a myocardial infarction history, uncontrolled type 2 diabetes, hypertension, dyslipidemia, MASLD, and severe bilateral knee osteoarthritis. She is on insulin therapy without GLP-1 therapy, and her body composition reveals extremely high fat mass and low muscle mass.

  • Baseline metrics
    • BMI: 35.7 (Class II Obesity)
    • HbA1c: 7.4%
    • Triglycerides: 256 mg/dL; HDL: 37 mg/dL
    • Elevated ALT/AST consistent with MASLD
    • DEXA: body fat 57.8%; muscle mass in 4th percentile; VAT 3.4 liters; waist 43.5 inches
  • Diagnoses
    • Class II Obesity with sarcopenic obesity
    • Uncontrolled type 2 diabetes
    • Hypertension; dyslipidemia, hypertriglyceridemia
    • MASLD
    • Severe knee osteoarthritis
  • Integrated plan
    • Nutrition: significant carbohydrate reduction; protein elevation; anti-inflammatory whole-foods pattern
    • Physical therapy: sarcopenia and osteoarthritis program; strengthen supporting musculature; pain-mitigating modalities
    • Orthopedic referral: injections or total knee replacement candidacy assessment; advocate against bias
    • Chiropractic and rehabilitation: gentle adjustments; peripheral soft tissue therapies; adjunct modalities for pain relief; graded loading
    • Medication management
      • Start GLP-1 receptor agonist (semaglutide): indicated for ASCVD risk reduction post-MI
      • Taper and discontinue insulin as glycemic control improves to avoid weight-promoting effects
      • Maintain statin and antihypertensives under medical oversight
    • Physical activity: non-impact cardio (swimming, water aerobics, stationary cycling); PT-guided resistance training
  • Advocacy against bias
    • Older women with obesity often face dismissal or minimized options
    • Our team communicates expectations to specialists and supports the patient through decisions, ensuring equitable, evidence-based care

For Maria, aligning pharmacotherapy, PT, and chiropractic care accelerates weight loss, reduces VAT, lowers triglycerides, and restores mobility.

Menopause and Metabolic Health: Vasomotor Symptoms, Central Adiposity, Insulin Resistance, and Bone-Muscle Changes

Menopause introduces systemic shifts that elevate cardiometabolic risk: rising LDL-C, insulin resistance, central fat accumulation, muscle loss, and bone remodeling changes that predispose to osteoporosis. Vasomotor symptoms correlate with weight gain and increased waist circumference, and sleep disruption worsens metabolic dysfunction.

  • Observed patterns
    • Weight gain across menopausal stages even without lifestyle change; maintenance requires adjustments.
    • Shift toward android fat distribution; reduced lean mass
    • Declines in moderate-to-vigorous activity due to pain, fatigue, stress
  • Clinical priorities
    • Prevent additional weight gain
    • Reduce visceral adiposity; preserve or increase muscle; protect bone density.
    • Improve sleep, mood, and VMS; enhance functional capacity
  • Strategy principle: treat obesity first
    • Lifestyle interventions: nutrition, activity, behavioral counseling, sleep and stress management
    • Pharmacotherapy: select anti-obesity medications (GLP-1 or dual GIP/GLP-1) per eligibility; avoid weight-promoting medications when viable; consider menopausal hormone therapy (NAMS, ACOG guidance)
    • Monitor cardiometabolic metrics and body composition
  • Protein and anabolic resistance
    • Higher protein intake needed to overcome anabolic resistance and support muscle synthesis
    • Distribute protein across meals; combine with resistance training for maximal effect.

Chiropractic integration reduces musculoskeletal barriers, optimizes posture and movement, and may modulate autonomic balance contributing to VMS and sleep improvements.

Exercise Prescription: Low-Impact Cardiovascular Training, Resistance Sessions, and Movement Quality

Exercise is medicine for obesity, diabetes, sarcopenic obesity, and menopause-related changes. Our prescriptions emphasize safety, progression, and neuromuscular quality.

  • Aerobic targets (Piercy et al., 2018)
    • 150–300 minutes per week moderate intensity or 75–150 minutes vigorous intensity
    • Spread sessions across the week; exceeding 300 minutes yields additional benefit
  • Resistance training
    • At least two sessions per week
    • Focus on posterior chain strength, core stability, and upper-body compound movements.
    • Closed-chain lower extremity exercises to reduce patellofemoral stress
  • Chiropractic role
    • Spinal and extremity adjustments optimize joint mechanics and motor control.
    • Myofascial techniques reduce pain and improve tissue pliability
    • Kinesiology taping and bracing for kinesthetic cues and offloading
    • Breathing mechanics training supports CPAP tolerance and exercise capacity
  • Mechanistic rationale
    • Resistance work stimulates mechanotransduction in cartilage and bone; improves insulin sensitivity via GLUT4
    • Graded exposure reduces fear-avoidance and central sensitization; improves resilience and adherence.

Nutrition Therapy: Lower Carbohydrates, Higher Protein, High Fiber, Whole-Food Emphasis

We prioritize dietary strategies that reduce insulin demand, improve satiety, preserve muscle, and lower inflammation.

  • Core principles
    • Lower-carbohydrate approach: mitigate postprandial hyperglycemia and hepatic glucose output
    • Higher protein: increase thermic effect; support muscle protein synthesis; counter anabolic resistance
    • High fiber: slow gastric emptying; blunt glycemic excursions; improve gut microbiota; enhance satiety
    • Whole-foods foundation: vegetables, fruits, lean proteins, healthy fats, legumes as tolerated
    • Limit ultra-processed foods: reduce emulsifiers and additives linked to hyperphagia and metabolic disruption.
  • Whey protein supplementation
    • Practical tool for busy patients; leucine-enriched shakes with vitamin D to potentiate muscle synthesis
  • Functional medicine integration
    • Assess micronutrient status (magnesium, vitamin D) and inflammatory markers.
    • Tailor nutrition to individual biochemistry and preferences; build sustainable patterns.

Sleep Optimization and Stress Management: Foundations of Metabolic Control

Sleep quality and stress resilience are indispensable for glycemic control, appetite regulation, and mood. We coach practical sleep hygiene and stress-downregulation methods.

  • Sleep strategies (St-Onge et al., 2017)
    • CPAP adherence for OSA; mask fit adjustments; humidification; pressure optimization
    • Sleep hygiene: consistent schedules; light management; cool temperatures; minimize stimulants
    • CBT-I referral for insomnia; leverage non-pharmacological gold-standard therapy
  • Stress reduction
    • Breathing exercises and biofeedback to reduce sympathetic dominance
    • Gentle mobility practices to relieve muscle tension
    • Chiropractic care reduces nociceptive stress; improves autonomic balance; supports restorative sleep

These foundations stabilize hormones (cortisol, ghrelin, leptin), restore appetite regulation, and improve energy for activity and self-care.

Pharmacotherapy Integration: Incretin-Based Therapies, Metformin, Statins, Antihypertensives, and MHT

We align pharmacotherapy with clinical goals and minimize weight-promoting effects.

  • Anti-obesity medications
    • GLP-1 receptor agonists (semaglutide): significant weight loss; cardiovascular risk reduction (SELECT)
    • Dual GIP/GLP-1 receptor agonists (tirzepatide): profound weight loss; reduced diabetes progression (SURMOUNT-1); OSA indication (SURMOUNT-OSA)
    • Titration schedules and side effect monitoring; hydration and gallbladder considerations
  • Diabetes management
    • Metformin ER: reduces hepatic glucose output; improves insulin sensitivity
    • Deprescribing sulfonylureas (e.g., glipizide) when starting incretins to avoid hypoglycemia
    • Careful tapering of insulin when initiating GLP-1 therapy in obesity to avoid weight promotion
  • Cardiovascular risk
    • Statins: LDL lowering and ASCVD risk reduction remain foundational
    • Antihypertensives: RAAS inhibitors (e.g., lisinopril) protect kidneys and lower blood pressure; adjust dosing as weight reduces
  • Menopausal hormone therapy (NAMS, ACOG)
    • Consider for VMS relief and insulin sensitivity improvements when indicated.
    • Balance risks and benefits with shared decision-making

Our medical oversight ensures safety through lab monitoring, side-effect management, and logical sequencing of agents to maximize efficacy.

Monitoring and Outcomes: Data-Driven Care Pathways

We continuously track objective metrics to demonstrate progress and guide adjustments.

  • Metabolic and cardiovascular measures
    • Weight, BMI, waist circumference
    • Blood pressure; lipids (LDL, HDL, triglycerides); ApoB; Lp(a) when indicated
    • A1c; fasting glucose; fasting insulin; HOMA-IR
    • Liver enzymes; FIB-4 score; imaging for MASLD/MASH when needed
    • CAC scoring in select high-risk cases
  • Functional and sleep metrics
    • Pain scales; mobility tests; Get-Up-and-Go timing
    • Exercise session logs; steps; heart rate recovery
    • CPAP usage duration and residual AHI from device reports
    • Quality of life indices and symptom checklists (including VMS)
  • Behavioral tracking
    • Nutrition adherence; sleep duration; stress scores
    • Motivational interviewing and habit scaffolding to maintain momentum

Collaborative Workflow: Roles of Dr. Cardenas and Dr. Jimenez

Our clinic operates through a coordinated, patient-centered workflow ensuring safety, efficacy, and alignment across modalities.

  • Dr. Cardenas
    • Internal medicine diagnostics; lab interpretation; pharmacotherapy guidance
    • Cardiometabolic risk management; deprescribing; complex case oversight
  • Dr. Jimenez
    • Chiropractic neuromusculoskeletal assessments; adjustments; manual therapies
    • Rehabilitation planning; movement re-education; pain science integration
    • Functional medicine evaluation; nutrition planning; sleep and stress coaching
  • Joint case reviews
    • Align priorities; refine interventions; co-manage specialist referrals
    • Support patient advocacy across disciplines and address healthcare bias

Clinical Observations from Practice: Movement Quality Enables Metabolic Success

Across sciatica.clinic and my professional updates on LinkedIn, I’ve documented how integrative chiropractic care creates the scaffold for consistent application of nutrition, sleep, and pharmacotherapy:

  • Pain reduction and joint mechanics restore confidence and capacity for daily activities and structured exercise
  • Autonomic modulation reduces sympathetic drive, supporting improved sleep, reduced stress, and better appetite regulation.
  • Movement control training improves efficiency and reduces compensatory patterns, enhancing adherence and outcomes.
  • Patients report earlier improvements in energy and mood when pain is addressed, reinforcing healthy habits.

When mobility improves, patients can prepare meals, attend therapy sessions, adhere to CPAP, and maintain exercise routines—converting clinical plans into durable health gains.

Practical Tips for Patients: Start Today, Build Momentum

  • Improve CPAP use
    • Check mask fit; humidification; nightly duration; device-reported AHI
  • Focus meals on protein and plants
    • Build plates around lean protein, vegetables, and high-fiber foods
  • Start low-impact activity
    • Daily movement; gradually add resistance training
  • Track progress
    • Sleep, exercise, meals; celebrate milestones (5%, 10%, 15% weight loss)
  • Ask for help
    • Share challenges early; our team adapts plans quickly and safely

Integrative Pearls for Clinicians: Align Musculoskeletal and Metabolic Care

  • Treat obesity first in menopausal care—benefits ripple across vasomotor symptoms, sleep, and mood
  • Avoid weight-promoting medications where possible; transition thoughtfully to metabolic-friendly regimens
  • Use objective metrics and share progress visually to reinforce patient motivation
  • Collaborate across disciplines—chiropractic, internal medicine, PT, sleep medicine—to ensure safety and comprehensive care
  • Address weight bias proactively—validate patient experiences and champion equitable treatment options

Conclusion: Evidence-Based Integration Transforms Midlife Health

Integrating chiropractic care, internal medicine oversight, functional medicine, rehabilitation, and targeted pharmacotherapy creates durable improvements for complex conditions in midlife—type 2 diabetes, sleep apnea, obesity, knee osteoarthritis, MASLD/MASH, hypertension, dyslipidemia, HFpEF, depression, stress, and menopausal changes. With clear goals, consistent support, and patient advocacy, we restore metabolic flexibility, reduce adiposity, preserve muscle, protect joints, and profoundly improve quality of life.

References

SEO tags: integrative chiropractic care, internal medicine oversight, El Paso injury medical clinic, Dr Alex Jimenez, Dr Maria Guadalupe Cardenas MD, obesity treatment, insulin resistance, type 2 diabetes, hypertension, dyslipidemia, cardiometabolic syndrome, epicardial fat, HFpEF, semaglutide, tirzepatide, SURMOUNT-1, SURMOUNT-OSA, SELECT trial, STEP trials, MAESTRO-NASH, MASLD, MASH, resmetirom, sleep apnea CPAP optimization, osteoarthritis pain reduction, knee OA, resistance training, low carbohydrate diet, high protein nutrition, functional medicine, personal injury care, rehabilitation, sciatica clinic, menopause weight gain, vasomotor symptoms, central adiposity, sarcopenic obesity, DEXA body composition, ApoB, Lp(a), CAC scoring, DASH diet, Mediterranean diet, stress and depression screening, PHQ-9, GAD-7, CBT-I, autonomic modulation

Regenerative Therapies for Gut Health and Healing

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Regenerative Therapies for Gut Health and Healing
Regenerative Therapies for Gut Health and Healing

Regenerative Therapies for Gut Health: BPC-157, Leaky Gut, and Integrative Chiropractic Care

Abstract

Can regenerative therapies help improve gut health? Emerging research suggests that regenerative medicine may eventually offer new ways to support the repair of damaged intestinal tissue, restore the mucosal lining, regulate inflammation, and improve the environment in which intestinal stem cells function. Researchers are studying stem cells, organoids, microbiome-based treatments, immune therapies, and specialized peptides for these purposes.

One peptide receiving attention is BPC-157, or Body Protection Compound-157. Laboratory and animal studies suggest that BPC-157 may support cytoprotection, blood vessel formation, epithelial repair, and control of excessive inflammation. These effects have created interest in BPC-157 for increased intestinal permeability, commonly called “leaky gut.” However, most evidence for BPC-157 remains preclinical, human research is limited, and BPC-157 is not currently an FDA-approved drug.

At Injury Medical Clinic PA in El Paso, Texas, a multidisciplinary model combines the clinical perspectives of Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, and Dr. Maria Guadalupe Cardenas, MD, a physician with more than 40 years of internal medicine experience. This approach brings together medical oversight, integrative chiropractic care, functional medicine, rehabilitation, personal injury care, and other appropriate services while keeping experimental regenerative treatments within proper medical and regulatory boundaries.

Regenerative Therapies for Gut Health and Healing

Can Regenerative Medicine Help the Gut Heal?

The short answer is possibly, but much of the science is still developing.

The intestinal lining is not a passive wall. It is an active layer of cells that helps:

  • Absorb nutrients.
  • Keep harmful substances out of the bloodstream.
  • Communicate with the immune system.
  • Interact with trillions of microorganisms.
  • Replace damaged intestinal cells.
  • Regulate inflammation.

The intestinal epithelium normally renews itself rapidly. Intestinal stem cells help produce the new cells needed to maintain this barrier. Research funded by the California Institute for Regenerative Medicine has explored stem cells and stem-cell-derived intestinal organoids as possible ways to restore damaged epithelial tissue in inflammatory bowel disease (California Institute for Regenerative Medicine [CIRM], n.d.).

This does not mean stem-cell therapy is currently a routine treatment for “leaky gut.” It means scientists are learning how regenerative biology may eventually help restore injured intestinal tissue.

The Gut Lining Is a Regenerative Organ

Every day, the digestive tract faces stomach acid, digestive enzymes, food particles, bacteria, medications, alcohol, inflammatory chemicals, and mechanical stress.

Fortunately, the intestine has its own repair system.

Intestinal stem cells continuously produce new epithelial cells. Newer research also shows that the gut microbiome may influence how well these stem cells work.

A 2026 report from the International Society for Stem Cell Research described animal research showing that age-related changes in gut bacteria reduced intestinal stem-cell activity. When researchers restored a more youthful microbial environment in older mice, intestinal stem-cell activity and tissue regeneration improved (International Society for Stem Cell Research [ISSCR], 2026).

Other research has found that metabolites produced by gut bacteria may stimulate intestinal stem cells and strengthen the intestinal barrier after major medical treatments such as radiation and stem-cell transplantation (Leibniz Institute for Immunotherapy, 2025).

Together, these findings suggest that regeneration, the microbiome, immune function, and the intestinal barrier are closely connected.

What Is “Leaky Gut”?

The term leaky gut is commonly used to describe increased intestinal permeability.

Normally, cells lining the intestine form a carefully controlled barrier. Tight junctions between these cells help determine what passes through the intestinal wall.

When this barrier is injured, or its regulation changes, substances from the intestinal contents may cross the barrier more easily.

Possible contributors include:

  • Intestinal inflammation.
  • Certain infections.
  • Alcohol exposure.
  • Some medications, including NSAIDs.
  • Changes in gut bacteria.
  • Poor nutrition.
  • Chronic gastrointestinal disease.
  • Severe illness or medical treatment.

Increased permeability has been studied in inflammatory and gastrointestinal disorders, but “leaky gut syndrome” should not be treated as a stand-alone diagnosis without determining why the intestinal barrier may be abnormal.

This is where a proper medical evaluation becomes important.

BPC-157: A Gastric-Protective Peptide Undergoing Research

BPC-157 is a synthetic peptide made from a sequence of 15 amino acids related to compounds studied in gastric tissues.

The peptide has attracted attention because preclinical research suggests that it may influence several healing pathways.

These include:

  • Cytoprotection: helping cells tolerate injury.
  • Angiogenesis: supporting formation of new blood vessels.
  • Fibroblast activity: helping cells involved in repair.
  • Collagen production: supporting tissue structure.
  • Nitric oxide signaling: influencing blood vessels and tissue protection.
  • Inflammatory signaling: potentially controlling excessive inflammatory activity.
  • Epithelial healing: supporting repair of surface tissues.

A 2020 review by Park et al. examined experimental evidence suggesting that BPC-157 could protect gastrointestinal tissues from NSAID-related injury and stabilize intestinal permeability. The authors discussed BPC-157 as a possible cytoprotective compound for gastrointestinal injury, but much of the evidence came from experimental models rather than large human clinical trials (Park et al., 2020).

A broader 2026 review also reported that animal studies have shown BPC-157 activity involving gastrointestinal healing, angiogenesis, collagen production, cell migration, and inflammatory pathways. Importantly, the authors stressed that human data remain very limited and that many proposed benefits are not yet clinically proven (Yuan et al., 2026).

How Might BPC-157 Affect the Intestinal Epithelium?

Think of the intestinal lining like a tightly connected tile floor.

If the tiles become damaged and the connections between them weaken, the barrier becomes less effective.

Experimental BPC-157 research suggests several possible ways the peptide could influence this repair process.

Supporting epithelial cell repair

Experimental studies have associated BPC-157 with pathways involved in cell migration and tissue rebuilding.

Supporting blood flow

Healing tissue needs oxygen and nutrients. BPC-157 appears to influence VEGF-related signaling and blood-vessel development in preclinical models (Yuan et al., 2026).

Modulating inflammation

A damaged intestinal barrier can activate immune responses. Experimental studies suggest BPC-157 may influence inflammatory cytokines rather than functioning simply as a traditional anti-inflammatory medication.

Protecting the gastrointestinal lining

Animal studies have reported protective effects in the stomach, esophagus, small intestine, and other gastrointestinal tissues.

These findings help explain why BPC-157 is being investigated for intestinal permeability. They do not, however, establish that BPC-157 is a proven treatment for human leaky gut, Crohn’s disease, ulcerative colitis, IBS, ulcers, or other gastrointestinal diseases.

Patient-education sources discussing BPC-157 appropriately describe the peptide as promising but unproven, since large controlled human studies are still lacking (Ubie Health, n.d.; Tucson Wellness MD, n.d.).

Regenerative Medicine Goes Beyond BPC-157

BPC-157 is only one small part of the larger regenerative-medicine field.

Researchers are investigating several ways to help damaged digestive tissue repair itself.

Intestinal stem cells and organoids

Scientists can grow miniature intestinal structures called organoids from stem cells. These models allow researchers to study epithelial repair and may one day contribute to treatments designed to replace severely damaged intestinal tissue (CIRM, n.d.).

Microbiome-based regeneration

The microbiome produces metabolites that interact with immune cells and intestinal stem cells. Williams et al. (2023) described the microbiome as a possible regenerative medicine target because microbial changes can affect inflammatory, metabolic, immune, and neurological pathways throughout the body.

Cellular therapies

Mesenchymal stromal or stem cells are being studied for their ability to influence inflammatory signaling, immune regulation, blood-vessel growth, and tissue repair. Research into disorders such as gastroparesis remains experimental, and commercial descriptions should not be mistaken for proof of effectiveness (Stemwell, 2025).

Emerging immune-based regeneration

Researchers have even used CAR T-cell technology experimentally to remove aging cells that interfere with intestinal regeneration. In mice, the approach improved epithelial healing, nutrient absorption, and inflammation. Early laboratory findings in human intestinal cells were also encouraging, but this remains research rather than routine gastrointestinal treatment (Cold Spring Harbor Laboratory, 2026).

Could Better Gut Integrity Reduce Whole-Body Inflammation?

Possibly.

The gut interacts continuously with the immune system. When the intestinal barrier, microbiome, and immune response become disturbed, inflammatory signaling may extend beyond the digestive tract.

Gut dysbiosis has been associated with inflammatory and autoimmune conditions, and diets high in processed foods and added sugars may contribute to microbiome changes and systemic inflammation (Williams et al., 2023).

This creates an important goal for integrative care: do not focus only on a peptide.

A broader program may examine:

  • Food quality and dietary patterns.
  • Protein and micronutrient intake.
  • Fiber tolerance.
  • Hydration.
  • Sleep.
  • Stress.
  • Medication use.
  • Metabolic health.
  • Physical activity.
  • Gastrointestinal disease.
  • Infection or dysbiosis when clinically appropriate.

The goal is to improve the environment in which normal tissue repair takes place.

Where Integrative Chiropractic Care Fits

Chiropractic treatment should not be described as directly sealing intestinal tight junctions or curing intestinal disease.

Its role is different.

Dr. Alex Jimenez’s published clinical observations emphasize combining the biological side of healing with the mechanical side of recovery. Regenerative strategies may address tissue biology, while chiropractic care and rehabilitation focus on mobility, joint mechanics, posture, strength, and movement patterns (Jimenez, 2026a, 2026b).

For someone experiencing both musculoskeletal problems and gastrointestinal concerns, integrative chiropractic care may therefore be one part of a broader plan that includes:

  • Improving spinal and joint mobility.
  • Reducing musculoskeletal limitations to physical activity.
  • Correcting movement problems after injury.
  • Progressive rehabilitation and exercise.
  • Nutritional and functional medicine evaluation.
  • Medical review of medications and chronic disease.
  • Appropriate laboratory testing.
  • Gastroenterology referral when needed.
  • Monitoring for warning signs requiring conventional medical treatment.

Dr. Jimenez describes this multidisciplinary approach as treating the patient from more than one clinical angle rather than expecting one treatment to solve every problem.

Medical Oversight: Dr. Maria Guadalupe Cardenas and Dr. Alex Jimenez

At Injury Medical Clinic PA in El Paso, Texas, Dr. Maria Guadalupe Cardenas, MD, works alongside Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN.

Dr. Cardenas has more than 40 years of medical experience and practices in internal medicine. Clinic materials identify her as the Medical Director and Collaborative Physician, while Dr. Jimenez serves in integrative chiropractic, advanced-practice nursing, functional medicine, injury care, and rehabilitation.

This type of multidisciplinary arrangement can provide several layers of care:

  • Internal medicine oversight: medical diagnosis, medication review, risk assessment, chronic-disease management, and referral.
  • Integrative chiropractic care: spinal and joint evaluation, mobility, biomechanics, and musculoskeletal treatment.
  • Functional medicine: investigation of nutrition, metabolism, lifestyle factors, and possible contributors to inflammation.
  • Personal injury care: evaluation and documentation of injuries after automobile, workplace, or other traumatic events.
  • Rehabilitation: progressive movement, strengthening, stability, and return to activity.
  • Regenerative-care review: careful consideration of emerging treatments based on evidence, regulation, medical need, and patient safety.

This teamwork is especially important when patients are asking about experimental treatments.

Important BPC-157 Safety and FDA Information

BPC-157 needs to be discussed carefully.

As of August 2026, BPC-157 is not an FDA-approved medication.

In July 2026, the FDA’s Pharmacy Compounding Advisory Committee voted to recommend BPC-157-related substances for possible inclusion on the Section 503A Bulks List. However, that vote was advisory, and it did not constitute final FDA approval or prove that BPC-157 is safe or effective for treating intestinal disease.

FDA scientific reviewers also concluded that there was insufficient clinical information to characterize BPC-157’s safety profile. FDA noted a lack of adequate human studies using proposed oral, subcutaneous, nasal, and transdermal routes and raised concerns about immunogenicity and peptide-related impurities.

Therefore:

  • BPC-157 should not be advertised as a proven cure for leaky gut.
  • Patients should not purchase injectable research peptides from unknown internet sources.
  • Human dosing and long-term safety remain uncertain.
  • Serious gastrointestinal symptoms require proper medical evaluation.
  • Patients should not abandon FDA-approved treatments in favor of experimental peptides without appropriate medical guidance.

The Future of Regenerative Gut Care

The science of intestinal regeneration is advancing quickly.

Researchers are learning that the intestinal barrier depends on far more than one drug or peptide. Stem cells, epithelial cells, blood vessels, immune pathways, the microbiome, nutrition, metabolism, and lifestyle all interact.

BPC-157 is interesting because experimental research suggests cytoprotective, regenerative, vascular, and anti-inflammatory effects. But its most convincing evidence remains laboratory and animal research.

The safest message today is therefore:

BPC-157 may represent a future tool for intestinal repair, but it remains an investigational therapy rather than an established treatment for leaky gut or gastrointestinal disease.

A comprehensive approach combines sound medical diagnosis, evidence-based treatment, nutrition, functional health strategies, movement, rehabilitation, and appropriate specialty care. At Injury Medical Clinic PA, the collaboration between Dr. Jimenez and Dr. Cardenas reflects this broader philosophy: combining medical oversight with integrative chiropractic and rehabilitative care while allowing emerging regenerative science to develop through careful research rather than unsupported promises.

***ESSENTIAL FATTY ACIDS*** & their therapeutic uses | El Paso, Tx (2021)

References

California Institute for Regenerative Medicine. (n.d.). Stem cell therapy for inflammatory bowel disease.

Cold Spring Harbor Laboratory. (2026, January 3). Scientists found a way to help aging guts heal themselves. ScienceDaily.

International Society for Stem Cell Research. (2026, January 22). New study shows gut microbiota directly regulates intestinal stem cell aging.

Jimenez, A. (2026a). Regenerative medicine and integrative chiropractic approaches.

Jimenez, A. (2026b). Regenerative therapies for fitness and recovery insights.

Jimenez, A. (n.d.). Dr. Alex Jimenez—Clinical and integrative health information.

Leibniz Institute for Immunotherapy. (2025, October 28). Protecting the gut after stem cell transplantation: New evidence for the potential of microbiome-based therapies.

Park, J. M., Lee, H. J., Sikiric, P., & Hahm, K. B. (2020). BPC 157 rescued NSAID-cytotoxicity via stabilizing intestinal permeability and enhancing cytoprotection. Current Pharmaceutical Design, 26(25), 2971–2981.

Ruggeri, C. (2026, January 26). What are peptides? Peptide benefits for skin and more. Dr. Axe.

Stemwell. (2025, August 15). Healing gastroparesis with stem cells: A new path to digestive health.

U.S. Food and Drug Administration. (2026). Certain bulk drug substances for use in compounding that may present significant safety risks.

U.S. Food and Drug Administration. (2026, July). Pharmacy Compounding Advisory Committee meeting: BPC-157-related bulk drug substances.

Ubie Health. (n.d.). Gut won’t heal? BPC-157 medical guide.

Williams, K. L., Enslow, R., Suresh, S., Beaton, C., Hodge, M., & Brooks, A. E. (2023). Using the microbiome as a regenerative medicine strategy for autoimmune diseases. Biomedicines, 11(6), 1582.

Yoo Direct Health. (2026). FDA peptide update: What the recent BPC-157, KPV, and TB-500 news means.

Yoo Direct Health. (n.d.). Best peptides for gut health: BPC-157, KPV, larazotide and more.

Yuan, C., Demers, A., Silva-Ortiz, V., Hasoon, J. J., Lee, W., Dave, K., Amirdelfan, K., Burke, H. W., Christo, P. J., & Robinson, C. L. (2026). From regeneration to analgesia: The role of BPC-157 in tissue repair and pain management. International Journal of Molecular Sciences, 27(6), 2876.

Chiropractic Rehabilitation Insights for Integrative OUD Care

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Transform your recovery with integrative OUD care and chiropractic rehabilitation, focusing on holistic healing and support.

Educational Abstract: Integrative, Evidence-Based Strategies for Opioid Use Disorder in Special Populations, with Collaborative Medical Direction

In this educational post, I present a comprehensive, first-person exploration of the latest evidence-based strategies for treating opioid use disorder (OUD) across special populations—individuals with co-occurring mental health conditions, pregnant patients, adolescents, older adults, and those using central nervous system (CNS) depressants. I synthesize research findings from leading organizations and peer-reviewed studies and share clinical observations from my integrative chiropractic and functional medicine practice in El Paso, Texas. Under the medical direction of Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine) (NPI #1164426749, Texas MD License #J2933), our multidisciplinary team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) integrates medical oversight, chiropractic care, functional medicine, rehabilitation, and personal injury care to optimize outcomes. I explain practical screening tools (PHQ-9, GAD-7, PCL-5), trauma-informed care principles, pharmacologic considerations (SSRIs/SNRIs; buprenorphine, methadone, naltrexone), risk management (QTc, serotonin syndrome), neonatal opioid withdrawal syndrome (NOWS) protocols, adolescent OUD approaches, and geriatric dosing nuances. I also demonstrate how integrative chiropractic care supports pain modulation, autonomic balance, mobility restoration, and adherence to MOUD, framed through clinical case vignettes and step-by-step rationale. Citations are provided in APA-7 format with hyperlinked references.

About Our Multidisciplinary Clinic and Leadership

  • I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. My clinical work focuses on integrative chiropractic care, functional medicine, pain recovery, and personal injury medicine. My clinical observations are shared on my sciatica resource site and professional profile:
  • Our Medical Director and Collaborative Physician is Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933), with over 40 years of experience as an internist. Dr. Cardenas provides medical direction, diagnostic oversight, and pharmacologic management for complex cases, including OUD and comorbid medical conditions.
  • Our clinic: Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic in El Paso, Texas. This integrated model is common in injury and functional care clinics where an MD leads medical direction while a chiropractor executes biomechanical restoration and rehabilitative care.
  • Team integration:
    • Cardenas oversees diagnostics, medication-assisted treatment for OUD, cardiometabolic risk management, and coordination with psychiatry and obstetrics when relevant.
    • I deliver integrative chiropractic care to address pain generators, functional biomechanics, autonomic regulation, and structured rehabilitation that improves adherence to MOUD and reduces relapse drivers like pain, insomnia, and dysautonomia.
    • Functional medicine services evaluate root-cause contributors—nutritional status, inflammation, endocrine-metabolic imbalances, gut-brain axis dysregulation—that often perpetuate pain and cravings.
    • Personal injury care adds context around trauma recovery, biomechanics, and medicolegal coordination when injuries precipitate opioid exposure.
    • Behavioral health partnerships provide evidence-based psychotherapies and peer support necessary for co-occurring conditions.

The Clinical Landscape: Special Populations and Opioid Use Disorder

Key Topic Overview

  • Co-occurring mental health conditions with OUD: depression, anxiety, PTSD
  • Trauma-informed care principles and screening tools
  • Evidence-based therapies and pharmacology (SSRIs/SNRIs)
  • Medication-assisted treatment (MOUD): buprenorphine, methadone, naltrexone
  • Safety considerations: QTc prolongation, serotonin syndrome
  • OUD in pregnancy: screening, NOWS/Eat-Sleep-Console, breastfeeding, MOUD
  • Adolescents: screening, protective/risk factors, buprenorphine approval ≥16
  • Older adults: dosing, renal/hepatic function, respiratory depression risk
  • CNS depressants and OUD treatment: risk-benefit management
  • Integrative chiropractic care’s role across these populations

Co-Occurring Mental Health Conditions with Opioid Use Disorder

Why Co-Occurring Disorders Matter

  • Approximately 21.5 million adults in the United States live with a co-occurring mental health disorder and substance use disorder, and OUD overlaps strongly with major depressive disorder (MDD), generalized anxiety disorder (GAD), and PTSD. Many receive mental health treatment more often than SUD-specific treatment, leaving OUD undertreated. This mismatch increases overdose risk and hinders recovery (Substance Abuse and Mental Health Services Administration [SAMHSA], 2022).
  • Clinical experience shows that untreated depression and anxiety amplify pain perception, reduce adherence to care, and potentiate cravings. Conversely, an integrated plan that concurrently stabilizes mood and pain reduces relapse risk.

Screening Tools: Practical, Actionable Steps

  • PHQ-9 for depression, GAD-7 for anxiety, PCL-5 for PTSD:
    • PHQ-9 thresholds guide severity and treatment intensity.
    • GAD-7 identifies anxiety’s functional impact and helps track improvement.
    • PCL-5 aligns with DSM-5 PTSD criteria; a score in the low 30s often indicates clinical need.
    • Reassess after initiating therapy or medication to quantify change. A 10-point PCL-5 reduction suggests therapeutic efficacy.
  • What I do in practice:
    • At intake, Dr. Cardenas’s team administers PHQ-9, GAD-7, and, when trauma is suspected, PCL-5. We repeat tools at defined intervals (4–6 weeks) and after key interventions (start of SSRI/SNRI, structured CBT).

Trauma-Informed Care: The Six Principles

  • Safety
  • Trustworthiness and transparency
  • Peer support
  • Collaboration and mutuality
  • Empowerment, voice, and choice
  • Cultural, historical, and gender considerations
  • Why it matters:
    • Trauma-informed care improves engagement, reduces re-traumatization, and supports autonomy—crucial for patients with histories of intimate partner violence and adverse childhood experiences.
  • How we apply it:
    • Predictability in scheduling, clear consent around procedures, shared decision-making for MOUD selection, and peer support referrals. We create physically and emotionally safe clinical encounters by explaining what we’re doing and why, every step of the way.

Evidence-Based Psychotherapies

  • Cognitive Behavioral Therapy (CBT) for depression and anxiety: targets maladaptive thoughts and behaviors that drive dysphoria and avoidance.
  • For PTSD:
    • Prolonged Exposure (PE) helps extinguish conditioned fear.
    • Cognitive Processing Therapy (CPT) reframes trauma-related beliefs.
    • Eye Movement Desensitization and Reprocessing (EMDR) engages memory reconsolidation.
  • Why these work physiologically:
    • CBT and trauma-focused modalities recalibrate the prefrontal cortex-limbic circuitry, reduce amygdala hyperreactivity, and improve emotion regulation, which lowers craving risk mediated by stress.

Pharmacologic Treatment for MDD, GAD, and PTSD with OUD

  • SSRIs/SNRIs are first-line:
    • Paroxetine: broad indications but higher sexual dysfunction risk.
    • Sertraline: effective for MDD and PTSD; GI side effects may occur early.
    • Fluoxetine: long half-life aids adherence but may pose overdose concerns regarding suicidality.
    • Escitalopram: effective for MDD/GAD; may cause weight gain.
    • Duloxetine: lower sexual dysfunction risk; GI side effects; added benefit for neuropathic pain.
    • Venlafaxine: effective for MDD/GAD; watch for weight gain and QTc considerations.
  • Rationale in OUD:
    • Treating mood and anxiety improves retention in MOUD programs and reduces self-medication with opioids.

Integrating SSRIs/SNRIs with MOUD: Risk-Benefit Nuances

  • Buprenorphine:
    • Partial mu-opioid agonist with ceiling effect for respiratory depression; low risk of serotonin syndrome when combined with SSRIs/SNRIs.
    • Benefits often outweigh the theoretical risk; combining MOUD with antidepressant therapy increases treatment retention.
  • Methadone:
    • Full agonist; monitor QTc prolongation, especially with citalopram or agents that increase QTc.
    • Cardiac safety plan:
      • Baseline ECG
      • Repeat ECG after 5 half-lives of the added QTc-active drug
      • Annual ECG and symptom-triggered checks (palpitations, syncope, chest pain)
  • Naltrexone:
    • Watch for mood changes; discuss black-box warnings on antidepressants for suicidality.
    • Shared decision-making emphasizes risk-benefit given the overdose risk of untreated OUD.

Serotonin Syndrome: Recognize and Respond

  • SHIVERS acronym:
    • Shivering
    • Hyperreflexia and myoclonus
    • Increased temperature
    • Vital sign abnormalities (tachycardia, hypertension)
    • Encephalopathy
    • Restlessness
    • Sweating
  • Action plan:
    • Immediate evaluation, medication review, supportive care; in severe cases, cyproheptadine is considered.

Case Vignette: Co-Occurring Depression/Anxiety with OUD

  • Patient: 32-year-old mother, chronic low back pain due to degenerative disc disease, history of opioid misuse, maintained on buprenorphine-naloxone 8 mg TID, severe OUD, persistent depressive and anxiety symptoms.
  • Screening:
    • PHQ-9: 18 (moderately severe)
    • GAD-7: 15 (severe)
    • PCL-5: 10 (no PTSD indication)
  • Plan:
    • Continue buprenorphine-naloxone.
    • Initiate SSRI/SNRI; consider sertraline or duloxetine (dual benefit for pain and mood).
    • Refer to CBT; prescribe naloxone; discuss crisis options such as the 988 hotline.
  • Integrative chiropractic care:
    • Pain modulation via lumbar stabilization, soft tissue release, graded exposure exercises, and autonomic regulation strategies (breathing training) reduces pain catastrophizing and improves function.
    • Functional medicine assessment: anti-inflammatory nutrition, sleep hygiene, and micronutrient optimization to reduce allostatic load.

Opioid Use Disorder in Pregnancy: Evidence-Based, Compassionate Care

Epidemiology and the Human Cost

  • OUD prevalence in pregnancy increased significantly between 1999–2014 and again between 2010–2017. Neonatal opioid withdrawal syndrome (NOWS) rose in parallel, with infants born with NOWS every approximately 24 minutes in 2021. Rural regions often face higher rates due to access barriers.

Confronting Stigma

  • Pregnant patients with OUD frequently report stigmatizing experiences—being labeled as unfit, drug-seeking, or criminal—which erodes trust and deters care. Trauma-informed, nonjudgmental engagement is essential for maternal and fetal safety.

Universal Screening in Pregnancy

  • Tools:
    • Four Ps (Parents, Partners, Past, Present) for quick risk recognition.
    • NIDA Quick Screen for substance use within the past year; triggers specific follow-ups.
    • CRAFFT in younger pregnant individuals (<27 years), examining behavior risks.
  • Protocol:
    • Universal application prevents bias and misses. Positive screens prompt confirmatory assessments and coordinated care with obstetrics.

Pregnancy Complications from OUD

  • Elevated risks:
    • Placental abruption
    • Fetal growth restriction
    • Preterm birth
    • Stillbirth
    • Overdose
  • Mechanisms:
    • Cycles of use and withdrawal induce hemodynamic swings and stress hormone surges (cortisol, catecholamines), compromising uteroplacental perfusion. Inconsistent prenatal care exacerbates risks.

Neonatal Opioid Withdrawal Syndrome (NOWS)

  • Clarification:
    • DSM-5: Substance use disorder requires behavioral patterns; newborns experience withdrawal but are not “addicted.”
  • Signs:
    • Tremors, feeding difficulties, high-pitched cry, diarrhea, vomiting, sleep problems, autonomic instability.
  • Assessment:
    • Eat-Sleep-Console (ESC): simple, functional criteria—eat ≥1 ounce per feed, sleep ≥1 hour, console within 10 minutes.
    • Finnegan Scoring: detailed 21-item tool; many institutions prefer ESC for practicality and caregiver involvement.
  • Outcomes:
    • NOWS duration: days to weeks depending on exposure.
    • No known lasting physical or intellectual problems when care is appropriate.
    • Rooming-in with mother encouraged; nonpharmacologic care (swaddling, skin-to-skin, breastfeeding) is foundational.

Pharmacologic Support for Newborns

  • First-line: Morphine for significant NOWS; avoid naloxone in infants.
  • Adjuncts: Clonidine, phenobarbital when indicated.

Breastfeeding Considerations

  • Benefits:
    • Reduced infant illness (asthma, ear infections, eczema), lower SIDS risk, maternal benefits (lower cancer risks, reduced postpartum depression).
  • Contraindications:
    • Return to non-prescribed opioid use, HIV, or certain incompatible medications.
  • Safe with MOUD:
    • Breastfeeding is compatible with buprenorphine and methadone when managed properly.

MOUD in Pregnancy: Buprenorphine and Methadone

  • Evidence:
    • Both are first-line, FDA-approved, and recommended by ACOG, SAMHSA, and WHO for improving maternal and neonatal outcomes.
  • Naltrexone:
    • Not first-line; consider carefully with a risk-benefit discussion.
  • Medically assisted withdrawal:
    • Not recommended due to high relapse and overdose risk.
  • Neonatal outcomes:
    • Increased likelihood of normal birth weight and full-term delivery with MOUD; no evidence of congenital disabilities due to buprenorphine/methadone; observe infants for 3–4 days given maternal medication half-lives.

Case Vignette: Pregnancy and OUD

  • Patient: 28-year-old, G2P1, 18 weeks pregnant, daily misuse of oxycodone ER (≈60 mg).
  • Labs:
    • UDS positive for opioids; CBC, CMP, HIV, hepatitis, STI panel normal.
  • Plan:
    • Initiate buprenorphine within 24 hours of last oxycodone dose; titrate from 2 mg to 24 mg as tolerated.
    • Prescribe naloxone; refer to prenatal care; psychosocial support; encourage breastfeeding if no contraindications.
  • Integrative chiropractic care in pregnancy:
    • Pelvic alignment, sacroiliac stabilization, and gentle myofascial release reduce pregnancy-related low back pain, improve gait mechanics, and reduce sympathetic overdrive. This supports adherence to MOUD and prenatal visits.
  • Functional medicine supports:
    • Nutritional counseling to reduce inflammation and stabilize glycemia, magnesium for muscle relaxation, sleep support, and stress coping strategies.

Adolescents with Opioid Use Disorder: Prevention, Early Intervention, and MOUD

Trends and Risks

  • Overdose deaths in 14–18-year-olds surged, driven by high-potency illicitly manufactured fentanyl (IMFs), even as some self-reported usage patterns decreased. Most fatalities involve polysubstance scenarios.
  • Many adolescents with OUD have psychiatric histories or prior opioid exposure; very few have received formal OUD treatment, highlighting a care gap.

Protective and Risk Factors

  • Protective:
    • Family engagement, guardian disapproval of substance use, school connectedness, self-efficacy.
  • Risk:
    • Social determinants of health, polysubstance use, early initiation, impulsivity, psychiatric disorders, maltreatment, familial SUD.
  • Strategy:
    • Build buffers by involving family and schools, strengthening self-efficacy through skill-building and positive peer networks.

Confidentiality and Trust

  • Explain confidentiality rules clearly at intake and maintain transparency about mandatory reporting. Establish one-on-one time to educate and deliver harm reduction advice.

Adolescent Screening Tools

  • S2BI: frequency-based screening for tobacco, alcohol, and drugs over the past year.
  • BSTAD: detailed days-used assessment and specific substance categories.
  • CRAFFT: behavior-focused identification of risk patterns relevant to SUD.

Treatment Recommendations

  • Naloxone:
    • Provide to adolescents, peers, and families; train on recognition and response. Encourage carrying naloxone in high-risk settings.
  • Behavioral health:
    • School-based therapy, community services, and peer support groups.
  • MOUD:
    • Buprenorphine is approved for ages 16+.
    • Methadone and naltrexone are generally approved at 18+.
    • Monitor emerging ASAM adolescent guidance anticipated in 2026.

Case Vignette: Adolescent Heroin Use

  • Patient: 16-year-old, declined grades and attendance; postoperative oxycodone exposure led to heroin via peers; daily intranasal use; found drowsy and nauseated.
  • UDS:
    • Positive for heroin; negative for fentanyl and other substances (important to discuss adulteration risks and harm reduction strategies).
  • Plan:
    • Start buprenorphine 12–24 hours after last heroin use; titrate 2–24 mg as tolerated.
    • Prescribe naloxone; coordinate psychosocial support; school engagement plan.
  • Integrative chiropractic care:
    • Lower extremity kinetic chain rehabilitation following ankle surgery to reduce residual pain and prevent relapse triggers.
    • Graded return to sport, balance training, and proprioceptive restoration to rebuild identity and resilience.
  • Functional medicine:
    • Nutrition for neuroplasticity and recovery, sleep optimization, and guidance to reduce inflammation and improve cognitive performance.

Enhancing Health Together: Embracing Multidisciplinary Evaluation and Treatment- Video

Enhancing Health Together: Embracing Multidisciplinary Evaluation and Treatment | El Paso, Tx (2023)

Older Adults with Opioid Use Disorder: Safety, Dosing, and Monitoring

Rising Prevalence and Disparities

  • OUD increased in adults aged 65–69 since 2013, with higher rates among those on Medicare/Medicaid. Disparities persist among Black Americans, Native Americans, and Alaska Natives.

Pharmacologic Considerations

  • Risk-benefit framing:
    • Given the potency of fentanyl in the illicit supply, MOUD benefits often outweigh risks.
  • Methadone:
    • Evaluate renal function; consider dose reduction if creatinine clearance is extremely low.
    • Monitor QTc; consider dose adjustments for QTc >450 ms in men and >460 ms in women.
    • Respiratory depression risk is higher due to full agonism and age-related pharmacokinetics.
  • Buprenorphine:
    • Generally safer for respiratory depression; dose adjustments for severe hepatic impairment.
    • Avoid certain subcutaneous formulations in moderate-to-severe liver impairment.
  • Strategy:
    • Close monitoring, conservative titration, regular ECGs, and interdisciplinary oversight.

Integrative chiropractic care for older adults

  • Gentle mobilization, core stabilization, and balance training help reduce pain, improve mobility, and lower fall risk—supporting adherence to MOUD and reducing the need for analgesic escalation.
  • Functional medicine:
  • Assess sarcopenia, vitamin D status, omega-3 intake, and sleep architecture to improve pain thresholds and cognition.

CNS Depressants with MOUD: Managing Real-World Complexity

FDA Guidance and Clinical Judgment

  • The FDA has urged caution against withholding MOUD in patients using benzodiazepines or other CNS depressants. The overdose risk from untreated OUD generally exceeds the additive respiratory depression risk of combined therapies.

Practical Steps

  • Education:
    • Explain risks clearly; emphasize avoiding illicit opioids and alcohol while on MOUD.
  • No arbitrary MOUD dose caps:
    • Do not reduce buprenorphine solely because of benzodiazepine co-use; titrate based on OUD control and withdrawal suppression.
  • Tapering strategies:
    • If possible, gradually taper benzodiazepines, replacing with SSRIs/SNRIs and CBT for anxiety to reduce respiratory risk.
  • Other CNS depressants:
    • Sedative-hypnotics, muscle relaxants (e.g., baclofen), antipsychotics (aripiprazole, paliperidone, quetiapine) require medication reconciliation and individualized risk-benefit analysis.

Autonomic Regulation through Integrative Care

  • Chiropractic can aid autonomic balance by reducing nociceptive input and improving mechanoreceptive signaling from the spine and extremities. Combined with breathwork and paced exhalation, patients often report improved sleep and reduced anxiety—crucial when tapering CNS depressants.

How Integrative Chiropractic Care Fits into Opioid Use Disorder Treatment

Mechanisms: Why It Works

  • Pain modulation:
    • By correcting segmental dysfunctions, reducing trigger points, and optimizing fascial glide, we reduce nociceptive load on the CNS. Less pain reduces the drive to self-medicate and supports stimulant-free functioning.
  • Autonomic balance:
    • Spinal and rib cage mechanics influence respiratory patterns and vagal tone. Improved thoracic mobility facilitates diaphragmatic breathing, lowering sympathetic arousal that fuels cravings and anxiety.
  • Biomechanical restoration:
    • Restoring kinetic chain integrity—lumbar-pelvic alignment, hip mobility, foot mechanics—decreases compensatory stress, enabling activity resumption that enhances dopamine reward in healthy ways.
  • Sleep improvement:
    • Reducing neck and back pain decreases night-time arousals; better sleep normalizes pain thresholds and executive function, strengthening treatment adherence.
  • Functional gains:
    • Graded activity and neuromuscular reeducation reinforce self-efficacy and help patients transition from passive care to active recovery.

Integrated Protocol: Step-by-Step

  • Intake and triage:
    • Cardenas reviews medical risks, labs, and ECG if indicated. I perform a biomechanical and pain mapping assessment.
  • MOUD initiation/optimization:
    • Buprenorphine or methadone selection via shared decision-making; naltrexone when appropriate.
  • Mental health:
    • CBT/PE/CPT/EMDR referrals; SSRIs/SNRIs guided by comorbidities and side-effect profiles.
  • Chiropractic plan:
    • Stabilization phases, soft tissue mobilization, joint adjustments when indicated, neurodynamic exercises, and breath training.
  • Functional medicine layers:
    • Anti-inflammatory nutrition, micronutrient repletion, sleep timing, circadian hygiene, stress resilience training.
  • Monitoring:
    • Reassess PHQ-9, GAD-7, PCL-5; pain scales; functional scores; MOUD adherence; side effects; ECGs where necessary.
  • Peer support and relapse prevention:
    • Recovery groups, naloxone distribution, overdose education, and trigger planning.

Clinical Observations from Practice

  • Patients who engage in structured rehabilitation alongside MOUD demonstrate:
    • Reduced pain catastrophizing and lower opioid craving intensity.
    • Improved sleep onset and maintenance after thoracic and cervical mobility work.
    • Higher adherence to MOUD and psychotherapies when physical function improves.
  • Our sciatica-focused protocols:
    • Emphasize hip hinge mechanics, core bracing, and neurodynamic glides to decompress nerve roots and reduce peripheral sensitization.
  • Outcomes:
    • Function gains frequently precede mood improvements, creating a positive feedback loop that stabilizes recovery trajectories.

Practical Algorithms and Safety Nets

When Initiating MOUD with SSRIs/SNRIs

  • Baseline assessment:
    • PHQ-9/GAD-7/PCL-5; substance use screen; ECG if methadone is considered; labs (CBC, CMP, liver function).
  • Start low, go slow:
    • Titrate antidepressants conservatively; monitor GI side effects and sexual dysfunction; consider duloxetine with neuropathic pain.
  • Methadone-specific:
    • Avoid high-dose citalopram; consider alternatives with lower QTc impact; schedule ECG follow-ups.
  • Buprenorphine:
    • Educate regarding precipitated withdrawal timing; consider microdosing protocols when transitioning from full agonists.
  • Naltrexone:
    • Verify adequate opioid-free interval to prevent precipitation; discuss mood risks.

Pregnancy Pathway

  • Universal screening; immediate obstetric collaboration.
  • Initiate MOUD; avoid medically assisted withdrawal.
  • Non-pharmacologic perinatal support; prepare for ESC-based newborn assessment.
  • Encourage breastfeeding when compatible; rooming-in preferred.

Adolescents

  • Establish confidentiality; leverage school networks.
  • MOUD with buprenorphine if ≥16; naloxone training; family-engaged relapse prevention.
  • Integrative rehab to rebuild athletic identity and social ties.

Older Adults

  • Renal/hepatic evaluation; ECG monitoring; conservative dosing; fall risk prevention.
  • Integrative care that emphasizes gentle mobilization, balance, and endurance.

CNS Depressants

  • Do not withhold MOUD; taper benzodiazepines when feasible.
  • Educate about overdose potential; maintain naloxone access; monitor sedation.

Synthesis and Clinical Takeaways

  • Treat co-occurring psychiatric disorders in OUD—this increases MOUD retention and reduces relapse.
  • MOUD during pregnancy is protective for mother and baby; neonatal outcomes are improved; breastfeeding is usually compatible with buprenorphine and methadone.
  • Adolescents require early, trust-centered intervention, with buprenorphine available at age 16 and strong family-school collaboration.
  • Older adults benefit from careful dose titration and monitoring, with buprenorphine often favored for respiratory safety.
  • Benzodiazepines and other CNS depressants do not contraindicate MOUD; risk-benefit analysis and tapering strategies are key.
  • Integrative chiropractic care addresses pain and autonomic dysregulation, improving functional capacity, sleep, and adherence to MOUD—crucial pillars across all special populations.
  • Our MD-chiropractic functional medicine model at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso ensures medical safety, whole-person care, and rehabilitative progression guided by evidence-based protocols.

References

SEO tags: opioid use disorder, co-occurring mental health, pregnancy and OUD, neonatal opioid withdrawal syndrome, Eat Sleep Console, SSRIs, SNRIs, buprenorphine, methadone, naltrexone, QTc prolongation, serotonin syndrome, adolescents OUD, older adults OUD, benzodiazepines CNS depressants, functional medicine, integrative chiropractic, rehabilitation, El Paso Injury Medical Clinic, Dr. Maria Guadalupe Cardenas MD, Dr. Alex Jimenez DC

MFAT for Car Accident Injuries: Regenerative Solutions

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
MFAT for Car Accident Injuries: Regenerative Solutions
MFAT for Car Accident Injuries: Regenerative Solutions

MFAT for Car Accident Injuries and Joint Recovery

Abstract

A motor vehicle accident can injure more than one part of the body at the same time. Joints may become painful or unstable, ligaments can be stretched or partially torn, muscles may tighten, and cartilage or other soft tissues may heal slowly. When these problems continue after conservative treatment, regenerative options may be considered.

Micro-Fragmented Adipose Tissue, or MFAT, is an autologous regenerative procedure that uses a small amount of a patient’s own fat tissue. The tissue is collected, washed, and gently processed into very small fragments without laboratory cell expansion. Many MFAT systems rely on mechanical processing rather than enzymatic digestion. The goal is to preserve the tissue’s natural structural matrix along with cells, growth factors, cytokines, and other signaling substances that may help create a healthier healing environment (Fu & Wang, 2025; Yuan et al., 2026).

For selected patients, MFAT may become one part of a larger recovery plan that includes medical evaluation, integrative chiropractic care, functional rehabilitation, movement correction, and progressive strengthening. This article explains how MFAT works, where the evidence is strongest, and how an integrated medical-chiropractic approach can address both the biological and mechanical sides of auto injury recovery.

MFAT for Car Accident Injuries: Regenerative Solutions

What Is Micro-Fragmented Adipose Tissue?

MFAT stands for Micro-Fragmented Adipose Tissue. Adipose tissue is simply body fat, but fat tissue contains much more than fat cells. It also contains a natural extracellular matrix, blood-vessel-related cells, mesenchymal stromal cells, pericytes, growth factors, cytokines, and other biological signaling components.

In an MFAT procedure, a clinician usually removes a small amount of fat from an area such as the abdomen, flank, or thigh. The fat is then processed through a sterile system that washes the tissue and reduces it into smaller fragments. Certain widely studied systems use mechanical processing without enzymes or laboratory cell expansion (Fu & Wang, 2025; Yuan et al., 2026).

The resulting tissue can then be placed into a selected joint or injured soft-tissue area when clinically appropriate.

MFAT should not automatically be described as a laboratory-grown “stem cell treatment.” A more accurate description is minimally processed autologous adipose tissue containing a natural tissue matrix and biologically active cellular components.

Because the material comes from the patient’s own body, it is called autologous.

Why Can Fat Tissue Be Useful in Regenerative Medicine?

Fat is easier to access than some other sources of regenerative tissue. More importantly, adipose tissue contains a supportive biological environment that researchers believe may influence inflammation and tissue repair.

Recent scientific reviews suggest that MFAT may work mainly through paracrine signaling. In simple terms, cells and tissue components communicate with nearby cells by releasing biological signals.

These signals may help:

  • Regulate excessive inflammation
  • Support blood-vessel stability
  • Influence immune responses
  • Support the extracellular matrix
  • Create conditions that favor tissue repair
  • Support cartilage and soft-tissue health
  • Provide a natural tissue scaffold

Researchers are still studying exactly which components are responsible for MFAT’s effects and how long those effects continue (Yuan et al., 2026).

This is important because MFAT should not be presented as a substance that simply “grows new tissue.” The process is much more complex.

Why Auto Accident Injuries Can Be Difficult to Heal

A car crash can expose the body to rapid acceleration, deceleration, twisting, compression, and impact.

A patient may therefore develop several injuries at once, including:

  • Joint sprains
  • Partial ligament tears
  • Tendon injuries
  • Cartilage damage
  • Muscle strains
  • Joint inflammation
  • Neck and back injuries
  • Altered spinal movement
  • Nerve irritation
  • Muscle guarding
  • Changes in posture
  • Reduced range of motion
  • Weakness
  • Abnormal walking or movement patterns

Some injuries heal well with chiropractic care, physical rehabilitation, exercise, activity modification, and time.

Others are more complicated.

For example, a knee that strikes the dashboard may develop cartilage damage while the hip and lower back begin moving differently to protect the painful knee. A shoulder injury may cause the patient to change how the neck, upper back, and shoulder blade move.

This is why treatment often needs to look beyond the single location where the patient feels pain.

When Might MFAT Be Considered After an Auto Injury?

MFAT is generally not the first treatment needed after a car accident.

Initial treatment may involve diagnostic evaluation, imaging when indicated, activity changes, chiropractic care, physical rehabilitation, medications when medically appropriate, or other conservative approaches.

MFAT may be considered when there is more significant tissue damage or when progress has slowed despite appropriate care.

Possible situations include:

  • Moderate or advanced post-traumatic joint degeneration
  • Persistent joint inflammation
  • Significant cartilage injury
  • Chronic tendon problems
  • Selected partial tendon or ligament injuries
  • Poor-quality or degenerative tissue
  • Persistent pain after conservative treatment
  • Loss of joint function despite rehabilitation
  • Symptoms associated with osteoarthritis that became worse following trauma

Research is strongest for knee osteoarthritis. Studies have reported improvements in pain and function in some patients, although evidence quality varies and MFAT has not consistently shown superiority over other orthobiologic treatments (Hohmann et al., 2025; Park et al., 2025).

Evidence involving tendons, ligaments, other joints, and specific auto-accident injuries is less developed.

MFAT Is Not Automatically Better Than PRP

Patients sometimes assume that because MFAT is more involved than platelet-rich plasma, or PRP, it must be better.

Current research does not support that conclusion.

PRP is produced from the patient’s blood. MFAT requires a small fat-harvesting procedure in addition to processing and injection.

A randomized controlled trial involving patients with knee osteoarthritis found that both PRP and MFAT groups improved over 12 months, with no significant difference between the treatments in major patient-reported outcomes (Baria et al., 2024).

A 2025 systematic review and meta-analysis similarly found no statistically significant clinical advantage for MFAT compared with other orthobiologic injections, although the authors noted limitations in the available evidence (Hohmann et al., 2025).

The question should therefore not be:

“Which treatment sounds more advanced?”

The better question is:

“Which treatment best fits this injury, this tissue, and this patient?”

How MFAT and Chiropractic Rehabilitation Can Work Together

MFAT and chiropractic rehabilitation address different parts of recovery.

MFAT targets the local biological environment of a damaged joint or soft tissue.

Integrative chiropractic care focuses more on the mechanical environment surrounding that injury.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, describes accident injuries in his published clinical observations as layered problems. A patient may have tissue damage along with muscle guarding, restricted spinal motion, altered posture, weakness, nerve irritation, and poor movement patterns.

Biological treatment alone does not necessarily resolve these mechanical problems.

A coordinated recovery plan may therefore follow several stages.

1. Diagnose the Injury

Before considering MFAT, the team must identify what is actually damaged.

This may involve:

  • Physical examination
  • Neurological examination
  • Range-of-motion testing
  • Strength testing
  • Functional testing
  • X-rays
  • MRI
  • Ultrasound
  • Review of previous treatment

Serious problems such as fractures, complete tendon tears, severe instability, or major nerve compression may require different treatment.

2. Stabilize the Mechanical Problem

Early chiropractic and rehabilitation care may focus on improving safe movement, reducing harmful compensation, and restoring motion in areas that can be treated conservatively.

3. Consider MFAT When Appropriate

If imaging, symptoms, examination findings, and treatment history support its use, MFAT may be considered for the specific damaged tissue.

4. Protect the Treated Area

The injection does not mean the joint should be heavily exercised or manipulated immediately.

Early treatment should follow the regenerative provider’s post-procedure instructions.

5. Restore Movement Gradually

When medically cleared, chiropractic care and rehabilitation may address:

  • Restricted movement
  • Postural changes
  • Muscle imbalance
  • Abnormal loading
  • Joint mechanics
  • Balance
  • Coordination

6. Build Strength

Progressive exercises can then help the recovering tissue tolerate more normal physical demands.

7. Return to Normal Activities

Work activities, exercise, lifting, and sports are gradually added based on measurable improvement.

Dr. Jimenez’s clinical model emphasizes that regenerative procedures should not be viewed as replacements for rehabilitation. Instead, biological support and biomechanical rehabilitation can be carefully sequenced as different parts of a broader recovery plan. Direct clinical trials proving that the exact combination of MFAT plus chiropractic care produces superior outcomes are still limited, so these observations should not be mistaken for proof of greater effectiveness.

Medical Oversight and Chiropractic Care in El Paso

At Injury Medical Clinic PA in El Paso, Texas, practice materials describe a multidisciplinary model involving Dr. Alexander Jimenez and Dr. Maria Guadalupe Cardenas, MD.

Dr. Cardenas is an internal medicine physician with more than four decades of medical experience. Practice materials describe her as board-certified in internal medicine and as the clinic’s medical director and collaborative physician. Independent NPPES-derived provider records list her Texas medical license as J2933 and her NPI as 1164426748.

This distinction matters because some clinic webpages list NPI 1164426749. Independent NPPES-derived records consistently identify 1164426748, so we use that number here.

Within the clinic’s published model, medical oversight from Dr. Cardenas can be coordinated with the chiropractic and rehabilitation work of Dr. Jimenez.

The larger care model may include:

  • Medical evaluation and oversight
  • Integrative chiropractic care
  • Functional medicine
  • Personal injury care
  • Rehabilitation
  • Movement correction
  • Diagnostic testing
  • Imaging review
  • Medication review when appropriate
  • Nutritional and metabolic evaluation
  • Referral to orthopedic, neurological, or other specialists when needed

This multidisciplinary structure is especially useful when an injured patient also has medical conditions, medications, cardiovascular concerns, metabolic problems, diabetes, infection risks, or other factors that may affect healing.

The Biology-and-Biomechanics Approach

One useful way to understand integrated auto injury treatment is to separate recovery into two connected areas.

Biology

MFAT and other regenerative approaches focus on the injured tissue environment.

The goal may be to influence:

  • Inflammation
  • Cellular signaling
  • Tissue support
  • Extracellular matrix health
  • Local repair processes

Biomechanics

Chiropractic care and rehabilitation focus on how the body moves and how forces pass through recovering tissues.

The goals may include:

  • Better joint motion
  • Improved posture
  • Reduced compensation
  • Improved muscle control
  • Greater stability
  • Progressive strengthening
  • Safer movement
  • Better tolerance for work and daily activity

One cannot simply inject a damaged joint and assume that all mechanical stresses disappear.

Likewise, improving movement does not necessarily repair significant cartilage or tendon damage.

That is the reason an integrative approach may make sense for selected complex injuries.

MFAT Has Important Limits

MFAT should not be marketed as a guaranteed cure.

It cannot reliably be expected to rebuild a severely destroyed joint, reconnect a completely ruptured tendon, stabilize every traumatic injury, or eliminate the need for surgery.

The FDA also warns consumers that many products marketed broadly as “regenerative medicine” have not been FDA-approved to treat orthopedic conditions such as osteoarthritis, tendonitis, back pain, neck pain, knee pain, or shoulder pain. Regulatory status depends on the exact product, processing method, intended use, and applicable regulatory pathway. Patients should understand exactly what tissue or product is being offered and how it is regulated (U.S. Food and Drug Administration, 2021).

Effective care begins with realistic expectations and accurate diagnosis.

Moving Forward After an Auto Injury

MFAT represents an interesting area of modern regenerative medicine. It uses a patient’s own adipose tissue, mechanically processed into smaller fragments while preserving a natural structural and cellular environment.

For selected patients with persistent joint problems, cartilage injury, chronic soft-tissue problems, or post-traumatic degeneration, MFAT may provide another option when standard treatment has not restored enough function.

But recovery after an auto accident often requires more than an injection.

The treatment plan may also need to restore joint motion, correct compensation, strengthen muscles, improve balance, retrain movement, address lifestyle factors, and carefully return the patient to normal activity.

That is where an integrated medical-chiropractic model can be valuable.

At Injury Medical Clinic PA, the published clinical model combines the chiropractic and rehabilitation focus of Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, with medical direction from Dr. Maria Guadalupe Cardenas, MD, along with functional medicine, personal injury care, rehabilitation, and related services.

The goal is not simply to treat where it hurts.

The broader goal is to understand what was injured, what is keeping it irritated, how the patient is moving, what biological factors may affect healing, and what steps are needed to restore function safely.

For complex auto injuries, that combination of biology, biomechanics, medical oversight, and progressive rehabilitation can provide a clearer path toward recovery.

The Non-Surgical Solution "Chiropractic Care" | El Paso, Tx (2023)

References

Baria, M., Barker, T., Durgam, S., Pedroza, A., Flanigan, D., Jia, L., Kaeding, C., & Magnussen, R. (2024). Microfragmented adipose tissue is equivalent to platelet-rich plasma for knee osteoarthritis at 12 months posttreatment: A randomized controlled trial. Orthopaedic Journal of Sports Medicine, 12(3), 23259671241233916.

Fu, H., & Wang, C. (2025). Micro-fragmented adipose tissue—An innovative therapeutic approach: A narrative review. Medicine, 104(9), e41724.

Hohmann, E., Keough, N., Frank, R. M., & Rodeo, S. A. (2025). Microfragmented adipose tissue has no advantage over platelet-rich plasma and bone marrow aspirate injections for symptomatic knee osteoarthritis: A systematic review and meta-analysis. American Journal of Sports Medicine, 53(4), 988–998.

Jimenez, A. (2026). When MFAT is recommended after injuries: Options. Dr. Alex Jimenez.

El Paso Back Clinic. (2026). Micro-fragmented adipose tissue helps complex injuries heal.

Jimenez, A. (2026). Can old car accident injuries heal with integrative care?. Dr. Alex Jimenez.

Ortho-Regen. (n.d.). Microfragmented adipose tissue (MFAT).

Park, Y.-B., Lee, S. K., Kim, K.-I., Yoo, J.-H., Jung, T., & Kim, J.-H. (2025). Microfragmented adipose tissue as an alternative to platelet-rich plasma for intra-articular injection in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials. American Journal of Sports Medicine, 53(14), 3554–3564.

Sellers Sports Medicine. (2025). Micro-fragmented adipose tissue: A breakthrough treatment for knee arthritis.

U.S. Food and Drug Administration. (2021). Important patient and consumer information about regenerative medicine therapies.

Yuan, C., Goyle, A. K., Guirguis, M., Kaye, A. D., et al. (2026). Micro-fragmented adipose tissue (MFAT) in orthopedic regenerative medicine: A narrative review of the biological basis and clinical evidence. International Journal of Molecular Sciences, 27(14), 6185.

Spinal Adjustments and IV Infusions for Recovery Benefits

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Spinal Adjustments and IV Infusions for Recovery Benefits
Spinal Adjustments and IV Infusions for Recovery Benefits

Spinal Adjustments and IV Infusions for Recovery in El Paso

IV infusion therapy and spinal adjustments can work together to help the body heal from injuries faster. This article explains what each treatment does, why they fit together, and how they calm tense muscles, lower joint inflammation, and speed tissue repair. You will also see how integrative chiropractic care belongs in the plan, how the El Paso medical and chiropractic team works, and what a personal recovery path can look like.

Spinal Adjustments and IV Infusions for Recovery Benefits

What IV Infusion Therapy Does

IV infusion therapy sends fluids, vitamins, minerals, and other nutrients straight into the bloodstream through a small vein. Because the nutrients skip the stomach and intestines, the body can use nearly all of them right away. This is often called 100 percent bioavailability.

A typical recovery mix includes fluids for hydration, magnesium to help muscles relax, B vitamins for energy and nerve support, vitamin C to fight inflammation and help build collagen, and sometimes antioxidants. These ingredients reach cells quickly. The result is better hydration at the cellular level, less oxidative stress, and faster tissue repair.

People often notice less muscle tightness and more energy within hours. The session itself usually lasts 30 to 45 minutes and is done in a comfortable clinic setting under medical supervision.

How Spinal Adjustments Support Healing

Spinal adjustments, also called chiropractic manipulations, gently restore proper alignment to the spine and other joints. When bones sit in the right place, nerves can send clearer signals, muscles can fire more evenly, and blood flow improves around injured areas.

Misalignment from a car accident, sports strain, or everyday wear can keep muscles in a protective spasm and limit the nutrients that reach damaged tissue. An adjustment reduces that mechanical stress. It also helps the nervous system settle, which can lower the body’s overall pain response.

Integrative chiropractic care looks at the whole person. It does not stop at the adjustment. It includes movement exercises, posture work, and coordination with other therapies so the structural change lasts.

Why the Two Treatments Work Better Together

IV infusion therapy complements spinal adjustments by administering 100 percent bioavailable fluids, magnesium, and vitamins directly to the bloodstream. This quick cellular hydration and nutrition bypass digestion to calm tense muscles, reduce joint inflammation, and speed tissue regeneration, preparing the body for structural restoration.

Think of the adjustment as resetting the frame of a house and the IV as delivering the right building materials and water to every room at once. Once the spine is better aligned, circulation and nerve signals improve. The nutrients from the IV can then travel more easily to the exact spots that need repair. Combining IV infusion therapy with spinal adjustments helps you recover faster by fixing structural misalignment and providing direct nutrition to reduce inflammation. This comprehensive strategy maximizes nutrient bioavailability, accelerates tissue healing, and alleviates the chronic pain associated with musculoskeletal injuries. Injury Medical & Chiropractic Clinic in El Paso will provide you with a comprehensive, individualized recovery plan.

Magnesium in the IV mix helps muscles relax after an adjustment. Vitamin C and antioxidants help quiet the inflammatory chemicals that often linger after a sprain, strain, or disc injury. Better hydration also keeps joints moving more freely, so the benefits of the adjustment last longer.

Key Benefits for Musculoskeletal Injuries

Patients with back pain, neck pain, whiplash, sports injuries, or post-accident stiffness often experience these improvements when they use the two therapies together:

  • Faster drop in muscle spasm and stiffness
  • Less swelling around joints and soft tissue
  • Quicker return of energy and daily function
  • Better collagen formation for ligaments and tendons
  • Reduced need for extra pain medication in many cases
  • Support for the immune system so healing is not delayed by extra stress

These effects are especially helpful after auto accidents or when recovery has stalled. Direct nutrient delivery can reach areas that have limited blood flow, such as some tendons and spinal discs.

How Integrative Chiropractic Care Fits the Picture

Integrative chiropractic care is more than a single adjustment. It includes a full assessment of posture, movement patterns, and how the injury affects the rest of the body. The chiropractor addresses the structural side, while the IV provides biochemical support.

This combination is common in clinics that treat personal-injury cases and chronic musculoskeletal problems. The adjustment improves joint motion and nerve function. The IV then gives the cells the raw materials they need to rebuild. Functional medicine principles—looking at nutrition, inflammation, and lifestyle—tie the two together so the plan is personalized.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, has observed that patients recover more completely when structural care and cellular nutrition are addressed at the same time. His clinical work in El Paso focuses on non-invasive, root-cause approaches that restore function after trauma rather than just masking symptoms.

The Team at Injury Medical Clinic PA

Injury Medical Clinic PA in El Paso uses a multidisciplinary model. Dr. Alex Jimenez provides the chiropractic and functional medicine expertise. Dr. Maria Guadalupe Cardenas, MD, board-certified in internal medicine (NPI #1164426749, Texas MD License #J2933), serves as medical director and collaborative physician. She has more than 40 years of experience as an internist.

This setup is typical in integrative injury-care clinics. The MD oversees medical safety, reviews lab work when needed, and ensures IV therapies are appropriate. The chiropractor handles spinal and musculoskeletal alignment. Together, they also coordinate rehabilitation, personal-injury documentation, and functional-medicine testing.

The team treats auto-accident injuries, sports strains, work-related pain, and chronic conditions such as sciatica or disc problems. Patients receive a plan that can include adjustments, targeted IV infusions, movement therapy, and nutrition guidance—all under one roof.

What a Typical Recovery Journey Looks Like

A first visit usually starts with a history and exam. Imaging or labs may be ordered if needed. The doctors then decide which IV formula (hydration, Myers’-style cocktail, or recovery blend) matches the injury and which adjustment techniques will help most.

Treatments are often scheduled close together at first—sometimes the same day or within 24–48 hours—so the nutrients and the alignment change can reinforce each other. Follow-up visits track pain levels, range of motion, and energy. Frequency is adjusted as healing progresses.

Safety is a priority. Trained staff administers IVs in a sterile setting. Patients are screened for any conditions that would make an infusion unsuitable.

Taking the Next Step in El Paso

If you are dealing with lingering pain, slow healing after an injury, or muscle tightness that will not ease, the combination of IV infusion therapy and spinal adjustments offers a practical, evidence-informed option. The goal is not just short-term relief but a body that can repair itself more efficiently.

Injury Medical & Chiropractic Clinic in El Paso will provide you with a comprehensive, individualized recovery plan. Contact the clinic to review your history, explain the options, and design a program that fits your needs.

Top Chiropractor Near Me | El Paso, Tx (Best)

References

Allen Medical Aesthetics. (n.d.). IV therapy for recovery and wellness support.

Form & Function Therapy. (n.d.). Feel better, heal faster: How IV therapy supports your PT plan.

Health Voice 360. (n.d.). IV therapy solutions for musculoskeletal injuries & immune support.

IV Elements. (n.d.). IV therapy for post-operative recovery.

Jaffe Chiropractic. (n.d.). The duo wellness: Hydration and chiropractic care.

Jimenez, A. (n.d.). Injury specialists.

Neighborhood Naturopathic. (n.d.). Recovery IV therapy program.

Spinal Injury Center. (n.d.). Vitamin infusion & nutritional guidance.

Spine and Wellness Centers of America. (n.d.). Dive into the refreshing benefits of IV therapy.

The Med Spa Austin. (n.d.). How IV therapy can boost athletic performance and recovery.

Ward Institute. (n.d.). Bounce back faster with the power of IV infusions.

OUD & Chronic Pain Solutions for Patients With Integrative Care

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Learn how integrative care can help treat OUD and chronic pain with personalized approaches that promote overall well-being.

Abstract

In this comprehensive educational post, I, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, present a unified, evidence-based roadmap for treating opioid use disorder (OUD) and chronic pain through medications for opioid use disorder (MOUD) — specifically buprenorphine, methadone, and naltrexone — integrated with chiropractic care, functional medicine, rehabilitation, and personal injury management. I explain the pharmacology and clinical rationale for each medication; detail standard inductions, high-dose rapid stabilization, and low-dose micro-induction strategies in the fentanyl era; and connect these protocols to a patient-centered plan that restores stability, function, and autonomy.

Our multidisciplinary practice in El Paso, Texas — Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) — operates under the medical direction of Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), an internist with 40+ years of experience. Dr. Cardenas serves as our Medical Director and Collaborative Physician, ensuring medical oversight, pharmacovigilance, and alignment with current standards. I deliver integrative chiropractic care to modulate spine-neuro-immune dynamics and biomechanics, paired with functional medicine strategies to reduce inflammation and improve sleep, stress resilience, and metabolic health.

In this post, I take you on a step-by-step journey that covers: why MOUD is lifesaving; how mu-opioid receptor pharmacodynamics inform safety and efficacy; fentanyl-specific challenges and precipitated withdrawal prevention; how Sublocade and Brixadi long-acting buprenorphine injections improve adherence; how Butrans and Belbuca fit into modern pain care; the ethical principles of harm reduction; and how I coordinate chiropractic rehabilitation with MOUD to reduce nociplastic pain and restore movement capacity. Throughout, I cite leading organizations and researchers using modern, evidence-based methods, and I include clinical observations from practice shared at sciatica. clinic and in my professional updates.

Key takeaway: medications for OUD save lives; when we pair them with integrative chiropractic and rehabilitation under medical oversight, we can reduce withdrawal and cravings, address pain drivers, restore function, and help patients reclaim their futures.

About our team-based model and me in El Paso

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. Over three decades of clinical practice, I have focused on integrative, patient-centered care for musculoskeletal injury, chronic pain, and complex neuro-metabolic conditions, including opioid-related complications. Our El Paso clinic, Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), was built to address whole-person health for patients navigating pain, function, and recovery.

  • Medical direction and collaborative care
    • Maria Guadalupe Cardenas, MD (NPI #1164426749; Texas MD License #J2933), Board Certified in Internal Medicine with 40+ years of experience, serves as our Medical Director and Collaborative Physician. Dr. Cardenas oversees medical safety, MOUD protocols, laboratory and cardiometabolic assessment, and comorbidity management to ensure our care aligns with the latest evidence and standards.
  • Integrative chiropractic and functional medicine
    • I provide chiropractic care (spinal and extremity adjustments, neurodynamic interventions, soft-tissue therapies) and rehabilitation (graded exercise, motor control, progressive loading), coordinated with functional medicine to optimize nutrition, sleep, autonomic regulation, and inflammation control.
  • Scope and safety
    • Our integrated pathway leverages medical assessment (labs, ECGs when indicated, medication management), chiropractic biomechanics, rehab, and social determinants of health (SDOH) navigation — helping patients regain function while mitigating risk.

This post reflects our integrated approach and my clinical observations, including insights I share at:

Why medications for opioid use disorder save lives

When I discuss OUD treatment with patients and clinicians, I emphasize a core truth: medications for opioid use disorder are lifesaving. Both buprenorphine and methadone reduce all-cause and overdose mortality, diminish illicit opioid use, and stabilize the neurobiological circuits that drive withdrawal and craving (Substance Abuse and Mental Health Services Administration [SAMHSA], 2021; American Society of Addiction Medicine [ASAM], 2020; National Academies of Sciences, Engineering, and Medicine [NASEM], 2019).

  • Key benefits of MOUD
    • Reduced mortality risk and emergency utilization
    • Reduced illicit opioid use and criminal justice involvement
    • Improved function and engagement in behavioral and rehabilitative care
    • Protection against overdose due to tolerance loss after abstinence
  • Why continuity matters
    • Continuity of MOUD is strongly associated with better outcomes; interruption increases overdose risk due to loss of tolerance (NASEM, 2019; ASAM, 2020).
    • Stabilization enables patients to participate in rehabilitation and movement-based care. In my clinic, this is foundational for successful chiropractic care and functional progress.
  • How we translate evidence to action
    • We prioritize rapid stabilization with buprenorphine or methadone, pair it with naloxone distribution for overdose prevention, and coordinate chiropractic and rehab as soon as cravings and withdrawal are sufficiently controlled to allow safe movement progression.

References:

Mu-opioid receptor pharmacodynamics and safety: translating physiology to practice

Physiology guides my induction strategies and safety planning. Understanding receptor dynamics clarifies why buprenorphine can prevent overdose but also precipitate withdrawal if mistimed.

  • Mu-opioid receptor basics
    • The mu receptor governs analgesia, reward-salience, respiratory drive, and stress response.
    • Full agonists (e.g., fentanyl, heroin, methadone) drive receptor activation to a high level, with high effectiveness for analgesia but dose-dependent respiratory depression.
    • Partial agonists (e.g., buprenorphine) exhibit high receptor affinity but a ceiling effect on respiratory depression — meaning a safer profile for overdose while still suppressing withdrawal and cravings (Dahan et al., 2006; Strang et al., 2020).
  • Why bbuprenorphine’sceiling effect matters
    • As dose increases, buprenorphine’s analgesia continues to improve while respiratory depression plateaus (Dahan et al., 2006). This underpins its outpatient safety profile and is a central reason I prefer buprenorphine for many patients with OUD and comorbid pain.
  • Antagonists and withdrawal
    • Naltrexone blocks mu receptors but offers no intrinsic analgesia; if physiological dependence is present, naltrexone can precipitate withdrawal. It’s best reserved for fully detoxified patients who prefer a non-agonist path (ASAM, 2020).

References:

Medications overview: indications, formulations, and clinical use

I individualize medication choices to align with patient goals, pain phenotype, substance history, and setting. Below is how I think through each medication, with Dr. Cardenas providing medical oversight.

Buprenorphine

  • Indications
    • First-line OUD treatment (ASAM, 2020; SAMHSA, 2021)
    • Chronic pain formulations: transdermal patch (Butrans) and buccal film (Belbuca)
  • OUD formulations
    • Sublingual monoproduct (historically Subutex)
    • Sublingual buprenorphine-naloxone combinations (e.g., Suboxone)
    • Long-acting injectables
      • Sublocade (monthly extended-release)
      • Brixadi (weekly or monthly extended-release)
  • Chronic pain formulations
    • Transdermal patch (Butrans)
    • Buccal film (Belbuca)
    • Parenteral buprenorphine (Buprenex) for acute pain in monitored settings
  • Off-label realities
    • Sublingual buprenorphine (monoproduct or combo) may be used off-label for chronic pain in carefully selected cases, particularly with central sensitization or high-risk opioid exposure (Srivastava, Kahan, & Njoroge, 2020).

References:

Methadone

  • Indications
    • OUD: must be delivered through federally certified Opioid Treatment Programs (OTPs)
    • Chronic pain: outpatient prescribable with careful monitoring
  • Pharmacology and safety
    • Full mu-agonist with NMDA antagonism — useful for hyperalgesia but with higher overdose risk due to long and variable half-life
    • QTc monitoring and careful titration are critical (ASAM, 2020)
  • Clinical interface
    • OTP coordination is essential. In our integrative setting, we align chiropractic sessions around sedation and symptom patterns to maximize safety and function.

Reference:

Naltrexone

  • Indications
    • OUD relapse prevention in fully detoxified patients (oral daily or monthly extended-release injection)
    • Alcohol use disorder: reduces heavy drinking days
  • Limitations
    • No analgesia and risk of precipitated withdrawal in dependent patients
    • Best for motivated patients who prefer antagonist therapy and can maintain abstinence

Reference:

Sublingual buprenorphine: dosing, administration, and counseling

Getting the fundamentals right improves success rates and safety.

  • Administration
    • Place the tablet/film under the tongue, avoid swallowing while it dissolves, and allow 10 minutes to dissolve for reliable transmucosal absorption.
    • If nausea occurs, the patient may spit pooled saliva; absorption is mucosal, not gastric.
  • Counseling
    • Physical dependence develops; avoid abrupt discontinuation.
    • Dental health: FDA warns of potential caries with buprenorphine products dissolved in the mouth — we emphasize meticulous oral hygiene, fluoride, and regular dental care (FDA, 2022).
    • Hepatic considerations: buprenorphine is hepatically metabolized; monitor LFTs, especially in hepatic impairment.
    • Avoid respiratory depressants: counsel on risks with alcohol and benzodiazepines.
  • Combination vs. monoproduct
    • Buprenorphine-naloxone combination is generally preferred; negligible sublingual naloxone bioavailability deters injection diversion.
    • Monoproduct may be considered for naloxone-related adverse effects or when clinically indicated; navigate insurance barriers with documented medical necessity.

Reference:

Long-acting injectable buprenorphine: Sublocade and Brixadi in real-world care

I increasingly rely on long-acting injectables for patients struggling with daily adherence, diversion risk, or peak-trough symptom fluctuations.

  • Why consider injectables
    • Improved adherence
    • Reduced diversion
    • More stable plasma levels
    • Fewer daily decision points, supporting behavioral focus and rehabilitation
  • Sublocade
    • Monthly depot after stabilization on transmucosal buprenorphine
    • Dosing typically 300 mg initially, then 100–300 mg monthly
    • Consider early supplemental sublingual doses if needed before steady-state
  • Brixadi
    • Weekly or monthly options; weekly flexibility facilitates fine-tuned adjustments early in care
    • Useful as a bridge before monthly transitions or in ED settings if protocols and follow-up are robust

References:

Buprenorphine initiation in the fentanyl era: preventing precipitated withdrawal and tailoring strategy

Fentanyl’s dominance in the illicit market requires precision and shared decision-making. I emphasize patient autonomy, clear options, and contingency planning.

Why precipitated withdrawal happens

  • Mechanism
    • Buprenorphine is a high-affinity partial agonist. If substantial full-agonist occupancy persists at the mu receptor, buprenorphine displaces the full agonist and provides lower net activation—triggering acute precipitated withdrawal (Varshneya et al., 2023; Volkow & Blanco, 2023).
  • Fentanyl-specific challenges
    • Fentanyl’s lipophilicity creates adipose tissue depots that slowly elute into circulation, maintaining receptor occupancy beyond expected timelines.
    • I have seen patients with severe anxiety-forward withdrawal in fentanyl exposure; GI signs may lag while restlessness, akathisia, and dysphoria dominate.

References:

Three evidence-based induction strategies

I present all three approaches with pros and cons, aligning the choice to the patient’s goals, history, and care setting, with Dr. Cardenas co-managing risk.

Traditional induction:

  • Method
    • Wait for mild to moderate withdrawal (e.g., COWS ≥ 8–12, often ≥12–13); start with 2–8 mg buprenorphine; titrate every 2–4 hours as needed to ~8–16 mg total on day 1; adjust to 12–24 mg by day 2–3.
  • Best use
    • Transitioning from short-acting prescription opioids with predictable pharmacokinetics
  • Limitations in fentanyl
    • Depot effects make timing unpredictable; increased precipitated withdrawal risk.
  • When I use it
    • Patient preference, low likelihood of fentanyl exposure, or controlled settings with close monitoring and readiness to pivot strategies

Low-dose initiation (microdosing/overlap):

  • Method
    • Start very low buprenorphine doses (e.g., 0.2–0.5 mg) while continuing full agonists; increase buprenorphine daily and taper the full agonist over 5–7+ days (Krook et al., 2020; Raheemullah et al., 2024).
  • Why it helps
    • Gradual receptor occupancy avoids abrupt displacement, reducing precipitated withdrawal risk — especially useful for fentanyl-exposed patients or those with prior precipitated episodes.
  • Adjuncts
    • Clonidine/lofexidine, hydroxyzine, trazodone, NSAIDs/acetaminophen, ondansetron, loperamide
  • Safety note
    • Overdose protection is not robust until buprenorphine approaches ~8 mg/day; harm reduction and naloxone are essential.

High-dose initiation (rapid stabilization):

  • Method
    • Confirm sufficient withdrawal (often COWS ≥ 16 with objective signs); administer 16 mg, reassess in ~30 minutes, then 8 mg increments up to 24–32 mg on day 1 as needed (CA Bridge, 2023; Herring et al., 2021).
  • Why it helps
    • Rapid receptor occupancy addresses severe withdrawal quickly and is particularly effective in ED/urgent care settings.

References:

Preventing and managing precipitated withdrawal

  • Prevention
    • Ensure adequate withdrawal for standard induction; consider microdosing for patients at high risk (notably fentanyl or methadone).
  • If it occurs
    • Do not stop buprenorphine prematurely. Increase the buprenorphine dose (often an additional 8–16 mg in divided doses) to saturate receptors and stabilize at the partial-agonist ceiling, while providing symptom support (clonidine, hydroxyzine, antiemetics, NSAIDs) and reassurance (CA Bridge, 2023).

Shared decision-making and patient-centered communication in initiation

Shared decision-making is not a courtesy — it’s the operating system for safe induction in the fentanyl era. Patients who have experienced precipitated withdrawal often carry trauma from that experience; trust and collaboration are essential (Nielsen et al., 2023).

  • What I emphasize
    • You are the expert in your own body; I am here with options.
    • We have three valid approaches (traditional, low-dose, high-dose) with clear trade-offs — we choose together.
    • We will use symptom-targeted adjuncts proactively; you will not be abandoned mid-process.
    • If you were precipitated before, we tailor to minimize risk.
  • Clinical workflow
    • Intake and risk stratification (substance history, comorbidities, SDOH)
    • Choose initiation method collaboratively
    • Provide a clear dosing map, printed instructions (including film splitting when applicable), and “when to call” rules
    • Schedule frontline follow-up contacts within 24–72 hours during critical early days

Reference:

Integrating chiropractic care with MOUD: how biomechanics and neurophysiology support recovery

In our model, once withdrawal and cravings begin to stabilize, I integrate chiropractic and rehabilitative strategies that reduce pain drivers, dampen nociplastic amplification, and build functional resilience.

  • Mechanistic synergy
    • Segmental adjustments and regional joint care provide high-fidelity mechanoreceptive input that can modulate descending inhibitory pathways (periaqueductal gray, rostral ventromedial medulla), reducing pain amplification.
    • Autonomic balance: gentle mobilization, breathing re-education, and thoracic adjustments can shift sympathetic-parasympathetic tone, reducing allostatic load and perceived threat.
    • Movement as medicine: graded exposure, neurodynamic glides, and progressive loading build capacity and confidence, decreasing reliance on pharmacologic relief.
  • Why this matters clinically
    • Pain and withdrawal amplify each other via shared autonomic and neuroimmune pathways. By reducing nociceptive input and improving movement confidence, I see less sympathetic overdrive, better sleep, and improved adherence to MOUD.
    • I share case experiences at the sciatica clinic where OUD stabilization with buprenorphine allowed patients to progress through neurodynamic and stabilization programs, reducing catastrophizing and improving gait symmetry.

References:

Functional medicine lens: reducing inflammation and supporting recovery physiology

We address systemic drivers that worsen pain and relapse risk. Dr. Cardenas and I coordinate non-sedating strategies, metabolic supports, and behavioral coaching.

  • Inflammation and pain
    • Anti-inflammatory nutrition (omega-3s, polyphenols), glycemic control, and micronutrient optimization attenuate neuroinflammatory pathways that amplify pain and craving.
  • Sleep and circadian health
    • Stabilizing sleep-wake cycles reduces hyperalgesia and limbic reactivity. Non-drug strategies (light hygiene, stimulus control, breathwork) complement non-sedating aids when indicated.
  • Stress buffering
    • HRV biofeedback, paced breathing, and mind-body practices reinforce medication effects by modulating the HPA axis and limbic activation.

Harm reduction: meeting patients where they are

Harm reduction is ethical, evidence-based, and practical. We never make abstinence a prerequisite for compassionate care. Instead, we emphasize survival, safety, and trust-building (WHO, 2014; CDC, 2024).

  • Core elements
    • Naloxone distribution with training for the patient and household (CDC, 2024)
    • Safer use counseling; wound care and infection prevention
    • Screening and vaccination for Hepatitis A/B and HIV
    • Syringe service referrals where legal and available
    • Social determinants support: transportation, housing, phones for telehealth
  • Why it works
    • Harm reduction reduces mortality, infectious spread, and stigma while increasing readiness for MOUD and rehabilitation.

References:

Buprenorphine for chronic pain: modern analgesia with a safety margin

I integrate buprenorphine into pain management when non-opioid and multimodal strategies are insufficient or when full agonists pose unacceptable risk. Its unique profile suits complex pain cases with high risk for opioid-induced hyperalgesia (OIH).

  • Mechanisms relevant to pain
    • Partial mu-agonism with kappa antagonism and ORL-1 activity may mitigate hyperalgesia and reduce dysphoria.
    • Stable receptor occupancy supports analgesia with a lower respiratory risk than full agonists (Dahan et al., 2006).
  • Formulations for pain
    • Transdermal (Butrans) and buccal (Belbuca) provide steady analgesia at lower total opioid exposure.
    • In select cases, off-label sublingual buprenorphine (mono or combo) can be used for severe pain or high opioid tolerance when indicated.
  • Clinical pearls
    • Consider dose splitting (e.g., 4 mg TID vs 12 mg QD) for analgesic effect if using sublingual formulations off-label.
    • Always pair with nonpharmacologic interventions: chiropractic adjustments, graded exercise, cognitive-behavioral coping, sleep optimization, and anti-inflammatory nutrition.

References:

Methadone for OUD and comorbid pain: when and why

Methadone is highly effective, particularly when buprenorphine trials have failed, in severe OUD, or when full agonist analgesia is clinically needed within an OTP framework.

  • Indications
    • Severe OUD or repeated failed buprenorphine trials
    • Significant comorbid pain where NMDA antagonism may benefit hyperalgesia
    • Pregnancy when methadone is preferred or already established
  • Safety and logistics
    • QTc monitoring and careful titration due to long/variable half-life
    • Coordinated care through OTPs is required by law
    • Chiropractic and rehab sessions timed to avoid sedation peaks and optimize safety

Reference:

Naltrexone for OUD: where it fits

Naltrexone is best for motivated, fully detoxified patients who prefer an antagonist approach and do not need opioid analgesia. It plays a more prominent role in alcohol use disorder.

  • Clinical considerations
    • Requires 7–10+ days opioid-free before initiation
    • Blunts opioid analgesia — perioperative planning is essential
    • Chiropractic and non-opioid pain strategies become even more important

Reference:

Special populations: pregnancy, perioperative care, and adolescents

  • Pregnancy
    • Continue or initiate buprenorphine for OUD during pregnancy; sublingual formulations are preferred. Long-acting injectables are not FDA-approved for pregnancy.
    • Physiological changes may necessitate higher or split dosing.
    • Coordinate with obstetrics; use gentle chiropractic techniques for pregnancy-related pelvic and low-back strain (ASAM, 2020).
  • Perioperative patients
    • Maintain buprenorphine through the perioperative period in coordination with anesthesia and surgery; apply multimodal analgesia and regional blocks.
    • Chiropractic-informed positioning and post-operative progressive mobilization support recovery.
  • Adolescents (≥16 years)
    • Buprenorphine is FDA-approved for OUD in adolescents ≥16 years.
    • Emphasize clarity, family engagement, and school coordination; chiropractic care supports sports-related pain and posture concerns.

Reference:

Safety considerations: polypharmacy, sedation, and respiratory risk

We address respiratory depressant combinations non-punitively to keep patients engaged and safe.

  • Benzodiazepines and alcohol
    • Co-use with buprenorphine heightens respiratory risk. We counsel clearly, coordinate benzodiazepine tapers when appropriate, and avoid abrupt cutoffs that drive disengagement.
  • Sedatives and CNS depressants
    • PDMP checks, staged changes, and emphasis on sleep hygiene and non-sedating anxiety strategies (breathwork, HRV biofeedback).
  • Liver disease
    • Baseline and periodic LFTs, adjusting monitoring to clinical status.

Reference:

Personal injury and OUD: special considerations in my practice

Acute injury often initiates an opioid exposure cascade. We minimize risk while restoring function.

  • Injury cascade
    • Early multimodal analgesia, clear opioid exit strategies, and rapid MOUD access when indicated prevent chronic opioid exposure.
    • For whiplash, lumbar strain, and radiculopathy: gentle cervicothoracic work, vestibular drills as needed, direction-specific spinal-sparing strategies, and neurodynamic techniques once irritability decreases.
  • Documentation and communication
    • We carefully document function, impairment, and return-to-work capacity. Under Dr. Cardenas’ medical direction, we align medical therapy and chiropractic progress with legal and occupational requirements.

Step-by-step clinic pathway: from intake to stabilization

  • Comprehensive assessment
    • OUD diagnosis and risk profile (overdose history, polysubstance use, SDOH)
    • Pain phenotype (nociceptive, neuropathic, nociplastic)
    • Function metrics, vitals, and labs as indicated
  • Shared decision-making
    • Present induction options (traditional, low-dose overlap, high-dose)
    • Align plan with patient goals, prior experiences, and logistics
  • Induction and early stabilization
    • Execute the chosen protocol
    • Provide naloxone, clear written guidance, and proactive adjuncts
    • Ensure follow-up within 24–72 hours
  • Chiropractic and rehab onboarding
    • Initiate low-threat mobilization, breath mechanics, and isometrics as cravings settle.
    • Progress mobility → motor control → strength → meaningful task capacity
  • Functional medicine adjuncts
    • Anti-inflammatory nutrition, hydration, and electrolytes
    • Sleep strategies and stress tools (breathing, HRV biofeedback)
  • Ongoing optimization
    • Titrate MOUD; consider Sublocade/Brixadi
    • Taper sedatives cautiously when safe
    • Regularly measure outcomes; iterate as needed

Patient education checklist for buprenorphine

  • How to take it
    • Place under tongue; let dissolve fully; okay to spit saliva if nauseated.
  • What to expect
    • Decreased withdrawal and cravings; improved function over days to weeks.
  • Safety
    • Avoid mixing with alcohol or benzodiazepines; keep naloxone available for household and community safety.
  • Dental care
    • Brush after dosing when feasible; use fluoride; schedule regular dental visits.
  • Liver health
    • Report jaundice, RUQ pain, or dark urine; keep lab appointments.

Reference:

Insurance navigation and access

  • Monoproduct buprenorphine
    • Provide documentation of medical necessity in naloxone-intolerant cases.
  • Long-acting injectables
    • Prior authorizations and patient assistance programs preserve continuity; our team coordinates with specialty pharmacies.
  • Dose coverage in fentanyl era
    • Many patients initially need >24 mg/day buprenorphine; document clinical necessity and align with evolving policies that accept doses up to 32 mg/day for selected cases (ASAM, 2023).

References:

Measuring outcomes that matter

  • Functional metrics
    • Return-to-work readiness, lifting tolerance, sit-stand endurance, gait quality, sleep quality
  • Pain and function scales
    • PEG, Oswestry Disability Index (ODI)/Neck Disability Index (NDI), Patient-Specific Functional Scale
  • OUD stability
    • Cravings trends, urine toxicology, days of nonmedical opioid use, retention in care

Clinical observations from my practice: sciatica, fentanyl-era inductions, injectables, and dental prevention

From my work in El Paso and insights I share publicly, including at sciatic a.clinic and on my professional updates, several patterns stand out:

  • Sciatica and neuropathic pain
    • Stabilizing OUD with buprenorphine allows meaningful participation in neurodynamic flossing, segmental stabilization, and graded loading, reducing catastrophizing and improving gait symmetry.
  • Fentanyl-era inductions
    • Micro-induction has been particularly valuable for patients with heavy fentanyl exposure who previously failed standard inductions due to severe precipitated withdrawal.
  • Long-acting injectables
    • Weekly Brixadi serves as a useful bridge for patients reluctant to commit to monthly dosing or needing fine-tuned early adjustments.
    • Transitioning stabilized patients to Sublocade simplifies logistics and supports adherence; some require early supplemental sublingual doses.
  • Dental prevention
    • Proactive oral hygiene guidance at buprenorphine initiation reduces reports of dental sensitivity and caries.

Resources:

Putting it all together: a case-inspired journey

  • Week 0–1
    • A patient with lumbar radicular pain and daily fentanyl exposure presents. We choose micro-induction, start low-dose buprenorphine while continuing a full agonist, layer in gentle neurodynamic drills and diaphragmatic breathing, and provide robust adjuncts and naloxone.
  • Week 2–4
    • Stabilized at ~16 mg/day, cravings diminish. I add targeted spinal adjustments, hip hinge drills, and sleep regularization; anti-inflammatory nutrition begins; close check-ins maintain momentum.
  • Month 2
    • Transition to monthly Sublocade for adherence; progress to posterior chain strength and graded aerobic conditioning; monitor for end-of-interval symptom drift and supplement sublingual doses if needed.
  • Month 3–6
    • Functional goals achieved (full shift tolerance, fewer flares). Behavioral coping skills solidify; relapse-prevention continues with naloxone access and scheduled follow-up.

Conclusion: our multidisciplinary ethos in El Paso

  • Medical safety and MOUD excellence
    • Maria Guadalupe Cardenas, MD (NPI #1164426749; Texas MD License #J2933), anchors our medical supervision, risk mitigation, and clinical governance.
  • Chiropractic, rehab, and functional medicine integration
    • My team and I guide biomechanical correction, movement retraining, and physiological resilience. We address nociplastic pain, autonomic dysregulation, and inflammatory drivers while MOUD stabilizes the reward/withdrawal circuitry.
  • Humane, precise, sustainable care
    • Our model pairs lifesaving medications with integrative chiropractic care and rehabilitation — a coordinated plan to reduce risk, improve function, and support long-term recovery.

Key takeaways:

  • MOUD is lifesaving; buprenorphine’s respiratory depression ceiling underpins its safety advantage (Dahan et al., 2006; NASEM, 2019).
  • Individualized induction — standard, high-dose, or micro-induction — is essential in the fentanyl era to prevent precipitated withdrawal (ASAM, 2023; CA Bridge, 2023).
  • Integrative chiropractic care complements MOUD by reducing pain drivers, restoring movement, and enhancing function (Chou et al., 2016).
  • Medical oversight by an experienced internist like Dr. Cardenas ensures safety, quality, and continuity.
  • Harm reduction, patient education, and functional metrics keep recovery grounded in outcomes that matter.

References

SEO tags: buprenorphine, methadone, naltrexone, opioid use disorder, OUD, Sublocade, Brixadi, Suboxone, Subutex, Butrans, Belbuca, buprenorphine induction, micro-induction, Bernese method, precipitated withdrawal, harm reduction, chiropractic care, integrative medicine, internal medicine oversight, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, El Paso, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, chronic pain, personal injury, functional medicine, rehabilitation, sciatica, evidence-based care, respiratory depression ceiling effect, naloxone, dental health buprenorphine, liver monitoring buprenorphine, benzodiazepines alcohol risk, QTc methadone, long-acting injectable buprenorphine, high-dose induction, low-dose overlap, shared decision making, fentanyl era, CA Bridge protocol, ASAM guidelines, central sensitization, autonomic regulation, graded exposure, neurodynamic glides, sleep optimization, anti-inflammatory nutrition

BHRT Benefits for Movement: Reduce Inflammation

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
BHRT Benefits for Movement: Reduce Inflammation
BHRT Benefits for Movement: Reduce Inflammation

BHRT Benefits for Movement, Muscle Strength, and Joints

Abstract: When hormone levels drop with age or menopause, bioidentical hormone replacement therapy (BHRT) can indirectly improve mobility and flexibility. It may lower joint stiffness, help conserve bone density, and support muscle strength. It is not a direct stretch and does not replace movement training. BHRT can also reduce joint inflammation, support cartilage health, and ease muscle tightness tied to low estrogen or testosterone. Integrative chiropractic care can add to these benefits by restoring joint motion, lowering nervous-system stress, and improving how the body moves. This article explains the hormone-joint link, what BHRT can and cannot do, and how medical care and chiropractic care work together in El Paso.

BHRT Benefits for Movement: Reduce Inflammation

A Simple Starting Point: Why Movement Changes With Age

Many people notice the same pattern. Getting out of a chair takes more effort. The first steps in the morning feel tight. Reaching overhead or turning to look over a shoulder is not as easy as it used to be.

Part of this comes from less activity, old injuries, and weaker muscles. Hormones also play a role. Estrogen and testosterone affect more than mood, sleep, and energy. They also affect joints, bones, cartilage, and muscle.

When those hormone levels fall, the body can become more inflamed. Cartilage may not stay as healthy. Bones can lose density. Muscles may shrink or feel stiffer. None of this means movement is lost forever. It does mean a plan for better mobility should address both hormones and how the joints actually move.

How Estrogen and Testosterone Affect Joints and Muscles

Estrogen helps keep joints quieter. It can reduce inflammatory signals and help cartilage stay stronger and more flexible. It also supports the fluid that lets joints glide. After menopause, estrogen drops. Joints may then feel more swollen, dry, and stiff. Bone density often falls at the same time, which puts more stress on the joints (Mobility Bone & Joint Institute, 2025).

Testosterone supports collagen and muscle mass. Collagen is a building block of cartilage, tendons, and ligaments. Muscle acts like a natural brace around a joint. When testosterone is low, repair can slow, muscles can weaken, and joints can feel less stable (BodyLogicMD, 2025; Sota Wellness, n.d.).

Hormonal changes can also change how people feel day to day:

  • More joint aching
  • Longer morning stiffness
  • Less energy for walking or exercise
  • Weaker grip or harder time getting up from the floor
  • Higher risk of bone loss

These symptoms can feed on each other. Pain reduces activity. Less activity weakens muscle. Weaker muscle loads the joints more. Better hormone balance may interrupt that cycle, but movement still has to be restored.

What Bioidentical Hormone Therapy Is

BHRT uses hormones that match the ones the body makes. They are often made from plant sources and then changed so they are chemically the same as human estradiol, progesterone, or testosterone.

A clinician usually reviews symptoms and lab work before choosing a plan. Delivery methods can include creams, patches, pellets, or other forms. The dose is meant to be personal, not one-size-fits-all.

It is important to stay clear-eyed. Mayo Clinic notes that bioidentical hormones are not proven safer or more effective than standard hormone therapy. Compounded products can also vary in quality (Mayo Clinic, 2024). Hormone therapy is a medical decision. It should be supervised, monitored, and based on the person’s health history.

How BHRT May Improve Mobility and Flexibility

BHRT does not stretch a tight muscle or unlock a restricted joint. Its help is mostly indirect.

  • It may lower joint inflammation. Estrogen and testosterone can reduce inflammatory activity that makes joints swell and feel tight (BodyLogicMD, 2025; Renew Health & Wellness, 2021).
  • It may support cartilage. Estrogen helps with lubrication and may slow some cartilage wear. Testosterone and related hormones can support collagen (BodyLogicMD, 2025).
  • It may protect bone density. Stronger bones provide a more stable base for joints and lower fracture risk (Balance Hormone Center, n.d.; Desert Sands Aesthetics, n.d.).
  • It may support muscle strength. Better muscle support can make daily movement easier and safer (Charleston Pain Relief Center, n.d.; Sota Wellness, n.d.).
  • It may raise energy for activity. When fatigue eases, people can walk, stretch, and train more often. That extra movement is what truly improves flexibility.

Some research and clinic reports show less joint pain in people using hormone therapy. A few studies have linked estrogen therapy with slower osteoarthritis progression in some groups. Other evidence is mixed. Medical groups do not list joint pain as a main reason to start hormone therapy (Maven Clinic, n.d.). Results vary.

Why BHRT Is Not a Direct Fix for Flexibility

Flexibility is the ability of a muscle and joint to move through a useful range. Mobility is a bigger idea. It is flexibility plus strength, control, and healthy connective tissue (Essentrics, 2026).

Hormones can make that range more comfortable. They cannot create it by themselves. People still need:

  • Regular movement through the full range
  • Strength around the hips, spine, and shoulders
  • Better posture and joint mechanics
  • Enough sleep and recovery
  • A plan for old injuries that never fully resolved

If someone only uses hormone therapy and never addresses stiff joints or weak muscles, flexibility often stays limited. The hormones may reduce the “background noise” of stiffness. The body still has to relearn easier movement.

How Integrative Chiropractic Care Fits Into This Treatment

This is where integrative chiropractic care becomes useful. Chiropractic care does not replace estrogen, progesterone, or testosterone. It does not change hormone levels on its own. It can help the body move better while hormone balance is being restored.

Chiropractic care can:

  • Restore motion in stiff spinal and extremity joints
  • Reduce muscle guarding around painful areas
  • Improve posture so joints are not loaded in a crooked way
  • Lower physical stress that keeps the nervous system on high alert
  • Make walking, stretching, and rehab more comfortable

Pain and poor sleep raise stress hormones such as cortisol. High cortisol can increase inflammation and make recovery harder. Better spinal motion and less nighttime stiffness can support calmer sleep and healthier movement patterns (Nightlight Chiropractic, 2025).

When joints move better, people can use the muscle and bone support that BHRT may provide. Hormone therapy and chiropractic care are not competing treatments. They work on different layers of the same problem.

A Team Approach in El Paso

At Injury Medical Clinic PA in El Paso, Texas, this kind of layered care is built into the clinic model. Dr. Maria Guadalupe Cardenas, MD, is board-certified in internal medicine.

  • She has more than 40 years of experience as an internist (NPI #1164426749, Texas MD License #J2933).
  • She serves as medical director and collaborative physician.
  • She provides medical evaluation, diagnosis, and oversight, including review of hormone-related concerns.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, provides chiropractic care and integrative clinical support. He is a chiropractor and board-certified family nurse practitioner. His work includes spinal care, functional medicine, personal injury rehabilitation, and wellness protocols.

This setup is common in integrative and injury-care clinics. An MD provides medical direction. A chiropractor restores joint motion and movement mechanics. The same team can also include:

  • Functional medicine support
  • Personal injury care after auto or work accidents
  • Rehabilitation and guided exercise
  • Nutrition and lifestyle care

The point is not to stack random services. The point is to treat the person as one system: hormones, joints, nerves, muscles, and daily function.

What Dr. Jimenez Observes in Practice

Dr. Jimenez’s clinical observations point to the same idea. Hormone health and musculoskeletal care work better together. Integrative chiropractic care can restore spinal and pelvic alignment, reduce muscle tightness, and improve autonomic balance. That may help patients sleep better, stay more active, and tolerate other therapies more easily (Jimenez, n.d.).

He has noted that pelvic and low-back care can improve hip mechanics. Better hip motion often makes walking and daily tasks feel less restricted. Movement then supports bone health, insulin sensitivity, and mood. In his practice, care is not only about a single adjustment or a single hormone prescription. It looks at inflammation, nutrition, sleep, alignment, and how the person actually moves (El Paso Back Clinic, n.d.; Jimenez, n.d.).

This matters after injury as well. A crash or workplace strain can leave ligaments stretched, joints restricted, and muscles tight. If hormone levels are also low, recovery can feel slower. Coordinated care can address both the tissue injury and the internal environment that affects healing.

What a Combined Plan Can Look Like

A practical plan often starts with a clear picture:

  • Medical history and symptom review
  • Labs when hormone imbalance is suspected
  • A movement exam for joint restriction, posture, and strength
  • A look at sleep, stress, nutrition, and old injuries

From there, care may include medical oversight of hormone therapy when it is appropriate, chiropractic care to restore motion, and rehab to rebuild strength and flexibility. Nutrition can support bone and muscle. Activity is progressed in a way the joints can handle.

People should not expect one visit or one prescription to restore full flexibility. The better path is stepwise. First, reduce pain and stiffness. Next, restore joint motion. Then build strength and control through that new range.

Putting the Pieces Together

Can bioidentical hormone therapy help with mobility and flexibility? It can help, but not as a direct stretch. When hormones decline, BHRT may lower joint stiffness, conserve bone density, support muscle strength, reduce inflammation, and ease muscle tightness. Those changes can make movement easier.

Integrative chiropractic care can boost those advantages. It restores joint motion, reduces nervous-system tension, and improves movement mechanics. Together, the two approaches address both the body’s internal chemistry and how it moves.

Anyone considering this path should work with qualified clinicians, review the risks and benefits, and avoid treating BHRT as a cure-all. In El Paso, Injury Medical Clinic PA offers a multidisciplinary model in which Dr. Cardenas provides medical direction, and Dr. Jimenez provides chiropractic and integrative care. That combination is designed to help people move with more comfort, strength, and control.

Modulating Women Hormones Part 1 of 3 l El Paso, Tx (2021)

References

Balance Hormone Center. (n.d.). The benefits of bioidentical hormone replacement therapy (BHRT).

BodyLogicMD. (2025, April 10). How BHRT supports joint health and reduces chronic pain.

Charleston Pain Relief Center. (n.d.). Hormone replacement therapy, energy, and aging.

Desert Sands Aesthetics. (n.d.). Hormone replacement therapy.

El Paso Back Clinic. (n.d.). Regenerative medicine and integrative chiropractic strategies.

Essentrics. (2026, March 16). Mobility for menopause.

Jimenez, A. (n.d.). Patient wellness and health with bioidentical hormones.

Mayo Clinic. (2024, October 3). Bioidentical hormones: Are they safer?.

Maven Clinic. (n.d.). HRT and joint pain in menopause: What the evidence says.

Mobility Bone & Joint Institute. (2025, March 12). A guide to joint health after menopause.

Nightlight Chiropractic. (2025, December 17). Hormones, your health, and the role chiropractic care can play.

Renew Health & Wellness. (2021, October 12). How BHRT helps relieve joint pain.

Sota Wellness. (n.d.). Bioidentical hormone therapy benefits for men and women.

Wellness Doctor RX. (2026, April 21). Integrative hormone optimization and chiropractic protocols.

BHRT Nutrition for Optimal Metabolic Balance

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
BHRT Nutrition for Optimal Metabolic Balance
BHRT Nutrition for Optimal Metabolic Balance

BHRT Nutrition: A Whole-Food Plan for Hormone Therapy

Abstract

Bioidentical hormone replacement therapy (BHRT) may use hormones such as estrogen, progesterone, or testosterone to address specific symptoms or medically identified hormone needs. There is no single approved “BHRT diet.” Instead, nutrition during hormone therapy is usually built around whole foods, adequate protein, healthy fats, fiber-rich carbohydrates, vegetables, fruits, and optimal hydration. A Mediterranean-style eating pattern is often a practical choice because it supports heart health, blood sugar control, healthy body composition, and overall metabolic health (Cano et al., 2020).

Nutrition does not replace hormone therapy or medical monitoring. Rather, it can support the systems that process nutrients and hormones, including the liver, digestive system, muscles, bones, and cardiovascular system. At Injury Medical Clinic PA in El Paso, a multidisciplinary approach can also combine medical oversight, functional medicine, integrative chiropractic care, rehabilitation, and lifestyle guidance. Chiropractic care may help patients move with less pain and participate more comfortably in exercise and healthy daily routines, but it should not be viewed as a treatment that directly controls hormone levels.

BHRT Nutrition for Optimal Metabolic Balance

What Is Bioidentical Hormone Replacement Therapy?

Bioidentical hormones are manufactured hormones designed to have the same chemical structure as hormones naturally produced by the body. Common examples include estradiol, progesterone, and testosterone.

Hormone therapy may be used for problems such as menopausal symptoms or medically diagnosed hormone deficiencies. However, treatment must be individualized because hormone therapy also has risks and possible side effects. Cleveland Clinic notes that FDA-approved bioidentical hormone products are available, while compounded products do not undergo the same FDA approval process and may have greater uncertainty in dosing and safety (Cleveland Clinic, 2022).

The Menopause Society also explains that custom-compounded hormones have not been shown to be safer or more effective than government-approved hormone products.

This is why good BHRT care should include more than simply giving a hormone. A healthcare provider may review:

  • Symptoms
  • Medical history
  • Medications
  • Blood pressure
  • Blood sugar
  • Cholesterol and triglycerides
  • Liver and kidney health
  • Hormone levels when clinically appropriate
  • Bone health
  • Body composition
  • Exercise
  • Sleep
  • Nutrition

Is There a Special BHRT Diet?

No medically approved diet exists that every person receiving estrogen, progesterone, or testosterone must follow.

A better way to think about nutrition is to ask:

What eating pattern supports the patient’s health while hormone therapy is being monitored?

For many people, the answer resembles a Mediterranean-style diet.

NuLife Institute recommends an eating pattern rich in plant foods, proteins, healthy fats, vegetables, legumes, nuts, whole grains, and omega-3 fats as part of lifestyle support during hormone care (NuLife Institute, 2022).

Research on menopause also supports Mediterranean-style eating for cardiometabolic health. Reviews have found possible benefits involving body weight, blood pressure, blood lipids, glucose control, and overall cardiovascular health in menopausal women (Cano et al., 2020; Silva et al., 2021).

A simple BHRT nutrition plate might contain:

  • Half the plate: vegetables or vegetables plus fruit
  • One-quarter: lean protein
  • One-quarter: high-fiber carbohydrates
  • A small amount: healthy fats

This approach is simple enough to follow without turning food into a complicated hormone prescription.

Eat Enough Protein

Protein becomes especially important as people get older because maintaining muscle can become harder.

Useful protein sources include:

  • Fish
  • Chicken
  • Turkey
  • Eggs
  • Greek yogurt
  • Cottage cheese
  • Beans
  • Lentils
  • Tofu
  • Lean beef
  • Protein-rich nuts and seeds

Protein can help support muscle repair, fullness, recovery from exercise, and stable meals.

This may be especially useful for a patient receiving testosterone therapy who is also beginning resistance exercise. However, eating extra protein does not automatically increase testosterone, and it should not replace proper hormone evaluation.

Baylor Scott & White Health recommends building meals around protein, fiber, and healthy fats to slow digestion and support steadier glucose and insulin responses (Baylor Scott & White Health, 2025).

Choose Healthy Fats

Fats should not automatically be avoided during BHRT.

Healthy fats can be found in:

  • Extra-virgin olive oil
  • Avocados
  • Walnuts
  • Almonds
  • Chia seeds
  • Flaxseed
  • Salmon
  • Sardines
  • Tuna

A Mediterranean-style eating pattern relies heavily on unsaturated fats instead of large amounts of saturated and heavily processed fats.

Baylor Scott & White recommends foods such as olives, olive oil, nuts, seeds, and avocados as sources of unsaturated fats within a hormone-supportive diet (Baylor Scott & White Health, 2025).

Omega-3-rich foods may also be helpful as part of an overall anti-inflammatory eating pattern.

Make Fiber a Daily Goal

Fiber is one of the most useful parts of a healthy BHRT nutrition plan.

Good sources include:

  • Beans
  • Lentils
  • Oats
  • Berries
  • Apples
  • Pears
  • Broccoli
  • Brussels sprouts
  • Leafy greens
  • Quinoa
  • Brown rice
  • Whole-grain foods
  • Chia and flaxseed

Fiber can support regular bowel movements, healthy cholesterol levels, gut health, fullness, and steadier blood sugar.

Some wellness sources use the term “estrogen detox.” A more medically accurate description is that the liver and digestive tract normally metabolize and eliminate hormone metabolites. Eating enough fiber and maintaining normal bowel function can support digestive health, but no food performs a special hormone “cleanse.”

This difference matters because BHRT patients need reliable nutrition guidance, not detox promises.

Control Refined Sugar and Highly Processed Foods

Patients do not have to eliminate every carbohydrate.

Instead, the goal is to improve carbohydrate quality.

Choose more:

  • Oatmeal
  • Beans
  • Lentils
  • Sweet potatoes
  • Quinoa
  • Brown rice
  • Whole grains
  • Fruits
  • Vegetables

Choose less often:

  • Sugary drinks
  • Candy
  • Pastries
  • Sweetened coffee drinks
  • Refined snack foods
  • Large portions of highly processed carbohydrates

The Life Fertility Center recommends whole foods, healthy fats, lean proteins, and fiber while limiting excessive refined sugar and highly processed foods as part of a lifestyle approach to metabolic and hormonal health (The Life Fertility Center, 2024).

This approach can be especially important when a patient also has insulin resistance, metabolic syndrome, elevated triglycerides, or unwanted weight gain.

Support Bone Health During Estrogen Changes

Estrogen plays an important role in bone health. When estrogen declines around menopause, bone loss may speed up.

Nutrition should therefore include adequate:

  • Calcium
  • Vitamin D
  • Protein
  • Magnesium
  • Vitamin K
  • Other minerals found in whole foods

Helpful foods may include dairy products when tolerated, fortified plant beverages, leafy greens, fish, eggs, beans, and nuts.

Vitamin D supplementation should be based on individual needs rather than guessing. Baylor Scott & White notes that food sources include fatty fish, egg yolks, and vitamin-D-fortified foods, while supplementation may be appropriate after discussion with a healthcare provider (Baylor Scott & White Health, 2025).

Do Not Forget Hydration, Sleep, and Exercise

A nutrition plan works best when it is part of a larger lifestyle plan.

BodyLogicMD recommends combining BHRT care with balanced nutrition, regular physical activity, stress-management strategies, sleep, hydration, and regular medical follow-up (BodyLogicMD Medical Review Board, 2025).

Patients can start with simple goals:

  • Drink water throughout the day.
  • Build meals from mostly whole foods.
  • Aim for regular sleep and wake times.
  • Walk regularly.
  • Add resistance training when medically appropriate.
  • Reduce excessive alcohol.
  • Avoid smoking.
  • Limit large amounts of added sugar.
  • Schedule regular follow-up visits.

These habits may also help reduce some of the cardiovascular and metabolic risks that become more important with aging.

What About “Hormone-Balancing Foods”?

Online discussions often claim that individual foods can “balance hormones.”

Foods certainly affect metabolism and overall health, but they usually do not work like hormone medications.

For example, berries, vegetables, fish, nuts, olive oil, seeds, and whole grains provide nutrients that help normal body function. Educational programs have also discussed foods such as salmon, flaxseed, vegetables, fruits, and healthy fats as part of hormone-conscious nutrition (NuLife Institute, 2022; New York Living, n.d.).

The key is the overall eating pattern, not one miracle food.

How Integrative Chiropractic Care Fits Into BHRT

Chiropractic treatment does not replace estrogen, progesterone, testosterone therapy, laboratory monitoring, or medical evaluation.

Its best role in an integrated hormone program is supportive.

For example, a patient with back pain, neck pain, poor movement, or joint stiffness may have trouble exercising. Chiropractic and rehabilitation strategies may help improve movement and reduce musculoskeletal barriers to physical activity.

Care may include:

  • Chiropractic adjustments when appropriate
  • Soft-tissue treatment
  • Mobility work
  • Posture training
  • Corrective exercises
  • Breathing exercises
  • Strength and stability training
  • Rehabilitation
  • Lifestyle coaching

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, describes clinical observations in which improving movement, sleep habits, nutrition, breathing mechanics, and physical activity forms part of a larger integrative care model (Jimenez, 2026).

Importantly, these are clinical observations and an integrative treatment philosophy, not proof that spinal manipulation directly changes estrogen, progesterone, testosterone, or cortisol levels.

A safer evidence-based explanation is that reducing musculoskeletal pain and improving movement may make it easier for a patient to exercise, sleep, manage stress, and follow healthy routines. Those changes can support overall metabolic health.

Medical Oversight and Chiropractic Care in El Paso

At Injury Medical Clinic PA in El Paso, Texas, the care model brings together different healthcare disciplines.

Dr. Alex Jimenez provides chiropractic, functional medicine, personal injury, physical rehabilitation, and related integrative services. His published clinical approach emphasizes combining musculoskeletal care with nutrition, movement, lifestyle changes, laboratory information, and collaboration with medical professionals.

Dr. Maria Guadalupe Cardenas, MD, is an El Paso internal medicine physician with more than four decades of medical experience. Clinic materials identify her as board-certified in internal medicine and as the Medical Director and Collaborative Physician for Injury Medical Clinic PA. Public professional listings identify her NPI as 1164426748. Her Texas physician license is J2933.

This type of multidisciplinary structure allows different parts of a patient’s care to be coordinated while each clinician remains within their professional scope.

For a patient receiving hormone therapy, this can help connect:

  • Medical evaluation and medication oversight
  • Laboratory monitoring
  • Nutrition
  • Functional medicine
  • Chiropractic care
  • Personal injury treatment
  • Exercise rehabilitation
  • Weight and metabolic management
  • Referral to specialists when needed

The goal is not for chiropractic care to replace internal medicine or hormone management. The goal is for the different parts of care to support one another.

A Simple BHRT Nutrition Day

A practical day might look like this:

Breakfast:
Eggs with spinach, avocado, berries, and oatmeal.

Lunch:
Grilled chicken over mixed vegetables with chickpeas, olive oil, and a small serving of quinoa.

Snack:
Greek yogurt with walnuts, or an apple with almond butter.

Dinner:
Salmon with roasted vegetables, lentils, and a leafy green salad.

Drinks:
Mostly water, mineral water, or unsweetened beverages.

This is not a prescription. Portion sizes and food choices should change based on body size, activity, medical conditions, goals, allergies, medications, kidney function, glucose control, and other personal factors.

The Bottom Line

There is no single required nutrition plan for people using bioidentical estrogen, progesterone, or testosterone.

For many patients, the strongest starting point is a whole-food, Mediterranean-style eating pattern built around vegetables, fruit, lean protein, fiber, whole grains, legumes, nuts, seeds, fish, and healthy fats.

Nutrition can support metabolic health, cardiovascular health, digestion, muscle maintenance, bone health, and stable energy. It should work alongside—not instead of—proper hormone evaluation and medical monitoring.

Integrative chiropractic care can add another layer by addressing musculoskeletal pain, movement, rehabilitation, posture, and physical function. At Injury Medical Clinic PA in El Paso, this approach is combined with medical oversight, functional medicine principles, personal injury care, and rehabilitation to create a coordinated model of care.

Patients considering BHRT should discuss their medical history, symptoms, medications, nutrition, laboratory findings, and individual risks with a qualified healthcare professional before beginning or changing hormone treatment.

Assessing Hormones *THERAPY* | El Paso, Tx (2022)

References

Baylor Scott & White Health. (2025, July 14). Tips for a hormone-balancing diet: Top foods that help balance hormones.

BodyLogicMD Medical Review Board. (2025, September 22). Lifestyle changes to make when you are on BHRT.

Cano, A., Marshall, S., Zolfaroli, I., Bitzer, J., Ceausu, I., Chedraui, P., Durmusoglu, F., Erkkola, R., Goulis, D. G., Hirschberg, A. L., Kiesel, L., Lopes, P., Pines, A., van Trotsenburg, M., Lambrinoudaki, I., & Rees, M. (2020). The Mediterranean diet and menopausal health: An EMAS position statement. Maturitas, 139, 90–97.

Cleveland Clinic. (2022). Bioidentical hormones: Therapy, uses, safety & side effects.

Jimenez, A. (2026). Patient wellness and health with bioidentical hormones.

Jimenez, A. (n.d.). Dr. Alexander Jimenez, DC, APRN, FNP-BC, IFMCP, CFMP. LinkedIn.

The Life Fertility Center. (2024). Hormonal balance: A comprehensive guide to unlocking wellness.

Motion Nutrition. (2018, January 25). The ultimate guide to your hormonal balance for men and women.

New York Living. (n.d.). Foods that help balance your hormones [Video]. YouTube.

NuLife Institute. (2022, July 18). Hormone therapy specialist: 6 foods you need to eat for a balanced hormone health.

Silva, T. R., Oppermann, K., Reis, F. M., & Spritzer, P. M. (2021). Nutrition in menopausal women: A narrative review. Nutrients, 13(7), 2149.

U.S. Women’s Medical Center. (n.d.). What role does nutrition play in hormone replacement therapy?.

A Clinical Approach to Integrative Care Essentials for OUD Treatment

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-

Find effective strategies and insights on clinical approaches to integrative care to support recovery from opioid use disorder.

Abstract

Opioid Use Disorder (OUD) represents a significant public health challenge, rooted in a complex history of pain management, substance development, and evolving legislation. This educational post, from my perspective as Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, delves into the multifaceted nature of OUD. We will embark on a journey through the history of opioids, from their natural origins to the potent synthetic versions driving the current crisis. By examining the three distinct waves of the opioid epidemic, we will gain a clearer understanding of how we arrived at this critical juncture. A central theme of our discussion will be deconstructing pervasive myths and the corrosive impact of stigma, which remains a formidable barrier to effective care. I will present the latest findings from leading researchers, grounded in evidence-based methods, to outline the most effective treatment recommendations. This includes a detailed look at the pharmacology of medications for OUD (MOUD), such as methadone, buprenorphine, and naltrexone, and the psychological framework of motivational interviewing. We will also explore the vital role of harm reduction strategies in saving lives and promoting health. At our clinic, we bring this comprehensive approach to life through a unique integrative model. This post details how my work in chiropractic and functional medicine is seamlessly integrated with the medical oversight of our esteemed Medical Director, Dr. Maria Guadalupe Cardenas, MD, to offer a holistic, patient-centered pathway to recovery.

Our Integrative Care Model: A Collaborative Approach to Healing

Hello, I’m Dr. Alex Jimenez. With a diverse background spanning chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP, ATN, CCST), my career has focused on understanding the intricate connections between the body’s structure, function, and overall well-being. At Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) here in El Paso, Texas, we have cultivated a unique environment where different medical disciplines converge to provide comprehensive, patient-centered care.

A cornerstone of our practice is our collaboration with Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933) and brings over 40 years of invaluable experience as an internist. She serves as our Medical Director and Collaborative Physician, providing the essential medical oversight that allows us to operate as a truly multidisciplinary clinic. This model is common and highly effective in integrative and injury care settings, where a medical doctor’s expertise enhances and guides the therapeutic strategies of other practitioners.

Our team integrates a wide array of services to address the whole person, not just a single symptom. This includes:

  • Medical Oversight (Dr. Cardenas): Cardenas provides medical direction, oversees complex cases, manages prescription medications when necessary, and ensures our protocols adhere to the highest standards of medical care. Her internal medicine background is crucial for managing the comorbidities often associated with chronic pain and substance use disorders.
  • Integrative Chiropractic Care (Dr. Jimenez): As a chiropractor, I focus on the biomechanical and neurological aspects of health. For patients with OUD, many of whom initially started using opioids for chronic pain, chiropractic care is a powerful, non-pharmacological tool. By addressing the root musculoskeletal causes of pain through spinal adjustments, soft tissue therapies, and corrective exercises, we can often reduce or eliminate the very pain that led to opioid use in the first place. This is a fundamental part of a long-term recovery strategy.
  • Functional Medicine: We look beyond the symptoms to understand the “why.” Using advanced diagnostics, we investigate underlying issues like gut health, nutritional deficiencies, hormonal imbalances, and inflammation, which can all contribute to chronic pain and affect mental health and recovery from OUD.
  • Rehabilitation & Personal Injury Care: We provide targeted physical rehabilitation to restore function, improve strength, and help patients regain their quality of life after an injury, which can be a critical factor in preventing the transition from acute to chronic pain.

By combining these disciplines, we create a synergistic effect. A patient struggling with OUD that began with a back injury might receive chiropractic adjustments to alleviate the structural source of their pain, functional medicine interventions to reduce systemic inflammation, medical management and counseling for the OUD itself under Dr. Cardenas’s direction, and rehabilitation to build resilience against future injury. This holistic approach empowers patients, addresses the multifaceted nature of their condition, and builds a sustainable foundation for lasting health and recovery.

A Journey Through Time: The History of Opioids

To truly grasp the complexities of the current opioid crisis, we must first travel back in time and understand the origins and evolution of these powerful substances. The story of opioids is not a recent one; it is a long and winding road that stretches back millennia, marked by discovery, medical application, and, ultimately, widespread societal impact.

From Poppy Plants to Potent Synthetics

The narrative begins with nature itself. When we discuss opioids, it’s crucial to differentiate between the various types, as their origins dictate their properties and potency.

  • Natural Opioids (Opiates): These are alkaloids derived directly from the resin of the opium poppy plant, Papaver somniferum. The primary substances in this category are morphine and codeine. They are the original template from which all other opioids were developed.
  • Semi-Synthetic Opioids: These are created in laboratories by chemically modifying natural opiates. Scientists synthesize these from the naturally occurring opium products to enhance certain effects, such as pain relief. This class includes some of the most well-known substances, such as heroin (synthesized from morphine), oxycodone, and hydrocodone.
  • Synthetic Opioids: These are entirely artificial in a laboratory, designed to mimic the effects of natural opiates by interacting with the same receptors in the brain. This category includes therapeutic medications like methadone and the notoriously potent fentanyl.

A Chronological Timeline of Opioid Development

The timeline of opioid discovery and use is not to scale. Still, it places key moments in chronological order, revealing a pattern of increasing potency and accessibility over time.

  • 3400 BC: Our story begins in Mesopotamia, where the opium poppy was first cultivated. Early civilizations recognized its profound effects, often using it in religious ceremonies and for medicinal purposes.
  • 1400s AD: The Greeks and Romans began to more formally document the use of opium as a potent pain reliever. Its ability to dull suffering was unparalleled at the time.
  • 1500s AD: The therapeutic applications expanded. Paracelsus, a Swiss physician, created a tincture of opium called laudanum, which became a popular remedy for a wide range of ailments, including diarrhea.
  • 1803: A pivotal moment occurs when a German pharmacist, Friedrich Sertürner, successfully isolates the primary active alkaloid from opium. He names it morphine, after Morpheus, the Greek god of dreams. This discovery allows for standardized dosing and marks the beginning of modern opioid pharmacology.
  • 1832: French chemist Pierre-Jean Robiquet isolates another alkaloid from opium, codeine, which proves to be an effective cough suppressant.
  • 1874: In a London hospital, chemist C.R. Alder Wright synthesizes heroin (diacetylmorphine) from morphine. Initially, it was marketed by the Bayer Company as a non-addictive alternative to morphine and a cough suppressant. The tragic irony of this initial marketing is now painfully clear.
  • 1939: During World War II, German scientists searching for a synthetic painkiller that could be produced with readily available precursors synthesized methadone.
  • 1959: Paul Janssen of Janssen Pharmaceutica develops fentanyl, a synthetic opioid estimated to be 50 to 100 times more potent than morphine. Its primary use was for managing severe pain during and after surgery.
  • 1966: Scientists at a British firm discovered buprenorphine, a unique compound that would later become a cornerstone of OUD treatment due to its distinct pharmacological properties.

This historical overview shows that while the roots of opioid use are ancient, the majority of the substances that define the modern crisis were developed or discovered within the last 200 years, with a significant acceleration in the 20th century.

Understanding Opioid Potency: Morphine Milligram Equivalents (MME)

When we prescribe or discuss different opioid medications, simply comparing milligram to milligram is not only inaccurate but also dangerous. The concept of Morphine Milligram Equivalents (MME) is a crucial tool that allows healthcare providers to standardize and compare the relative potencies of different opioids. The MME calculates a dose’s equivalent strength to morphine, which serves as the benchmark.

Here is a list of common opioids, ordered by increasing potency relative to morphine. Understanding this hierarchy is essential for safe prescribing and for appreciating the risks associated with different substances.

  • Tramadol: This is often considered a “weaker” opioid, but it still carries risks. Its potency is such that 1 milligram of morphine is equivalent to 10 milligrams of tramadol (an MME conversion factor of 0.1).
  • Codeine: Slightly more potent than tramadol, with a conversion factor of 15.
  • Hydrocodone: This is a commonly prescribed opioid for moderate pain (e.g., in products like Vicodin or Norco). It has a 1-to-1 equivalence with morphine.
  • Oxycodone: Found in medications like Percocet and OxyContin, oxycodone is more potent than morphine, with a conversion factor of 5. This means 10 mg of oxycodone is equivalent to 15 mg of morphine.
  • Hydromorphone (Dilaudid): This is a significantly more potent opioid, typically used for severe pain in hospital settings. Its conversion factor is 0.
  • Fentanyl (Transdermal Patch): Fentanyl’s potency is in a different league altogether. It is so potent that it is measured in micrograms (mcg), not milligrams. Its MME conversion factor is 4 micrograms per hour for a transdermal patch, which is equivalent to 1 mg of oral morphine per day, but this conversion can be complex. The key takeaway is its extreme potency, which is why illicitly manufactured fentanyl has been so devastating.

From my clinical observations, the transition from a prescribed, lower-potency opioid like hydrocodone to a higher-potency one, whether prescribed or illicit, is a critical point where risk escalates dramatically. A patient accustomed to a certain dose of oxycodone may not realize that a similar-sized amount of fentanyl could be lethal. This is a vital educational point for every patient.

The Three Waves of the Opioid Crisis in the United States

The current opioid crisis did not emerge overnight. The U.S. Centers for Disease Control and Prevention (CDC) has characterized its progression in three distinct waves, each defined by the primary type of opioid driving overdose deaths.

First Wave (1999–2010): The Rise of Prescription Opioids

The crisis began in the late 1990s, fueled by a confluence of factors. There was a cultural shift in medicine to treat pain more aggressively, with pain being promoted as the “fifth vital sign.” This was coupled with the aggressive marketing of new opioid formulations, like OxyContin, which were claimed to be less addictive. The result was a dramatic increase in opioid prescribing.

  • Between 1999 and 2010, prescription opioid sales quadrupled in the United States.
  • Concurrently, opioid-involved overdose deaths doubled, rising from 2.9 to 6.8 deaths per 100,000 people.
  • This wave laid the groundwork for the crisis by creating a large population of individuals exposed to and, in many cases, dependent on opioids.

Second Wave (2010–2013): The Shift to Heroin

As awareness of prescription opioid misuse grew, regulations tightened, and it became more difficult and expensive to obtain these medications illicitly. Many individuals who had developed a dependence on prescription opioids turned to a cheaper and more accessible alternative: heroin.

  • From 2010 to 2013, heroin overdose deaths surged, increasing from 1.0 to 9 per 100,000 people.
  • During this period, heroin-related deaths surpassed those from prescription opioids for the first time.
  • This transition marked a shift from a problem primarily involving the healthcare system to one deeply enmeshed with the illicit drug market.

Third Wave (2013–Present): The Devastation of Synthetic Opioids

The third and most lethal wave began around 2013 with the infiltration of the illicit drug supply by potent synthetic opioids, most notably illicitly manufactured fentanyl. Fentanyl is not only incredibly potent but also cheap to produce, making it a profitable adulterant for drug traffickers. It began to be mixed into heroin, cocaine, methamphetamine, and pressed into counterfeit pills made to look like legitimate prescription opioids (like Xanax or oxycodone).

  • Since 2013, death rates from synthetic opioids have increased by over 1,000%, skyrocketing from 1.0 to 11.4 deaths per 100,000 people in just five years.
  • A deeply concerning recent trend within this wave is the emergence of xylazine, a non-opioid animal tranquilizer, being mixed with fentanyl. This combination, known as “tranq,” increases the risk of overdose and can cause severe, necrotic skin wounds. By 2017, xylazine was found in up to 10% of fentanyl-related overdoses in some areas.

In 2017, recognizing the catastrophic scale of the problem, the U.S. Department of Health and Human Services officially declared the opioid crisis a Public Health Emergency.

The CDC graph below visually demonstrates the staggering impact of these three waves. The teal line represents the first wave of commonly prescribed opioids, showing a steady rise and then a leveling off. The blue line shows the second wave’s rise in heroin deaths starting in 2010. But it is the purple line, representing the third wave of synthetic opioids, that is most striking. It remains relatively flat until 2013 and then skyrockets exponentially, dwarfing the death tolls of the previous two waves. The sheer verticality of this line is a stark illustration of the lethality of fentanyl.

The Current Landscape of Opioid Misuse

Data from the 2021 SAMHSA National Survey on Drug Use and Health provides a snapshot of the current situation. Among people aged 12 or older in the United States:

  • 9.2 million people misused opioids in the past year.
  • This can be broken down further:
    • Misuse of Prescription Pain Relievers: This remains the larger issue by volume, with approximately 8.1 million people exclusively misusing pain medication.
    • Heroin Use: Approximately 0.5 million people reported using only heroin.
    • Overlap: A significant group of about 0.5 million people reported misusing both prescription pain relievers and heroin.
    • In total, about 1 million people reported using heroin.

These numbers underscore the continued importance of responsible prescribing practices for pain relievers, as this remains a primary pathway into OUD for millions of Americans.

Key Legislation and Milestones in Opioid Treatment

The legal and regulatory landscape surrounding opioids has profoundly shaped both the problem and its potential solutions. Understanding these key legislative acts provides context for why treatment is structured the way it is today.

  • Harrison Narcotics Tax Act of 1914: This was one of the first federal laws to regulate and tax the production, importation, and distribution of opiates and cocaine. Crucially, it criminalized the non-medical use of opiates, framing addiction more as a legal problem than a medical one and driving it underground.
  • Controlled Substances Act (CSA) of 1970: This act created the drug scheduling system (Schedules I-V) that classifies substances based on their medical use and potential for abuse. It also established the Drug Enforcement Administration (DEA) to regulate these controlled substances.
  • Narcotic Addiction Treatment Act of 1974: This law specifically regulated the treatment of opioid addiction. It mandated that methadone could only be dispensed through highly regulated, federally certified programs, known as opioid treatment programs (OTPs) or “methadone clinics.” This created a siloed system, separating OUD treatment from mainstream medical care.
  • Drug Addiction Treatment Act of 2000 (DATA 2000): This was a landmark piece of legislation. It created the “buprenorphine waiver” (often called the “X-waiver”), which, for the first time, allowed qualified physicians to prescribe buprenorphine—a Schedule III opioid—for the treatment of OUD in an office-based setting. This was a monumental step toward integrating addiction treatment into general medicine.
  • Comprehensive Addiction and Recovery Act (CARA) of 2016: This act expanded access to treatment by allowing Nurse Practitioners (NPs) and Physician Assistants (PAs) also to obtain a waiver and prescribe buprenorphine, significantly increasing the number of potential providers.
  • SUPPORT for Patients and Communities Act of 2018: This act further expanded access to care, particularly by addressing reimbursement issues within Medicare and Medicaid for OUD treatment.
  • Mainstreaming Addiction Treatment (MAT) Act of 2023: This legislation marked another revolutionary change. It eliminated the buprenorphine waiver (X-waiver) requirement. Now, any prescriber with a standard DEA license who is permitted to prescribe Schedule III medications under their state license can prescribe buprenorphine for OUD. This has been a game-changer in “mainstreaming” addiction care and reducing barriers for both patients and providers.

Enhancing Health Together: Embracing Multidisciplinary Evaluation and Treatment- Video

Enhancing Health Together: Embracing Multidisciplinary Evaluation and Treatment | El Paso, Tx (2023)

The Rationale for Treatment: A Disease That Demands a Medical Response

Opioid Use Disorder is not a moral failing; it is a chronic, relapsing brain disease. The statistics paint a sobering picture of an undertreated epidemic.

  • Of the estimated 9 million adults in the United States who need treatment for OUD, only a little over 2 million (about 22%) actually receive medications for opioid use disorder (MOUD).
  • In 2022, there were nearly 82,000 opioid overdose deaths.
  • The economic impact is staggering, costing the nation over $193 billion annually in healthcare costs, lost productivity, and criminal justice expenses.

These numbers make it unequivocally clear that treating OUD is not just a compassionate choice; it is a medical, social, and economic necessity.

Deconstructing the Myths and Stigma Surrounding OUD Treatment

One of the greatest barriers to effective treatment is the persistent stigma that surrounds OUD and the medications used to treat it. This stigma is often rooted in deeply ingrained myths. The best way to dismantle these myths is to reframe them in the context of other chronic medical conditions.

Myth 1: “Medications for OUD (MOUD) just replace one addiction with another.”

Fact: This is perhaps the most common and damaging misconception. Let’s apply this logic to another chronic disease: diabetes. We would never say that giving a patient insulin is “replacing a sugar addiction with an insulin addiction.” We understand that insulin is a life-saving medication that corrects a physiological deficit. Similarly, medications like buprenorphine and methadone work by stabilizing the brain’s neurochemistry, which the disease of addiction has hijacked. They normalize brain function, reduce cravings, and prevent withdrawal, allowing a person to focus on recovery, hold a job, and rebuild their life. It is treatment, not a replacement.

Myth 2: “Recovery without medication is superior to recovery with medication.”

Fact: This myth creates a false hierarchy of recovery. Let’s consider a patient with hypertension. We might first recommend diet and exercise. If their blood pressure comes down, that’s a successful outcome. If another patient tries diet and exercise but their blood pressure remains dangerously high, we add medication. We would never think that the second patient’s treatment plan is “inferior.” They are simply two different patients with different physiological needs requiring different treatment plans. The goal is a healthy outcome—a stabilized patient. The same is true for OUD. For many, medication is an essential component of a successful treatment plan.

Myth 3: “MOUD is not effective.”

Fact: The evidence is overwhelmingly to the contrary. Extensive research has demonstrated that MOUD is the gold standard of care. When individuals with OUD are treated with medications like buprenorphine or methadone, their risk of fatal overdose is dramatically reduced. Studies show up to a 60% reduction in all-cause mortality among patients receiving MOUD compared to those who are not.

Myth 4: “MOUD is a crutch for weak people who can’t stop on their own.”

Fact: This statement completely misunderstands the neurobiology of addiction. OUD is a chronic disorder that profoundly alters brain circuits involved in reward, stress, and self-control. It hijacks the brain’s decision-making capacity. The intense cravings and withdrawal symptoms are not a matter of willpower; they are powerful physiological and psychological compulsions. Just as we would medically treat the pathophysiology of any other chronic organ disease, we must medically treat the pathophysiology of this brain disease.

What is a Substance Use Disorder?

The language we use to discuss these conditions has evolved. We have moved away from terms like “abuse,” “dependence,” and “addiction” in a clinical context. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), now classifies these conditions as Substance Use Disorders (SUDs).

  • SUDs are defined as chronic, relapsing medical conditions that occur within the brain.
  • They are diagnosed using a specific set of 11 criteria and categorized by severity (mild, moderate, or severe) based on how many criteria a person meets.
  • The good news is that there are effective, evidence-based treatments

The DSM-5 Criteria for Opioid Use Disorder

To be diagnosed with OUD, a person must exhibit at least two of the following 11 criteria within 12 months. As we review these, notice how many relate to behavioral changes and life impact rather than a specific quantity of substance used. This highlights that OUD is about the loss of control and the negative consequences of use.

  1. Using in larger amounts or for a longer period than intended.
  2. A persistent desire or unsuccessful efforts to cut down or control use. (This is the loss of control.)
  3. Spending a great deal of time obtaining, using, or recovering from the effects of the substance. (The substance becomes the central organizing principle of life.)
  4. Craving, or a strong desire or urge to use.
  5. Recurrent use failing to fulfill major role obligations at work, school, or home.
  6. Continued use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the substance.
  7. Giving up or reducing important social, occupational, or recreational activities because of use.
  8. Recurrent use in situations in which it is physically hazardous (e.g., driving while impaired, using non-sterile needles).
  9. Continued use despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance. (The reward system overrides the brain’s self-preservation system.)
  10. Tolerance: Defined by either needing markedly increased amounts of the substance to achieve the desired effect or a markedly diminished effect with continued use of the same amount.
  11. Withdrawal: Manifested by either the characteristic withdrawal syndrome for the substance or using the substance (or a closely related one) to relieve or avoid withdrawal symptoms.

It is important to note that meeting only the criteria for tolerance and withdrawal (10 and 11) does not constitute an OUD diagnosis. This is because a patient taking opioids as prescribed for chronic pain can develop physiological tolerance and withdrawal without having the compulsive, life-disrupting behaviors that define the disorder. They must also meet at least one of the first nine criteria.

The Pervasive Impact of Stigma on Care

Stigma is a powerful, destructive force that directly affects patient outcomes. It manifests at every level of society and creates formidable barriers to seeking and receiving care.

Public Stigma

Public stigma involves the negative attitudes and beliefs held by the general population.

  • Not recognizing SUD as a chronic condition: This leads to the belief that it is a moral failing, which in turn fuels judgment and blame.
  • Association with crime: People with OUD are often unfairly stereotyped as dangerous or criminal.
  • Opposition to treatment access: Stigmatizing beliefs lead to “Not In My Backyard” (NIMBY) sentiment, where communities oppose the establishment of treatment facilities or harm reduction services.
  • Some studies suggest that this stigma tends to increase with age.

Structural Stigma

Structural stigma is woven into the very fabric of our institutions, policies, and laws.

  • Public Policy: The declaration of the “War on Drugs” in 1971 framed substance use as a criminal justice issue, not a public health one. This led to mass incarceration, disproportionately affecting racial and ethnic minorities, with very low levels of SUD treatment available within the criminal justice system.
  • The Buprenorphine Waiver: The history of the X-waiver itself is an example of structural stigma. We required providers to undergo extra training and special licensing to prescribe a medication to treat OUD. At the same time, no such barriers existed for prescribing the very opioids that often caused the disorder.
  • Lack of Funding and Organizational Policies: Inadequate funding for treatment and harm reduction services is a form of structural stigma. Additionally, stigmatizing policies like mandatory drug testing for employment or housing can penalize individuals in recovery and create barriers to stability.

Individual Stigma and Provider Bias

Individual stigma includes the prejudice and discrimination directed at people with OUD.

  • Stereotypes: Believing that individuals with OUD are “dangerous” or “unpredictable.”
  • Prejudice: Feelings of anger, fear, resentment, and moral outrage toward people with OUD.
  • Discrimination: This can manifest as coercive treatment (“You must stop using completely, or I won’t treat your other conditions”) or social restrictions.
  • Internalized Shame: Individuals with OUD often internalize these negative messages, leading to feelings of worthlessness and hopelessness. Some may also tell them in the recovery community that they are not “truly sober” if they are taking MOUD.

This stigma also presents as provider bias. Studies have shown that some healthcare providers hold negative attitudes toward this patient population, are worried about legal implications, or believe that SUD is a moral failing. The direct consequence is a reduced likelihood that providers will prescribe life-saving MOUD.

The Power of Language: Using Person-First Language to Reduce Stigma

One of the most powerful tools we have to combat stigma is our language. Person-first language reorients our thinking to see the person, not the disease. It is a conscious choice to use words that are objective, medically accurate, and free of judgment.

  • Instead of: “addict” or “junkie” → Use: “person with a substance use disorder” or “person in recovery.”
  • Instead of: “user” or “abuser” → Use: “person who uses drugs” (PWUD) or “person who injects drugs” (PWID).
  • Instead of: “a baby born addicted” → Use: “a baby born with neonatal opioid withdrawal syndrome (NOWS).” A baby cannot have the compulsive behaviors that define addiction; they can, however, experience physiological withdrawal.
  • Instead of: a “clean” or “dirty” urine test → Use: “negative for substance X” or “positive for substance Y.” If a patient’s A1c were high, we wouldn’t call their blood “dirty”; we would state the objective lab result. The same standard should apply here.
  • Instead of: “medication-assisted treatment (MAT)” → Use: “medications for opioid use disorder (MOUD).” This subtle but important shift emphasizes that medication is not merely “assisting” treatment—medication is a primary, evidence-based treatment.
  • Instead of: “abuse” → Use: “misuse” or “use.” The word “abuse” carries heavy connotations of violence and judgment. “Misuse” or “use” are more neutral and medically accurate terms.

Case Study: Putting Person-First Language into Practice

Let’s review a sample case study, first as it might be written with stigmatizing language, and then rewritten using a person-first approach.

  • Original (Stigmatizing) Version:
    • Substance Use History: Patient reports abusing heroin IV from age 20 to 30. Last use of heroin was one month ago after seven years clean.
    • Treatment History: Entered recovery after an overdose. Started medication-assisted treatment.
    • Protective Factors: Regularly involved with the addict community.
    • Family History: She has a female child, nine years old, born addicted to heroin, who is healthy now.

Now, let’s see how different it reads when we apply person-first principles.

  • Revised (Person-First) Version:
    • Substance Use History: The patient reports misusing heroin IV from ages 20 to 30. Last use of heroin was one month ago after seven years of no use.
    • Treatment History: She entered recovery after an overdose and started medications for opioid use disorder (MOUD).
    • Protective Factors: She is regularly involved with the recovery community.
    • Family History: She has a female child, nine years old, who was born with neonatal opioid withdrawal and is healthy now.

The second version is more respectful, medically accurate, and less judgmental. It frames the patient’s history as a medical journey rather than a series of moral failings.

Evidence-Based Treatments: A Toolkit for Recovery

Effective treatment for OUD is multifaceted, combining psychosocial support with pharmacological intervention.

Motivational Interviewing: Partnering with the Patient for Change

Motivational Interviewing (MI) is a collaborative, goal-oriented communication style focused on the language of change. It is designed to strengthen a person’s own motivation for and commitment to a specific goal by eliciting and exploring their own reasons for change in an atmosphere of acceptance and compassion. It is not about confronting or persuading; it is about partnering.

The Spirit of MI

The core philosophy of MI is built on four pillars:

  • Partnership: You are not the expert on the patient’s life; they are. You collaborate with them, supporting them rather than trying to persuade them.
  • Evocation: The motivation for change already lies within the patient. Your job is to evoke it, to draw it out by focusing on their own perceptions, goals, and values.
  • Acceptance: This involves recognizing the patient’s absolute worth, affirming their strengths, supporting their autonomy, and conveying accurate empathy.
  • Compassion: The guiding principle is to act in the patient’s best interest with a non-judgmental, non-blaming, and non-shaming attitude.

The Process of MI

MI generally follows four overlapping processes:

  1. Engaging: Building a strong therapeutic alliance and rapport.
  2. Focusing: Collaboratively identifying a specific goal or target for change. What does the patient want to work on?
  3. Evoking: Eliciting the patient’s own motivations for change. This is the heart of MI.
  4. Planning: Developing a specific, concrete plan for change, exploring options, and building support.

The Tools of MI: OARS and DARN CATS

Motivational interviewing provides helpful acronyms that serve as practical guides for structuring conversations.

OARS represents the core communication skills:

  • Open-ended questions: “Can you tell me a little bit about your recovery journey?” instead of “Have you been to meetings?”
  • Affirmations: Recognizing and acknowledging the patient’s strengths and efforts. “That’s a really creative idea for how to avoid a situation where you might be tempted to use.”
  • Reflective listening: This is the most critical skill. It involves listening carefully and reflecting the meaning of what the patient said. In good MI, the provider should be doing more reflecting than questioning.
  • Summaries: Pulling together the key points of the conversation. “Let me make sure I understand… is that correct?” This shows the patient you are listening and helps to reinforce their own insights.

DARN CATS is an acronym for the different types of “change talk” you want to elicit from the patient.

DARN (The “Preparatory” Change Talk):

  • Desire: “What do you hope our work together will accomplish?”
  • Ability: “What do you think you might be able to change about your opioid use?”
  • Reasons: “Why do you want to stop or cut back your use?” This helps connect the change to the patient’s core values (e.g., “I want to be present for my child’s graduation”).
  • Need: “What needs to happen for you to feel ready to give up opioids?”

CATS (The “Mobilizing” Change Talk):

  • Commitment: “I will start attending meetings.”
  • Activation: “I am ready to reduce my use to two times a week.”
  • Taking Steps: “I’ve already started looking up phone numbers for therapists.”

Listening for this language helps you gauge where the patient is in their readiness for change.

Understanding the Stages of Change

The Transtheoretical Model of Change provides a framework for understanding that readiness is not an all-or-nothing state. People move through different stages on their journey to change.

  1. Precontemplation: The person is not currently considering change. (“I don’t think my drug use is a problem.”)
  2. Contemplation: The person is ambivalent about change, seeing both pros and cons. (“I think my marriage might improve if I reduce my use, but I’m not sure I can handle the stress without it.”)
  3. Preparation: The person is committed to change and is preparing to take action. (“I’ve looked up an NA meeting to attend near my house.”)
  4. Action: The person is actively taking steps to change. (“I reduced the number of days per week I use drugs.” or “I initiated buprenorphine treatment.”)
  5. Maintenance: The person is working to sustain the change and prevent relapse. (“I have been using medications for opioid use disorder for a year now.”)

Identifying a patient’s stage of change allows you to tailor your approach. Trying to force an action plan on someone in pre-contemplation will only create resistance. For that patient, the goal is to start a conversation about the pros and cons.

Non-Pharmacological Management: Building a Support System

Psychosocial support is a critical component of a comprehensive treatment plan. While it should not be mandatory for receiving MOUD, it greatly improves recovery outcomes.

  • Behavioral Therapy: This can be one-on-one therapy with a psychologist, social worker, or licensed counselor. Recovery coaches and peer support specialists also provide invaluable one-on-one support.
  • Group Therapy: Mutual support groups offer a sense of community and shared experience that can be profoundly healing. Options include:
  • SMART Recovery (Self-Management and Recovery Training): Based on principles of Cognitive Behavioral Therapy (CBT) and Rational Emotive Behavior Therapy (REBT).
  • Alcoholics Anonymous (AA) and Narcotics Anonymous (NA): These are 12-step programs that are widely available. While they often have a spiritual or religious component centered on a “higher power,” many groups are very welcoming to diverse beliefs.
  • Secular Organizations for Sobriety (SOS): These offer a non-religious alternative for those who prefer a secular approach.

As a healthcare provider, I strongly encourage my colleagues to attend an open meeting of one of these groups. It provides invaluable insight into the supportive environment you may be recommending to your patients.

Pharmacological Management: Medications for Opioid Use Disorder (MOUD)

To understand how MOUD works, we must first review the basic pharmacology of the opioid receptor. The primary target for opioids is the mu-opioid receptor in the brain. Different substances interact with this receptor in different ways.

  • Full Agonists: These substances bind to and fully activate the mu-opioid receptor. This produces the full opioid effect, including euphoria and, at higher doses, dangerous respiratory depression. Examples include heroin, fentanyl, morphine, and methadone.
  • Partial Agonists: These substances bind to the mu-opioid receptor but activate it only partially. This produces a limited opioid effect that is sufficient to prevent withdrawal and reduce cravings. Still, it has a “ceiling effect,” meaning that beyond a certain dose, the effects do not increase. Buprenorphine is the primary example.
  • Antagonists: These substances bind to the mu-opioid receptor but do not activate it. Instead, they block the receptor, preventing any agonist from binding and having an effect. Naloxone and naltrexone are pure antagonists.

The key takeaway is buprenorphine’s ceiling effect. This property is what makes it a much safer medication for OUD treatment than a full agonist.

Methadone

  • Mechanism: Methadone is a long-acting full mu-opioid agonist.
  • Regulation: It is a Schedule II controlled substance that, for OUD treatment, can only be dispensed through federally certified Opioid Treatment Programs (OTPs).
  • Side Effects: Common opioid side effects include constipation, sedation, dizziness, and sweating.
  • Serious Side Effects: The most significant serious side effect is QTC prolongation, an electrical disturbance in the heart that can lead to fatal arrhythmias. This risk increases at higher doses (generally over 100 mg/day). As a full agonist, it also carries a significant risk of respiratory depression.
  • Contraindications: Acute or severe asthma (due to respiratory risk) and GI obstruction (due to its effect of slowing the gut).

Buprenorphine

  • Mechanism: Buprenorphine is a partial mu-opioid agonist and a kappa-opioid antagonist. It has a very high affinity (strong binding) for the mu-receptor but low intrinsic activity (it only partially activates it).
  • Key Properties:
    • Its high affinity means it can displace full agonists like heroin or fentanyl from the receptor. This is why initiating it requires the patient to be in a state of moderate withdrawal. If given when a person has a full agonist in their system, it will “bump off” the full agonist and rapidly lower receptor activation, causing a severe, abrupt withdrawal known as precipitated withdrawal.
    • Conversely, if a person is already in withdrawal (low receptor activation), buprenorphine will bind and bring the activation up to its ceiling level, relieving withdrawal symptoms.
    • It reduces cravings but does not provide the intense euphoria of full agonists due to its ceiling effect.
  • Side Effects: Headache, constipation, nausea, oral hypoesthesia (numbness in the mouth from sublingual formulations).
  • Serious Side Effects: While much lower than with full agonists, there is still a risk of respiratory depression, especially when combined with other central nervous system depressants like benzodiazepines or alcohol. Other rare but serious effects include hepatotoxicity.
  • Drug Interactions:
    • Benzodiazepines: This combination increases the risk of respiratory depression. However, the FDA has issued guidance stating that the benefits of treating OUD with buprenorphine in a patient taking benzodiazepines outweigh the risks of withholding it, as the alternative (illicit fentanyl use) carries a much higher risk of overdose. Patients should be counseled on the risks and monitored closely.
    • CYP3A4 Inhibitors (e.g., erythromycin, grapefruit juice): These will slow the metabolism of buprenorphine, increasing its concentration.
    • CYP3A4 Inducers (e.g., rifampin, St. John’s wort): These will speed up the metabolism of buprenorphine, decreasing its concentration.

Naloxone

  • Mechanism: Naloxone is a pure opioid antagonist. It is the primary medication used to reverse an opioid overdose.
  • Use in Combination Products: You will often see buprenorphine formulated in combination with naloxone (e.g., Suboxone). The purpose of the naloxone in this oral formulation is as a deterrent to misuse. When taken sublingually as directed, the naloxone has very poor bioavailability and has no effect. However, if a person were to crush and inject the tablet, the naloxone would be bioavailable. It would block the opioid receptors, preventing the buprenorphine from working and potentially causing withdrawal.
  • Use in Overdose Reversal: Naloxone has a shorter half-life than most opioids. This is critically important. When you administer naloxone to someone who has overdosed on fentanyl, the naloxone will knock the fentanyl off the receptors and reverse the respiratory depression. However, the naloxone will wear off in 30-90 minutes, while the fentanyl is still present in the body. When the naloxone is gone, the fentanyl can re-bind to the receptors and cause the overdose to resume. This is why it is essential to call 911 and seek emergency medical care even after naloxone has been administered.
  • Side Effects: If given to someone with opioids in their system, it will induce an acute opioid withdrawal syndrome (tachycardia, irritability, fever, nausea, vomiting, diarrhea). If given to someone without opioids in their system, it has no effect.
  • Formulations:
    • Intranasal: Commonly known by the brand name NARCAN, it is available as a 4 mg/0.1 mL nasal spray. Education should include giving one dose in one nostril, waiting 2-3 minutes, and if there is no response, giving the second dose (from the second device in the box) in the other nostril.
    • Injectable: Often used by EMS personnel.

Naltrexone

  • Mechanism: Naltrexone is a mu and kappa opioid receptor antagonist. It completely blocks the opioid pathway. It is also used for Alcohol Use Disorder.
  • Use in OUD: It reduces cravings and, by blocking the receptors, prevents a person from feeling any effect if they do use opioids.
  • Important Consideration: A patient must be completely opioid-free for 7-10 days before starting naltrexone. If given sooner, it will precipitate a severe withdrawal. Patients also need to understand that if they are on naltrexone, standard opioid pain relief will not work in an emergency or surgical situation.
  • Side Effects: Headache, nausea, diarrhea, and injection-site reactions with the long-acting formulation.
  • Serious Side Effects: Rare but serious risks include acute hepatitis, eosinophilic pneumonia, and depression. Liver enzymes should be monitored.
  • Formulations:
    • Injectable (Vivitrol): A 380 mg extended-release injectable suspension given as a deep IM gluteal injection once a month.
    • Oral (PO): Typically dosed at 50 mg daily.

Harm Reduction: A Pragmatic and Life-Saving Approach

Harm reduction is a set of practical strategies and ideas aimed at reducing the negative consequences associated with drug use. It is a movement for social justice built on a belief in, and respect for, the rights of people who use drugs. It is about meeting people where they are, without judgment.

  • Naloxone Co-prescribing: I make it a practice to co-prescribe naloxone to any patient who uses drugs (not just opioids) or is on prescription opioids for chronic pain. The illicit drug supply is so contaminated that even people who think they are using cocaine or methamphetamine are at risk of a fatal fentanyl overdose. Their family and friends must be trained on how to use it.
  • Fentanyl Test Strips: These are small, inexpensive strips of paper that can detect the presence of fentanyl in a drug supply. Providing these to patients allows them to test their drugs before using them. Discovering that their supply is contaminated with fentanyl can be a powerful motivator to change their use or seek treatment.
  • Never Use Alone Hotline: This is a service where a person can call a confidential hotline before they use drugs. They provide their location, and an operator stays on the line. If the person becomes unresponsive, the operator calls emergency services to that location.
  • Clean Needle Exchanges (Syringe Service Programs): These programs provide sterile syringes and other injection equipment to people who inject drugs. They are proven to dramatically reduce the transmission of bloodborne pathogens like HIV and Hepatitis C, and they also serve as vital access points to connect people with treatment and other health services.
  • Urine Drug Screens (UDS): A UDS should not be used as a punitive tool. It is a therapeutic tool. A patient may tell you, “I don’t use fentanyl,” and genuinely believe it. When their UDS comes back positive for fentanyl, it opens the door for a non-judgmental conversation: “It looks like your heroin supply might have fentanyl in it. That’s incredibly dangerous. Let’s talk about how to keep you safe.”
  • Prescription Drug Monitoring Programs (PDMPs): These state-level electronic databases track controlled-substance prescribing. They are an essential tool for providers to ensure coordinated, safe care and to identify patients who may be receiving prescriptions from multiple sources.
  • Motivational Interviewing: As discussed, MI is itself a form of harm reduction. It prioritizes the patient’s own goals, which may not be immediate abstinence but could be a smaller step like “not sharing needles” or “using less frequently.”

In my own practice, integrating these harm reduction strategies with chiropractic care and functional medicine is key. By reducing a patient’s pain through manual therapies, we reduce their reason to seek out opioids. By optimizing their nutrition and gut health, we improve their mental clarity and resilience. This holistic approach, guided by Dr. Cardenas’s medical expertise, embodies the principle of meeting patients where they are and offering every available tool to move toward a healthier life.

Conclusion: A Path Forward

The history of opioids provides a crucial context for understanding the modern OUD crisis. It is a story of medical innovation intertwined with profound social and legal consequences. Stigma remains one of the most significant and damaging barriers to care. Still, we can actively combat it through our language and our commitment to treating OUD as the chronic medical condition it is.

Fortunately, we have a growing arsenal of effective, evidence-based treatments. These include life-saving medications for opioid use disorder (MOUD), powerful psychosocial tools like motivational interviewing, and pragmatic, life-affirming harm reduction techniques.

At Injury Medical Clinic, our multidisciplinary approach embraces this complexity. By weaving together the diagnostic acumen of internal medicine, the biomechanical focus of chiropractic care, the systems-based approach of functional medicine, and a deep commitment to evidence-based OUD treatment, we can offer our patients a comprehensive and compassionate path to recovery.

If you have any questions, please feel free to reach out. Thank you for taking the time to engage with this important topic.

References and Further Reading

SEO Tags: Opioid Use Disorder, OUD Treatment, Integrative Chiropractic Care, Dr. Alex Jimenez, Dr. Maria Cardenas, El Paso TX, Functional Medicine, MOUD, Buprenorphine, Methadone, Naltrexone, Naloxone, Opioid Crisis, Harm Reduction, Motivational Interviewing, Person-First Language, Stigma, Substance Use Disorder, Chronic Pain Management, Personal Injury Care, DSM-5, Fentanyl, Heroin, Prescription Opioids, Overdose Prevention, Recovery, Multidisciplinary Clinic

Missed MVA and Workplace Injuries Causing Pain Solutions

By
Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP
-
Missed MVA and Workplace Injuries Causing Pain Solutions
Missed MVA and Workplace Injuries Causing Pain Solutions

Missed MVA and Workplace Injuries Causing Pain

Abstract

Motor vehicle accidents (MVAs) and workplace accidents can cause injuries that are not obvious during the first medical visit. A person may have normal X-rays and still have pain from damaged muscles, ligaments, spinal discs, facet joints, nerves, or other soft tissues. Mild traumatic brain injuries, including concussions, may also occur without obvious findings on routine imaging. Some symptoms develop hours or days later.

This article explains why hidden injuries can be difficult to identify, including spinal ligament micro-tears, annular disc tears, facet joint capsule injuries, myofascial trigger points, and mild concussions. It also explains how a coordinated approach may combine medical evaluation, integrative chiropractic care, rehabilitation, functional medicine, pain management, and selected biological therapies. At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, works within a multidisciplinary model that includes medical oversight from Dr. Maria Guadalupe Cardenas, MD.

Missed MVA and Workplace Injuries Causing Pain Solutions

Why Some Accident Injuries Are Hard to See

After a car crash, fall, lifting injury, or workplace accident, the first goal is usually to rule out emergencies. Doctors may look for fractures, internal bleeding, severe brain injury, spinal cord damage, or other dangerous problems.

This emergency approach is important. However, a normal initial test does not always mean that every tissue is healthy.

Plain X-rays are mainly designed to show bones and their general alignment. They do not provide the same soft-tissue detail as MRI. Therefore, injuries involving muscles, tendons, ligaments, spinal discs, nerves, and joint capsules may require a different type of evaluation when symptoms continue.

The American College of Radiology notes that when ligament, spinal cord, or nerve-root injury is suspected after spinal trauma, MRI may be appropriate even when other imaging has already been performed (American College of Radiology, n.d.).

Several accident-care resources also describe delayed or overlooked symptoms after crashes, especially with whiplash, soft-tissue injuries, back injuries, and concussions (Advantage Healthcare Systems, 2025; Xcell Medical Group, 2026).

The key message is simple: a normal X-ray is useful information, but it does not rule out every possible injury.

Spinal Ligament Micro-Tears

Ligaments are strong bands of tissue that connect bones and help stabilize joints.

During a rear-end collision, side impact, fall, or sudden workplace accident, the spine can move rapidly beyond its normal range. This may stretch or injure the small ligaments that help stabilize the neck and lower back.

A person may develop:

  • Neck or back stiffness
  • Pain with movement
  • Headaches
  • Muscle guarding
  • Reduced range of motion
  • A feeling that the spine is weak or unstable
  • Pain that becomes worse with sitting, lifting, or repetitive work

Whiplash-related soft-tissue injuries may not produce an obvious abnormality on a basic X-ray. Careful history, physical examination, neurological testing, and additional imaging may be needed when symptoms or examination findings justify it (Advantage Healthcare Systems, 2025).

Annular Tears in Spinal Discs

Intervertebral discs sit between the spinal bones. Each disc has a softer center surrounded by a stronger outer ring called the annulus fibrosus.

Sudden twisting, bending, compression, or acceleration-deceleration forces can stress this outer ring. Small separations in the fibers are called annular fissures or annular tears.

Some annular tears cause no symptoms. Others may contribute to back or neck pain, especially when nearby structures become irritated. Annular tears can also exist with disc bulges or herniations (Tenny et al., 2023).

Because discs are soft tissues, plain X-rays cannot directly show an annular tear. When clinically appropriate, MRI can provide much more information about discs, nerves, ligaments, and other soft tissues.

This is one reason persistent pain after a normal X-ray deserves a complete clinical assessment rather than assuming nothing is wrong.

Hidden Facet Joint Capsule Trauma

Facet joints are small joints located at the back of the spine. They guide spinal movement and help control excessive motion.

Each facet joint is surrounded by a capsule made of connective tissue. During whiplash or another sudden injury, the capsule can stretch or become irritated.

Facet-related pain may cause:

  • Local neck or back pain
  • Pain with turning or bending
  • Pain that spreads into the shoulders or upper back
  • Headaches associated with neck movement
  • Muscle tightness around the injured area

Research on whiplash has identified the cervical facet region and its supporting tissues as possible sources of persistent neck pain after trauma.

Because the injury can involve soft tissues rather than a broken bone, it may not be visible on standard X-rays.

Persistent Myofascial Trigger Points

Muscles can also become part of the injury pattern.

After trauma, muscles often tighten to protect an injured joint or spinal segment. Sometimes painful areas develop within these muscles. These areas are commonly called myofascial trigger points.

Trigger points may produce:

  • Deep aching pain
  • Muscle stiffness
  • Referred pain
  • Headaches
  • Shoulder or back discomfort
  • Reduced movement

A study comparing people with whiplash-associated disorders with people who had mechanical neck pain found more active myofascial trigger points in the whiplash group (Castaldo et al., 2014).

This helps explain why a person can have continuing pain even when a basic X-ray does not show a fracture.

Mild Concussions Can Be Difficult to Recognize

A concussion does not always require a direct blow to the head.

The Centers for Disease Control and Prevention explains that mild traumatic brain injury can result from a blow to the head or from a hit to the body that makes the head and brain move rapidly back and forth (Centers for Disease Control and Prevention [CDC], 2025).

Symptoms can include:

  • Headache
  • Dizziness
  • Brain fog
  • Memory problems
  • Trouble concentrating
  • Light or noise sensitivity
  • Sleep changes
  • Nausea
  • Balance problems
  • Irritability

Importantly, concussion is usually a clinical diagnosis. Routine CT or MRI is not required to diagnose most mild concussions. Imaging is generally used when a doctor is concerned about problems such as bleeding or another more serious brain injury (CDC, 2025).

This means that a person can have a real concussion even when structural brain imaging is normal.

Workplace Injuries May Develop Slowly

Not every workplace injury occurs during one dramatic event.

Workers may experience cumulative trauma from:

  • Repetitive lifting
  • Bending and twisting
  • Frequent reaching
  • Computer work
  • Vibrating tools
  • Repeated overhead work
  • Poor lifting mechanics
  • Long periods of standing or sitting

These repeated stresses can gradually affect joints, muscles, tendons, and other tissues.

Workplace injury resources describe sprains, strains, repetitive stress injuries, and cumulative trauma as important causes of work-related pain and disability (Bridgman Gantt Law Offices, 2025; Stern & Cohen, n.d.).

A worker may therefore have a significant physical problem even without one clearly remembered accident.

Finding the Injury Requires More Than One Test

A complete injury evaluation begins with the patient, not the image.

Depending on the situation, the healthcare team may evaluate:

  • How the accident happened
  • Direction and force of impact
  • Location and timing of symptoms
  • Range of motion
  • Muscle strength
  • Reflexes
  • Sensation
  • Balance
  • Gait and posture
  • Joint stability
  • Orthopedic findings
  • Neurological findings
  • Changes in work or daily function

Imaging is then selected according to the clinical findings.

X-ray, CT, and MRI are different tools. No single test can identify every injury.

Integrative Chiropractic Care: Restoring Mechanical Function

Once serious injuries have been ruled out and the diagnosis is better understood, recovery often requires more than simply reducing pain.

Integrative chiropractic care can focus on restoring the way the body moves.

Depending on the diagnosis and patient, care may include:

  • Gentle chiropractic adjustments or mobilization
  • Soft-tissue treatment
  • Range-of-motion exercises
  • Corrective exercise
  • Strengthening
  • Neuromuscular retraining
  • Posture and movement correction
  • Progressive rehabilitation

Clinical guidelines for neck pain recommend a combination of manual therapy, mobility exercises, and strengthening for appropriate patients rather than depending solely on passive treatments (Blanpied et al., 2017).

The goal is not simply to “put a bone back into place.” It is to improve movement, reduce unnecessary mechanical stress, rebuild strength, and help the patient return safely to normal activity.

Combining Mechanical Restoration With Biological Support

An integrative injury model can look at two major parts of recovery:

Mechanical restoration focuses on movement, spinal and joint function, strength, flexibility, and rehabilitation.

Biological support focuses on the injured tissue itself and the physical conditions needed for healing.

Depending on the diagnosis, this broader plan may include rehabilitation, nutrition, sleep support, medical management, image-guided procedures, or selected orthobiologic procedures.

PRP and other biologic approaches are being studied and used for selected musculoskeletal conditions. However, patients should understand that evidence varies greatly by tissue, diagnosis, procedure, and product. Regenerative treatments should not be presented as guaranteed ways to rebuild damaged spinal tissue.

The FDA also warns consumers that many marketed stem-cell, exosome, and other human cell or tissue products have not been approved for orthopedic conditions such as back pain, neck pain, disc disease, tendon problems, or joint pain.

Medical screening and informed decision-making are therefore essential.

Multidisciplinary Injury Care in El Paso

At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, describes a clinical model that combines chiropractic care, medical evaluation, functional medicine, personal injury care, rehabilitation, and related services.

In his published clinical observations, Dr. Jimenez reports that patients with traumatic joint and spinal injuries may show changes in posture, gait, muscle control, and spinal movement in addition to pain at the injured site. His approach therefore looks beyond one painful structure and evaluates how the injury affects the larger movement system (Jimenez, 2026). These observations represent his clinical experience and should be distinguished from controlled clinical research.

Clinic materials identify Dr. Maria Guadalupe Cardenas, MD, as a board-certified internal medicine physician, Medical Director, and Collaborative Physician at Injury Medical Clinic PA. The clinic lists her NPI as 1164426749 and Texas medical license as J2933 and describes her as having more than 40 years of experience in internal medicine.

Within this multidisciplinary structure:

  • Dr. Jimenez focuses on chiropractic care, musculoskeletal assessment, functional medicine, personal injury care, and rehabilitation.
  • Dr. Cardenas provides medical direction and collaborative physician oversight within her scope of practice.
  • Rehabilitation helps restore strength, movement, coordination, and work capacity.
  • Functional medicine may examine nutrition, sleep, metabolic health, and other factors that can influence overall recovery.
  • Medical or interventional options can be considered when conservative treatment alone is not enough.

Multidisciplinary pain and injury programs may similarly combine medical treatment, rehabilitation, exercise, and complementary approaches when appropriate for the individual patient.

The Main Lesson: Normal X-Rays Do Not Always End the Investigation

After an MVA or workplace injury, some problems are obvious. Others are not.

Soft-tissue injuries, ligament sprains, annular disc injuries, facet joint irritation, myofascial pain, and mild concussion symptoms may require careful clinical examination and, in selected cases, different imaging or specialist evaluation.

The best approach is not to assume that every person with pain has a hidden injury. It is also not safe to assume that a normal X-ray means all tissues are normal.

A better approach is to connect the accident mechanism, symptoms, examination findings, imaging, and response to treatment.

For appropriate patients, coordinated care can then combine mechanical restoration through chiropractic and rehabilitation with medical oversight and evidence-based biological support. This gives the healthcare team a broader view of both the damaged tissue and the way the whole body is functioning after an accident.

El Paso, TX Cervical Pain Treatment Chiropractic Care

References

American College of Radiology. (n.d.). ACR Appropriateness Criteria: Acute spinal trauma.

Advantage Healthcare Systems. (2025). The hidden soft-tissue injuries most people miss after a car accident.

AlpernSchubert, P.C. (n.d.). What are the most commonly overlooked car accident injuries?.

Blanpied, P. R., Gross, A. R., Elliott, J. M., Devaney, L. L., Clewley, D., Walton, D. M., Sparks, C., & Robertson, E. K. (2017). Neck pain: Revision 2017 clinical practice guidelines. Journal of Orthopaedic & Sports Physical Therapy, 47(7), A1–A83.

Bridgman Gantt Law Offices. (2025). 5 common injuries that lead to a workers’ comp claim.

Castaldo, M., Ge, H.-Y., Chiarotto, A., Villafañe, J. H., & Arendt-Nielsen, L. (2014). Myofascial trigger points in patients with whiplash-associated disorders and mechanical neck pain. Pain Medicine, 15(5), 842–849.

Centers for Disease Control and Prevention. (2025). About mild TBI and concussion.

Edwards & Ragatz, P.A. (2025). 3 commonly misdiagnosed conditions that could put you at risk.

Horwitz, Horwitz & Associates. (2020). Common overlooked workplace injuries to be on the lookout for.

Jimenez, A. (2026). Integrative chiropractic and regenerative medicine in El Paso.

Jimenez, A. (2026). MVA joint trauma: Comprehensive chiropractic approaches.

Jimenez, A. (2026). Regenerative medicine and integrative chiropractic strategies.

Jimenez, A. (2026). How regenerative medicine and chiropractic care work together.

Jimenez, A. (n.d.). Dr. Alex Jimenez: El Paso chiropractor and personal injury care.

Cohn, J. (n.d.). Regenerative orthopedics: PRP, stem cells, and healing from within.

MHK Attorneys. (n.d.). Top 5 personal injury claims that often go undetected.

Morgan & Morgan. (2025). 15 work injuries you may not know about.

Ramos Center. (n.d.). Non-surgical pain management: Eight treatment approaches.

Sherwood Law Group. (n.d.). Personal injury cases that often get overlooked but shouldn’t.

Stern & Cohen. (n.d.). Workplace cumulative trauma and your right to compensation.

U.S. Food and Drug Administration. (2021). Important patient and consumer information about regenerative medicine therapies.

Virtaj Singh, MD. (n.d.). Radiculopathy (pinched nerve).

Xcell Medical Group. (2026). The most overlooked injuries after a crash.

Zlotolow & Associates. (n.d.). Five easily missed injuries common in personal injury cases.

1...345...166Page 4 of 166